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ABSTRACT 
Approximately one in twenty men has impaired spermatogenesis due to mutation of genes 
involved in the establishment or maintenance of fertility. Our understanding of male 
infertility is complicated by the variable phenotypes produced by similar genetic changes, 
largely due to the practise of screening a single fertility gene in isolation. 
This thesis aimed to increase our understanding of the role of synergistic mutations in 
relation to differences in semen quality. Each sample was analysed for mutation in: CAG 
trinucleotide repeat variation in the X-linked androgen receptor (AR) gene, micro-
deletion within the three Y chromosome azoospermic factor (AZF) regions, and CAG 
trinucleotide repeat variation and exonuclease domain mutation in the nuclear 
polymerase gamma (POLn gene. These genes have been associated with reduced semen 
quality in past research. 
Each gene region was amplified by polymerase chain reaction (PCR), followed by 
sequencing. Suspected AZF micro-deletions were confirmed by Southern blot 
hybridisation. Associations with semen quality were evaluated using either a t-test or G-
test for independence at a=0.05. 
Yq AZF micro-deletions were observed in 6.6% (141211) of men with poor semen quality 
but not in normozoospermic samples (0(104); P<O.OOl). Micro-deletion frequency was 
greatest in azoospermic and severely oligoasthenozoospermic individuals (15% and 11.5%, 
respectively) . 
AR CAG repeat length ranged from 9-38 CAG repeats in the normozoospermic 
population (n=98) and 13-31 CAG repeats in men with poor semen quality (n= 119). 
Variation in AR CAG trinucleotide repeat number was not significantly related to poor 
semen quality (P>0.05). 
Variation in POLy CAG repeat number was not significantly different between 
normozoospermic men (n=93) and men with poor semen quality (n= 182); P>0.05. No 
nucleotide changes were observed in any of the three POLyexonuclease motifs (n=83 
normozoospermic and 191 non~normozoospermic motifI, 61 and 65 motif II, and 60 and 
64 mo tif III). 
Although most gene regions did not show an association with poor semen quality on their 
own, there was a general trend towards greater severity of impaired spermatogenesis with 
the presence of both Yq micro-deletion and mitochondrial DNA substitutions or 
moderately expanded AR CAG repeats. These results support the idea that male 
infertility is a complex process, due to many factors, some of which act dominantly and 
others act in concert. 
vi 
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Chapter One - Introduction 
1.1 Introduction 
The majority of idiopathic male infertility cases are thought to be due to genetic changes 
in one or more genes involved in the establishment and maintenance of male sexual 
characteristics and sperm production (De Kretser and Baker 1999; Yong et al. 2000a). 
Frequently, studies of male infertility are hampered by the considerable variation observed 
in fertility status resulting from seemingly similar gene mutations (De Kretser and Baker 
1999). In addition, many associations between gene mutation and reduced semen quality 
are considered controversial, showing population specific correlations (Erasmuson et al. 
2003). Although recent research indicates there are an enonnous number of genes with 
testes specific expression that are predicted to be involved in the establishment and 
maintenance of sperm production, most research focuses on associations between a 
particular gene mutation and reduced semen quality in isolation; very few studies have 
analysed a set of candidate fertility genes at once. My thesis research aims to analyse 
several gene regions known or suspected to be involved in normal fertility in a single 
population of men: the X chromosome androgen receptor gene (AR), the Y chromosome 
azoospermic factor (AZF) region, and the nuclear polymerase gamma (POL-lJ gene whose 
gene product has an important role in mitochondrial DNA replication. 
These three genes were chosen to cover important areas of fertility research. The Y 
chromosome has been well studied, and recently DNA sequenced, it is important not only 
for sex determination but semen quality as well (Skaletsky et al. 2003). The X 
chromosome is the homologous partner to Y, although they share very little identical 
sequence and so cannot recombine. Recently nine novel testis-specific genes been found 
on the X chromosome demonstrating it plays an important role in influencing male semen 
quality (Wang et al. 2001). The AR gene is X-linked but involved in male sexual 
development (Loy and Yong 2001). Similarly, the POLygene is autosomal but is involved 
in replicating the mitochondrial genome which plays an essential role in cellular energy 
production (Longley et al. 1998). High frequencies of mitochondrial DNA mutation have 
been implicated in defective sperm function due to a reduction in electron transport 
2 
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chain enzyme activity (Ruiz-Pesini et al. 1998). It is hypothesised that errors in replication 
might contribute to the elevated number of single nucleotide polymorphism of the 
mitochondrial genome (Holyoake et al. 2001). Both the Y chromosome and 
mitochondrial genome generate enormous research interest; and the discovery of fertility 
genes on X has renewed research interest in it. 
1.1.1 Male Fertility 
Male sexual development is a complex process involving the interaction of numerous 
gene products and pathways, many of which have not been characterised, others whose 
role is ambiguous, and more that we have not yet identified. Recently more than a 
thousand novel testes-specific genes were discovered by expression analysis in mouse 
spermatogonia (Wang et al. 2001; Schultz et al. 2003). A surprising number of these were 
encoded on the X chromosome and expressed in premeiotic male germ cells suggesting a 
role in spermatogonial cell establishment and proliferation (Wang et al. 2001). 
Importantly, this indicates that females playa larger role in shaping the fertility status of 
men than ever before suspected, because akin to mitochondrial DNA, these factors are 
inherited through the female lineage since X carrying sperm create female embryos 
(Wang et al. 2001). Hence, although the Y chromosome encodes more than just the male 
determining gene SRY, it does not hold the monopoly on spermatogenesis genes, and like 
male pattern baldness the mother is an important determinant of male fertility, yet 
indicators of abnormality may not be apparent in her. 
Male infertility affects approximately one in twenty men (De Kretser and Baker 1999; 
Yong et al. 2000b). Rarely is the cause attributable to an obvious clinical condition, such 
as cryptorchidism, testicular atrophy, epididymal obstructions, or infections; more often, 
the reason for poor semen quality is unexplained; otherwise known as idiopathic male 
infertility. For these men the underlying basis is likely to be due to genetic mutation of a 
gene whose normal function is essential for nonnal sperm production, however diagnosis 
is hindered by the defiCits in our understanding and knowledge of the genes involved in 
3 
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fertility (Yong et a1. 2000b; Mclachlan and de Kretser 2001). Diagnosis is further 
complicated by the fact that semen quality does not always explain fertility status, since 
men with normozoospermia can be infertile and men with reduced semen quality can 
father offspring without medical intervention (Matzuk and Lamb 2002; Thangaraj et a1. 
2003; Jensen et a1. 2004). 
The use of animal models such as Drosophila and mouse has aided our understanding of 
the roles of specific genes in germ cell establishment and maturation. Saturation 
mutagenesis screening in Drosophila gave weight to the idea that infertility can result 
from the combined effect of mutation in many genes (Hack stein et a1. 2000). The ability 
to manipulate the mouse genome has provided a means of deciphering the order of events 
in meiosis, allowed the creation of mouse models of diseases that show associated 
infertility, identified important signalling pathways and proteins involved in reproduction 
and faciliated targeted deletion of candidate spermatogenesis genes in order to determine 
function (Cooke and Saunders 2002; Matzuk and Lamb 2002). More than 200 mouse 
models of infertility have been created contributing to our understanding of male 
gametogenesis and reproduction using targeted gene disruption and chemical 
mutagenesis, and even spontaneous mutants, such as hypo gonadal (bpg) and testicular 
feminisation (tlin) (Matzuk and Lamb 2002; BaJ;chi andJasin 2003; Libby et a1. 2003). 
In addition mouse models can be used to trial potential infertility treatments; currently 
germ cell transplantation is showing promise as both a means of expressing gene mutation 
and preserving the reproductive capacity of young men undergoing cancer treatment or 
infertility (Cooke and Saunders 2002; Shinohara et a1. 2003). 
1.1.2 The Testes 
In addition to germ cells the testes contain two other important cell types; Leydig cells, 
which produce male sex androgen (testosterone), and Sertoli cells. Sertoli cells are a fixed 
population of non dividing cells that are linked by tight junctions to fonn a physical 
4 
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barrier between the body's circulatory system and the testicular environment so that male 
germ cells are maintained in an immunologically privileged location (Browderet a1. 1991; 
Shinohara et a1. 2003). This separation is necessary because spermatogenesis begins at 
puberty long after the body's immune system has developed; if no barrier existed, sperm 
cells would be recognised as foreign bodies and eliminated by the immune system. Sertoli 
cells produce androgen-binding protein which transports testosterone intracellularly and 
acts as a testosterone reservoir within the seminiferous tubule, maintaining a high level of 
testosterone around the developing spermatocytes (Browder et a1. 1991). 
Germ cells are arranged specifically according to the maturation stage within seminiferous 
tubules. Spermatogonia (stern cells) and young spermatocytes are near the basal layer 
close to Sertoli cells; as they mature they progress towards the centre of the tubule for 
transport into the lumen and the epididymus (Browder et a1. 1991). 
1.1.3 Spermatogenesis 
Spermatogenesis involves three specific phases: proliferation of spermatogonia, meiosis, 
arid spermiogenesis; at· any stage abnormal fUf\ction can result in reduced sperm 
production (Matzuk and Lamb 2002). In the initial stages of spermatogenesis, 
spermatogonia divide by mitosis generating two daughter cells, one that remains to divide 
again (self-renewal) and a primary spermatocyte that enters the first meiotic division to 
produce secondary spermatocytes, and then the reductive meiotic division to produce 
round, haploid spermatids (Figure 1.1) (Foresta et a1. 2001). 
Spermatogonia have the highest proliferation rate in the body; A balance between 
apoptosis stimulating and inhibiting proteins is essential for normal· germ cell 
establishment. Female primordial follicles, which proliferate only in the developing 
embryo, produce a finite quantity of oocytes. In contrast, male germ cells proliferate 
throughout the lifetime of a male. The spermatogonia of a 40 year old man have 
5 
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replicated 26 times that of a female ovum (Figure 1.1). It is this difference that is thought 
to result in the higher rate of base substitution in males than females (Crow 2000). 
1 f 1 
1 , • "' . ". 
1 
'h ! 
... 
, , 
': '1 t ' '~ 
., ..... 
.. 
I " I._I 
Figure 1.1. Cell divisions during oogenesis and spennatogenesis. The total replicative cell divisions 
in the life of an ovum is 23. In males the total nwnber is dependant on the age of the man. S, stern 
cell; G, gonia I cells; M, meiotic cells. Reproduced from Crow (2000). 
~ . 
. , 
~ ...... 
Spermatozoa are specialized cells, dedicated to fertilisation of the oocyte (Figure 1.2) 
(Vernet et al. 2004). The spenn cells that are released from the genninal epithelium of 
the mammalian testis are unable to fertilise an oocyte (without the aid of artificial 
reproductive techniques) (Aitken et al. 2004). Immature spennatids acquire functional 
competence during two post-testicular maturation stages (Aitken et al. 2004). Spennatids 
undergo the first stage of maturation as they travel along the epididymus which results in 
nuclear condensation and a reduction in cytoplasm content, replacement of histone 
proteins with protamines, formation of the acrosome, arrangement of mitochondria in the 
midpiece, and motility (Foresta et al. 2001; Jimenez et al. 2004; Vernet et al. 2004). In 
humans it takes approximately 10 days for spennatozoa to reach the storage area at the 
end of the epididymidis (Vernet et al. 2004). 
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J.-__ -_~------JI L-..JL......J 
Tail Mid Head 
Figure 1.2. A hwnan spenn cell. Microscope image on left Gimenez et al. 2004), and schematic 
representation on right. Mature sperma tids have three parts, the head, midpiece (Mid), and tail. 
Within the head is the acrosome vesicle. Mitochondria are arranged in a helix surrounding a 
central axial filament in the midpiece. 
The second stage; capacitation, occurs only once speml cells have entered the female 
reproductive tract (Taylor 200 1; Aitken et a1. 2004). The molecular basis of Speffil 
capacitation is believed to involve the establishment of a unique, cell-specific signal 
transduction pathway involving a redox-regulated, cAMP-mediated, tyrosine 
phosphorylation cascade (Aitken 1997; Aitken et a1. 2004). The initial stages of 
capacitation involve a rise in intracellular calcium and cAMP levels, the production of 
ROS, and the development of highly vigorous movement (hyperactivation) (Aitken 
1997). The production of low levels of ROS seems to be important in the initiation and 
regulation of tyrosine phosphorylation since scavenging of H20 Z results in a loss of 
spermatocytesensitiviry to progesterone and wna-pellucida glycoproteins (Aitken 1997). 
The final stage of capacitation involves the influx of calcium into the sperm head in two 
waves (Aitken 1997; Tomes et a1. 2004). 
Thus once spennatocyres reach the oocyte they are primed for action, but in order to 
penetrate the oocyte (and achieve fertilisation), they mu~;t undergc; d'c acrosoffi'~ reaction 
(Aitken 1997). The acrosome is a membrane-bound vesicle that overlies the nucleus of 
the mature speffilatozoon (Figure 1.3) (Tomes et a1. 2004). Speffil cells undergo the 
acrosome reaction upon contact with progesterone, in the surrounding follicular flUid, or 
glycoproteins (ZP3) of the oocyte zona-pellucida (Gonzalez-Martinez et a1. 2002). This 
triggers fusion of the acrosome vesicle with the sperm plasma membrane followed by 
exocytosis of the acrosomal contents (hydrolytic enzymes) allowing the spemlatocyte to 
7 
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pass through the zona-pellucida and fuse with the oocyte plasma membrane Oaiswal et a1. 
1998; Gonzalez-Martinez et a1. 2002). 
Figure 13. Staining of the acrosome vesicle. A spcnnatid showing staining of the tail (red) and 
acrosome vesicle (yellow) in the spenn head. A scale line of 3/-Lm is given. Reproduced from 
Tomes et al. (2004). 
The ability of the spennatocyte to fuse with the oocyte membrane is enhanced by a speml 
plasma membrane rich in polyunsaturated fatty acids (Vemet et a1. 2004). However, this 
leaves spemlatozoa susceptible to lipid peroxidation as a result of reactive oxygen species 
(ROS) attack. Paradoxically, evidence suggests spenn cells actively produce low 
concentrations .of ROS (°2_, and H20 2) presumably because they play an important 
positive role in the regulation of capacitation and actually enhance the ability of 
spermatocytes of fuse with the oocyte membrane (Aitken et a1. 1989; Vemet et al. 2004). 
This necessitates a balance between ROS production and scavenging, since high 
concentrations of ROS damage sperm cells but removal inhibits capacitation and 
fertilisation (Taylor 2001; Aitken et a1. 2004). 
1.1.4 Artificial Reproductive Techniques 
Low numbers of mature sperm can be found even in awospermic men. These spenn are 
capable of achieving fertilisation when injected directly into an egg, in a process called 
intracytoplasmic sperm injection (lCSI) (Mulhall et a1. 1997). It was presumed that 
epididymal and especially testicular spenn lacked the ability to fertilise an oocyte since 
testicular spenn had not undergone the necessary maturation changes (formation of the 
acrosome, and chromatin and protein changes) and neither type of sperm cell has 
undergone capacitation within the female reproductive tract. However, the relative 
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success of artificial reproductive techniques (ART) suggests that the changes that take 
place during maturation and capacitation are not absolutely necessary for normal 
embryonic development (Okabe et al. 1998). Hence the advent of ART has removed the 
selection pressure on fertility. However, it seems unlikely that this practise will increase 
the quality of sperm in future generations; we may only be prolonging the existence of 
deleterious traits in our gene pool. Widespread concern surrounds the possibility that 
infertility-causing genetic mutations could be passed from father to sons or grandsons who 
then have a greater likelihood of experiencing infertility as adults (Aitken et al. 1998; De 
Kretser and Baker 1999; Foresta et al. 2001) . 
. 1.2 Thesis Research Aims 
The objective of my thesis was to elucidate the role of mutation in a number of genes 
known or suspected to perform a vital role in male fertility, in a single population of 
males, in an effort to better understand why such variation in semen quality exists. The 
research aimed to establish how the frequency of synergistic mutations (multiple 
mutations in several fertility genes) relates to the occurrence and severity of impaired 
spermatogenesis by analysing the following three gene regions for the presence or absence 
of mutation: (1) Micro-deletion within the three Y chromosome azoospermic factor 
(AZF) regions; (2) CAG trinucleotide repeat variation in the X,linked androgen receptor 
(AR) gene; and (3) CAG trinucleotide repeat variation and the three exonuclease motifs 
of the nuclear polymerase gamma (POLYJ gene. 
The Y chromosome has a well established role in both sex-determination and sperm 
production. Deletions within one particular region, the azoospertnic factor (AZF) region 
are found in approximately 10% of men with idiopathic infertility (Foresta et al. 2001). 
Although there is abundant evidence linking candidate spermatogenesis genes within 
each of the three AZF regions and cases of reduced semen quality, there is no absolute 
relationship between particular Y chromosome micro-deletion and characteristics of 
semen quality (Foresta et al. 2001). In several such studies it is thought that the particular 
9 
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AZF deletion interval is likely to extend beyond the set of STS (sequence tagged site) 
markers into adjoining AZF regions (Foresta et al. 2000). To avoid obscuring 
relationships between particular combinations of Yqll micro-deletions and semen 
characteristics a selection of STS markers representing all three AZF regions were 
screened for micro-deletion in this study. 
The X-linked AR gene has a long established role in male sexual development and has 
also been implicated in causing male infertility in otherwise healthy men through 
moderate expansion of a trinucleotide repeat region. Many population studies have 
reported a correlation between low sperm count and AR CAG repeat length and suggest 
the association is due to a reduction in male-vigour gene transcription initiation by the 
AR with increasing numbers of CAG trinucleotide repeats. However, the association 
between moderately expanded repeat regions and reduced sperm production is 
controversial, with numerous population studies reporting no such association. The 
hypothesis is supported by several in vitro studies demonstrating a subtle reduc tion in AR 
activity with increases in the AR CAG repeat length. In this study variation in 
trinucleotide repeat number was evaluated in relation to semen quality. 
The accumulation of mitochondrial DNA (mtDNA) single nucleotide polymorphisms 
(SNPs) and deletions is linked with an increased risk of reduced semen quality (Kao et al. 
1995; Kao et al. 1998; Holyoake et al. 2001). The suggestion that aberrant polymerase 
gamma (POLJ1 replication might result in the increased frequency of mtDNA 
polymorphisms and deletions in these men has been somewhat supported by cell culture 
experiments and DNA screening in PEO (progressive external ophthalmoplegia) patient 
families. Substitution of several highly conserved amino acid residues within the 
exonuclease and polymerase domains (D198A, E200A, Y955C) results in error-prone 
DNA replication and an increased mitochondrial DNA mutational load during cell 
culture (Spelbrink et al. 2000). These same substitutions have been observed in PEO 
patients whose polymerases show low dNTP binding-affinity leading to error-prone 
mtDNA synthesis (Lamantea et al. 2002; Copeland et al. 2003). Each sample was 
screened for mutation within the three exonuclease motifs that make up the exonuclease 
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domain. Importantly, 91 samples (44 normozoospermic and 47 men with poor semen 
quality) from the study population have been previously analysed for the presence or 
absence of single nucleotide polymorphisms (SNPs) of the mitochondrial genome 
enabling analysis of the potential relationship between POLymutation and mitochondrial 
polymorphisms. 
There is already some evidence linking the POLy gene and reduced semen quality; the 
amino-terminal CAG trinucleotide repeat region of POLy has recently been associated 
with oligozoospermia and normozoospermic-infertility (Rovio et al. 2001; Jensen et al. 
2004). The CAG trinucleotide repeat is unique to the human POLy and is commonly 
found to encode 10 CAG units in the population (Rovio et al. 1999). The contribution of 
POLyCAG repeat variation to fertility status was analysed in this population. 
Each sample was analysed for mutation in each of the three genes and mutation 
frequencies compared against semen characteristics of the sample population. It is 
predicted that men with reduced semen quality will display a greater frequency of 
nucleotide changes in these genes, and that the highest mutational load will be observed 
in men with the most severely reduced semen quality (azoospermia and severely 
oligoasthenozoospermia) . 
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2.1 Materials 
All chemicals used in this research were molecular biology grade. Abbreviations are listed 
in Appendix A. Chemicals and suppliers are listed in Appendix B. Water was de ionised 
and ultra-filtrated (NANOpure ultra pure water system, Barnstead, 10, USA). All water 
was sterilized by autoclaving before use. 
2.2 Sample Population 
All individuals were recruited from the New Zealand Centre for Reproductive Medicine 
in Christchurch, New Zealand. Semen was initially given by couples for analysis of a 
suspected fertility problem. Because a couple's infertility may be due to one or either 
partner, semen samples show large variation in semen characteristics from severely 
reduced semen quality to high sperm count and motility. Individuals with semen 
parameters within the normal range (~ 20x106 sperm/ml and ;:::: 50% motility) were 
classified as normozoospermic and included in the control population, although fertility 
was not proven. Each individual gave semen samples by masturbation after three days 
abstinence, their consent was obtained for the sample to be used further in molecular 
research. Semen parameters such as sperm count and motility were recorded by staff at 
the New Zealand Centre for Reproductive Medicine at the time of donation, and in 
addition, morphology and testicular histology noted for some individuals. This data was 
entered into our own laboratory database. The entire study population along with semen 
parameters and any other noted factors are recorded in Appendix C. 
Ethical approval for the research project was gained from the Canterbury Ethics 
Committee, research progress was reported annually. 
Semen samples were stored in 200 J.LI aliquots at -BODC to avoid DNA damage by repeated 
freeze/thawing. Extracted seminal DNA was stored at _20DC or 4DC while in daily use. A 
total of 321 individuals were used in this research after being categorised into one of 
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seven semen classifications based on World Health Organisation guidelines (Table 2.1) 
(WHO 1999). However, DNA extracted from 29 samples was not in sufficient quantity 
for use in analysis of all genes. Thus, 292 individuals were used for the majority of the 
research (Appendix C). This group includes 50 samples where research has been 
previously conducted to evaluate the frequency of single nucleotide polymorphisms within 
their mitochondrial DNA (mtDNA), including the NDgenes 1,2,5, and 6, ATPase 6, 
and 8, and COl, JJand JIJ(Holyoake 1998; Wu 2000; Gomas 2002; Weir 2003). 
Of the 292 individuals in the study population 195 were men with poor semen quality (19 
Azoospermic, 48 Severe Oligoasthenozoospermic, 17 Severe Oligozoospermic, 28 
Oligoasthenozoospermic, 27 Oligozoospermic, and 56 Asthenozoospermic) and 97 were 
men with normal semen quality. Sample population details and the number of samples 
analysed in each gene region are given in Table 2.1 below. 
Table 2.1. Classification of semen samples. 
Semen Classification 
Spenn Spenn AR Yq POLy Exo Exo II & Count Motility n CAG M.del CAG I III (1()6/ml) (%) 
Azoospermia 0 0 19 12 19 11 19 5 
Severe 0-5 <50 48 31 48 47 46 16 Oligoasthenozoospennia 
Severe Oligozoospermia 0-5 >50 17 11 17 14 16 6 
Oligoasthenozoospermia 5·20 <50 28 26 28 28 28 11 
Oligozoospermia 5-20 >50 27 24 27 27 27 9 
A sthe nozoo spermia ~20 <50 56 53 56 53 55 18 
N onnozoospennia ~20 >50 97 89 97 92 83 61 
Total 292 246 292 272 274 126 
Detail on samples and gene analysis can be fOlllld in Appendices C and D. N refers to the total 
sample number in the sample population subgroup. Each column gives the number of samples 
analysed in each subgroup for each gene region. Semen classifkations are shortened in some 
tables to: Az, azoospermia; SOAs, severely oligoasthenozoospermia; SO, severely oligozoospermia; 
OAs, oligoasthenozoospermia; 0, oligozoospermia; As, asthenozoospemua; N, nonnozoospermia; 
and 'zoospennia' to ZS. The last five columns indicate munbers of individuals analysed in each 
gene region. 
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2.3 General Methodology 
There are several aspects of the research method that were common for all gene regions 
investigated. These are outlined below so that the methods section of each chapter is 
condensed, and only particular characteristics noted. 
2.3.1 Human Seminal DNA Extraction 
Total genomic DNA was extracted from semen samples using a standard 
Phenol/Chloroform extraction method as outlined in Kao et al (1995). The extraction 
was carried out in 1.5 ml Eppendorf tubes; if required, semen samples were transferred to 
these tubes from 0.5 ml Eppendorf tubes after thawing. Approximately 200 pI of semen 
sample (200-300 pI if possible from men with poor semen quality) was thawed on ice after 
which sperm cells were pelleted by centrifugation at 6800 x g, at 4°C for 10 min in an 
Eppendorf centrifuge (model 5417R). The supernatant was poured off leaving the pellet 
of sperm cells behind. This pellet was then resuspended in 100 JLI of extraction buffer/lysis 
mix (0.1 M Tris-HO (pH 8.0),0.1 M NaO, 20 mM EDTA (pH 8.0) 11 % (w/v) SDS, 10 
mM dithiothreitol (DTT) , and 100 JLg/ml proteinase K) by gently flicking the tube. Tubes 
were wrapped in parafilm and incubated at 50°C iIi a waterbath overnight (16-20 hours). 
After incubation, samples were centrifuged briefly to collect condensation. An equal 
volume (100 JLI) of phenol saturated with TE (pH 8.0) buffer (10 mM Tris-HCI (pH 8.0), 
1 mM EDT A (pH 8.0» was added and tubes gently inverted in order to extract proteins 
from the lysed sperm cell mix. Tubes were centrifuged at 15300 x g for 5 min at room 
temp to separate the aqueous and organic phases. The aqueous phase was then 
transferred to a fresh tube using a wide bore pipette to avoid mechanical shearing of 
DNA. The residual interphase and organic layer were back extracted with an equal 
volume (~1 00 JLI) of TE (pH 8.0) to maximally recover remaining DNA. The combined 
aqueous phases were extracted with an equal volume (~200 JLI) of 
phenol:chloroform:isoamyl alcohol (25:24:1) and the aqueous layer transferred to a fresh 
tube. To remove residual phenol from the sample the aqueous layer was then extracted 
with an equal volume (~200 JLI) of chlorofoffil:isoamyl alcohol (24:1) and transferred to a 
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fresh tube. This extraction was repeated if a white interphase was observed after 
centrifugation. Finally, DNA was precipitated out of solution overnight (16-20 hrs) by 
adding 0.1 volumes of 3 M sodium acetate (NaOAc, pH 7.0) and two volumes of cold 
absolute ethanol (stored at -20°C). The DNA pellet was collected by centrifugation at 
13800 x g at 4°e for 20 min, and then washed in 300 ILl of cold 70% ethanol (stored at -
20°C). The DNA was repelleted and washed for a total of three times before air drying for 
seven to ten min. The DNA pellet was resuspended in 50 ILl TE (pH 8.0) (30 ILl if the 
sample was from a non-normowospermic man). DNA was stored at _20oe until required 
for use at which time it was stored at 4°C. 
2.3.1.1 Visualisation of Extracted Genomic DNA 
Successful extraction of genomic DNA was confirmed by electrophoresis of 3 ILl of 
extracted DNA with 1 x orange G loading buffer (30% glycerol, 0.35% orange G) through 
a 1.5% (w/v) agarose gel made up with 1 x TAE (0.04 M Tris-acetate/O.OOl M EDTA 
(pH 8.0)) buffer. Electrophoresis was carried out at 5 V /ern for 20 min. Gels were stained 
with ethidium bromide (0.5 ILg/ml) on a shaker for 20 min and the DNA visualised using 
an ultra-violet (UV) transilluminator (300 nm). 
2.3.1.2 Quantification of Genomic DNA 
The purity and yield of extracted DNA was calculated by reading the absorbance of 2 ILl 
of DNA in 498 ILl of TE (pH 8.0), vortexed to mix, at 260 nm (A26o) and 280 nm (A28o) 
on a spectrophotometer (model LKB Biochrom Ultraspec II 4050). DNA concentration 
was calculated based on the absorbance reading at 260 nm (1 optical density (OD) unit at 
260 nm equals 50 ILg/ml double-stranded DNA) and adjusted for volume (500 ILl to 1 ml) 
and dilution factor (2 ILl to 1 ILl): 
DNA concentration (ds DNA) (;.tg/ml) = A260 x 50 ILg/ml 
(Sambrook et al. 1989). 2 (volume factor) X 2 (dilution factor) 
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DNA purity was estimated using the ratio of light absorbance at 260 nm to that at 280 
nm (A26o:A28o)' An optimally pure DNA sample will have a ratio equal to 1.8, less than 
1.8 indicates contamination due to the presence of proteins in the sample (high Az8o) , 
while greater than that suggests RNA contamination (Sambrook et a1. 1989). 
2.3.2 Polymerase Cha.in Reaction (PCR) Analysis 
2.3.2.1 Primer Design 
All primers used to conduct this research were based on DNA sequences submitted to the 
National Centre for Biotechnology Information (NCBI) (http://www.ncbLnlm.nih.gov). 
Primers were designed so that they were located in the regions of DNA flanking the gene 
of interest so that amplification proceeded through the entire sequence. Primer pairs were 
designed using the Primer3 programme (http://www.path.com.ac.uk/cgLbin/primer3.cgi) 
and checked for specificity, secondary DNA structure, primer dimer and multiple priming 
sites using the PCR simulation programme AmplifY 1.2 (Engels 1993). AU primer pairs 
were designed based on an optimal primer length of 10 base pairs (bp), similar melting 
temperature (Tm), and GC content of around 50%. Primers were chemically synthesised 
by Invitrogen, Life Technologies Ltd (Auckland, New Zealand). Specific primer pairs for 
each gene region are given in the corresponding chapter. 
2.3.2.2 peR Reactions 
PCR reaction conditions: annealing temperature and magnesium (Mi+) were optimised 
for each primer pair using a temperature gradient PCR machine (Eppendorf 
Mastercycler® gradient). Each new PCR primer pair was£)ptimised by amplification in 
two normowosperrnic samples with a median annealing temperature of S8°C, varying 5°C 
either side to produce a gradient temperature range 1Setween 53°C and <53°C. Magnesium 
concentration was set at the standard 10 x buffer Plus Mg2+ concentration of 1.5 mM for 
temperature optimisation. None bfthe PCR reactions in' this research reqUired. a higher 
magnesium concentration thall' i.5 mM. 
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Each 25 I.Ll PCR reaction mix contained approximately 200 ng of genomic DNA plus 0.5 
units of Taq DNA polymerase (Roche), 1 x PCR buffer (10 mM Tris-HCI, 1.5 mM 
MgClz, 50 mM KCl, pH 8.3), 200 J.LM of each deoxyribonucleoside triphosphate (dNTP; 
dATP, dGTP, dCTP, and dTTP) , and 0.4 J.LM of each primer. The multiplex PCR 
employed for the Y chromosome sequence tagged site (STS) deletion analysis (Chapter 
Three) required some additional optimising for the multiplex PCR reaction conditions 
where five sets of primer pairs were added, each with its own optimum annealing 
temperature. Therefore, some primer concentrations in the multiplex were less than 0.4 
J.LM, and the annealing temperature of the PCR programme higher than for other gene 
regions to reduce non-specific printing. All reactions had a drop of mineral oil added to 
the tube before cycling to prevent evaporation. 
PCR reactions were cycled in either a MJ Research Inc. (PTC-100) or Eppendorf 
(Mastercycler® gradient) thermal cycler machine. PCR programmes followed standard 
programme cycling times, although CAG trinucleotide repeat sequences required longer 
amplification times and a greater number of cycles than other DNA sequences amplified 
(Chapters Four, and Five). 
PCR products were stored at 4°C after completi9n of thermal cycling until required. 
2.3.2.3 Visualisation of peR Products 
To ascertain the quantity of gene product generated by the PCR programme, 3 J.LI was 
electrophoresed through a 1.5% (w/v) agarose gel (2% for Yq multiplex products) with 1 x 
TAE buffer at between 7 and 10 V/cm for 20 min (a longer runrring time and lower 
voltage was used for Yq multiplex products). Agarose gels were stained with ethidium 
bromide (0.5 J.Lg/ml) for 15-20 min and illuminated under UV (as per DNA extraction 
gels). 
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2.3.2.4 Purification of peR Products 
peR products were precipitated and washed to remove contaminants, such as 
unincorporated primers or dNTPs, before sequencing. The cycled peR reaction was 
transferred from the reaction tube onto parafilm then into a fresh tube to remove excess 
mineral oil. One volume of 4 M ammonium acetate and two volumes of isopropanol were 
added and tubes inverted several times to mix. The reaction was incubated at room temp 
for 20 min (25 min if the peR product concentration was low) and then centrifuged at 
15300 x g at. room temp for 20 min. The supernatant was drawn off carefully and 
discarded, and the pellet washed with 100 III of 70% ethanol (stored at room temp). The 
pellet was recentrifuged for 10 min and washed again, before air-drying for 5 min. The 
precipitated peR product was resuspended in 15 ILl of TE (pH 8.0) buffer and stored at 
4°C. 
2.3.2.5 Visualisation of the Purified peR Product 
To ensure retention, and calculate approximate concentration of the amplified product, 3 
ILl of the pUrified PCR product was electrophoresed through a 1.5% (w/v) agarose gel as 
per PCR reaction visualisation. 
2.3.JDNA Sequencing 
Various methods of DNA sequencing were employed throughout this research; 32p and 
33p labelled sequencing, and fluorescent T3-tagged sequencing· using a LICOR DNA 
sequencer (modeI4000L). Each will be discussed in the relevant chapter. 
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2.4 Results 
2.4.1 DNA Extraction 
Genomic DNA was extracted from the semen of 215 men with poor semen quality and 
106 men with normozoospermia as defined by WHO (1999) (Figure 2.1) (refer Appendix 
C for details of sample population characteristics). 
DNA yield and purity varied. In general, DNA yield from both normozoospermic and 
non-normozoospemlic samples was similar (approximately 2.5 ILg from 200 ILl of semen 
sample) where original semen samples were of similar viscosity (high) and volume (2-4 
ml). For some azoospermic and severe oligozoospermic samples, one or both of the volume 
and viscosity was low. In these cases the DNA yield and purity tended to be lower 
(around 0.6 ILg of genomic DNA from 100-200 ILl of semen sample; purity of greater than 
1.8 (ranging between 1.7 and 2.1)) in an effort to maximise yield. DNA purity was 
generally closer to 1.8 (1.7 -2 .0) in all other samples. 
M I 2 3 4 5 6 7 8 9 10 A. I I 12 13 14 15 16 17 18 19 20 A 
Figure 2.1. Electrophoresis images of genomic DNA after extraction. The marker (M) is AH/E 
(1amba DNA digested with HindIII and EeaRl restriction enzymes); the top band is 21226 bp. 
Samples numbered 1 to 10 have semen classifications of 0, Az, 0, SOAs, SOAs, SO, SOAs, 
SOAs, SOAs, N, and 11 to 20 are SO, SOAs, OAs, OAs, OAs, 0, 0, OAs, 0, and OAs. A 20 ng 
A DNA size reference was loaded in the last lane of each gel. 
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3.1 Introduction 
DNA sequence analysis is forcing scientists to rethink assumptions about the Y 
chromosome. Thought to be a decaying mess of partial sequences, pseudogenes, and 
repetitive elements, it now seems to encode a surprisingly complex system of near perfect 
amplicons arranged into longer palindromes, separated by hundreds and even thousands 
of base pairs (Skaletsky et a1. 2003). It no longer appears that the Y chromosome is 
passively losing genes to mutation, but actively correcting them to preserve the integrity 
of its spermatogenesis genes. 
3.1.1 The Human Sex Chromosomes 
The human sex chromosomes X and Y evolved from a pair of homologous autosomes 
some 300 million years ago (Figure 3.1). The Y chromosome has a special status as the 
sex-determining chromosome. It encodes the SRY gene (~x-determining region of the y), 
which stimulates a cascade of gene activity resulting in the development of male sexual 
characteristics (Graves 2002). 
Mole vole 
130 Myr: Marsupial split from Therians 
SRY l'V( Ivnl 
170 Myr: Mouotremes diverge 
Y·('bromosom(' cvolvl'() 
Figure 3.1. Evolutionary timescale of mammalian Y chromosome and SRY. Sequence comparison 
between mammalian groups indicates an approximate timescale for Y chromosome and SRY 
evolution. Detection of sex-specific SRYin both Platypus and Echidna (Monotremes) by peR and 
Southern Blot have failed, hpwever, two SOX genes are autosomal. Adapted from Graves (2002). 
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Four separate inversion events beginning in distal Yq and ending with proximal Yp 
triggered the end of sexual recombination between X and Y (Lahn and Page 1999a; 
Skaletsky et al. 2003). While the loss of recombination allowed Y to specialise in male 
vigour genes it also made it vulnerable to mutation and consequent loss of functionally 
important genes by Muller's ratchet (Charlesworth 1978; Rice 1998). A comparison of X 
and Y sequences suggests that in 300 million years the Y chromosome has lost 1500 genes, 
5 genes per million years; it currently encodes between 50 and 78 genes, a mere 3% of 
what it once did (Graves 2002; Skaletsky et al. 2003). 
However, should the Y chromosome lose all its genes the fate of humankind is unlikely to 
result in a race of women, instead the future of human sex-determination is likely to lie 
with another SRYanalogue. This has already happened in two species of the mole vole 
Ellohius which achieve dimorphic sexual development with an identical sex chromosome 
complement in both sexes; one active X chromosome, while a close relative retains the 
SRY sex-determination mechanism. The alternative means of sex-determination in these 
voles remains unclear but once discovered it will give insight into how one system of sex-
detennination evolves from the last (Graves 2002). It is hypothesised that a new sex-
determining gene could stimulate another burst of human evolution; the accumulation of 
new sex-benefit genes at this new site will begin sex-chromosome evolution aU over again 
and, if more than one sex-determining gene arises, may eventuate in human populations 
that cannot interbreed (Graves 2002). Moreover, if this new successor is not on Xor Y 
would we lose X as well, as new versions of its genes accumulate on the new sex-
determining chromosome pair? 
In addition to directing testis development the Y chromosome is vital for sperm 
production, . a characteristic that was not at first apparent until identification of several 
azoospermic men with deletions of distal portions of the Y chromosome long ,<!.J!Ul 
suggested the presence of 'fertility genes' on Y (Tiepolo and Zuffardi 1976). 
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and chimpanzee lineages diverged. It makes up 15% of MSY and encodes only two genes, 
TGIF2LY (TGF (beta)-induced transcription factor 2-like) expressed in the testes, and 
PCDHllY(Protocadherin 11 Y) expressed in the brain (Skaletsky et al. 2003). 
'X-degenerate' sequences are remnants of the autosomal ancestor of X and Y. These 
sequences encode single-copy or pseudogene homologs of 27 X chromosome genes. Y 
chromosome pseudogenes show sequence similarity to the exons and introns of their 
functional X-linked gene counterpart. X-degenerate sequences are older and have lower 
sequence homology to X-linked genes than X-transposed sequences. SRY is the only 
testis-specific X-degenerate sequence; however, all 12 ubiquitously expressed protein-
coding transcripts are made up of X-degenerate euchromatin, suggesting that X-
degenerate transcripts predominantly encode house-keeping genes (Skaletsky et al. 2003). 
The majority (70%) ofMSY euchromatin is 'ampliconic', so called because each sequence 
is duplicated, or amplified to multiple-copy along the Y chromosome. These sequences are 
unique to the Y chromosome and encode the highest density of genes; 13.3 transcription 
units per Mb, compared with 2.2 and 0.6 for X-degenerate and X-transposed sequences. 
In total, ampliconic euchromatin encodes 60 protein-coding genes divided into nine gene 
families all expressed solely, or primarily in the testes,· suggesting these genes are 
important for spennatogenesis and male sexual development. Ampliconic sequences were 
derived by three processes: amplification of ancestral autosomal genes, translocation and 
amplification of autosomal genes, and retroposition and amplification of autosomal genes 
(Figure 3.3) (Lahn and Page 1999b; Skaletsky et al. 2003). 
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palindromes, which in some instances encodes the only copies of vital spermatogenesis 
genes, suggests it was favoured by selection (Kuroda-Kawaguchi et a1. 2001). 
3.1.2.1 Micro-deletions of AZF 
Defective spermatogenesis is the most common form of male infertility. In 1976, Tiepolo 
and Zuffardi observed that a region of the Y chromosome long arm (Yq) adjacent to the 
heterochromatic region was absent in six patients with severe spermatogenic failure; 
azoospermia. This region, termed AZF (azoospermic factor) was further characterised into 
three sub-regions, AZFa, band c in proximal, middle and distal Yqll, based on the 
clustering of micro-deletions (Figure 3.4) (Vogt et a1. 1996). 
A fourth region lying between AZFb and c, AZFd was later described as a result of a 
single study (Kent-First et a1. 1999). This small region beginning distal to RBMY2 spans 
only eight STS', however, commonly only the three original AZF regions are referred to. 
YplU2 
Yp112 
Yq11,;'21 
Yqi'I,22 
YqlU3 
Y''112 
t"- ""MY 
tAZFc-Ji'DAZ 
1 ; 
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Figure 3.4. A schematic 
illustration of the human Y 
chromosome showing cytological 
banding and deletion intervals. 
On the right is a deletion map of 
the Y chromosome as defined by 
Vollrath et a1. (1992) and the 
genes that map within in them. 
AZF regions and candidate 
spermatogenesis genes are 
indicated. Adapted from Foresta 
etal. (2001). 
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Approximately 10-15% of severely oligozoospermic and azoospermic men have micro-
deletions within Y q 11. Nearly all are de novo and each sub-region is associated with a 
different phenotype and deletion frequency (Foresta et al. 2001). Deletions within AZFc 
are most common (3xlO-4) (Yen 2001), but produce variable phenotypes from severe to 
mild spermatogenic arrest. Deletion of AZFa is associated with severe infertility; very 
early spermatogenic arrest characterised by an absence of germ cells, Sertoli-cell only 
(SeO) syndrome, and small testis volume (Foresta et al. 2001). AZFb deletions can also 
produce variable phenotypes but generally result in premeiotic disruption to 
spermatogenesis where spermatogonial cells are present (often in reduced numbers) but 
do not undergo meiosis to produce haploid spermatocytes. (Foresta et al. 2001; Krausz et 
al. 2003). 
Many AZF deletions share the same proximal and distal breakpoints, suggesting they 
occur by a common mechanism. The majority of both AZFa and c deletion intervals have 
similar breakpoints bounded by repeat sequences, non-homologous recombination 
between these repeats eliminates the spermatogenesis genes between them (Kamp et al. 
2000; Sun et al. 2000; Kuroda-Kawaguchi et al. 2001). The 800 kb AZFa region encodes 
only three genes, USP9Y, DBYand UTY; intrachromosomal recombination between two 
nearly identical (94%) HERV15 endogenous. retroviruses completely eliminates both 
USP9Yand DBY (Kamp et al. 2000). 
The AZFc region consists almost entirely of long direct- and inverted repeat units divided 
into six amplicon families which make up three larger palindromes (Figure 3.5), Each 
amplicon is 99.8% identical to other amplicons in its family and at least one amplicon lies 
in the opposite orientation. Sequencing revealed eleven gene families: five known 
(RBMYl, PRY, DAZ, BPY2, and CD}), and six new families (CSPG4CY, GOLGA2LY 
and TTY3-6} , comprising a total of 27 potentially functional genes all expressed solely or 
predominantly in the testes. Remarkably, there are no single-copy genes (Kuroda~ 
Kawaguchi et al. 2001). 
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3 4 Mb 
I ' " , .• • . , . , I 
b4 c======:. 
Figure 3.5. AZFc. The entire 4.5 Mb DNA segment sequenced by Kuroda-Kawaguchi et al. 
(2001). The AZFc region (defined by common deletions) extends from amplicon b2 to b4. 
Amplicons and their orientation are indicated by the numbered coloured arrows, those belonging 
to the same family are the same colour (blue, turquoise, green, red, grey, or yellow). Protein-
coding genes are indicated by triangles. The largest palindrome, PI is centred between r3/r4 and 
extends from b3 to b4; within its arms lie two more palindromes Pl.l and P1.2. P2 encompasses rl 
and r2, and P3 extends from bl to b2. Adapted from Repping et a1. (2003). 
Most AZFc deletions (98%) involve the removal of a 3.5 Mb segment, flanked by rwo 229 
kb direct repeats (amplicons b2 and b4), which completely eliminates seven gene families 
altogether, including all four copies of the DAZ gene (Figure 3.6) (Kuroda,Kawaguchi et 
a1. 2001). Homologous recombination berween other amplicons is predicted to account 
for the variation in AZFc-deletion phenotypes. For example, the gr/gr deletion spans 1.6 
Mb and is Significantly associated with reduced spermatogenesis (Figure 3.6). This 
deletion does not eliminate any of the eleven AZFc testes-specific gene families but does 
reduce the copy number of eight, adding support for the idea that dosage of some genes is 
important for normal sperm production . 
. 1>3 , 
Figure 3.6. Common deletion intervals of the AZFc region. The reference sequence and protein-
coding genes are indicated at top. The deletion breakpoints have not been located precisely but 
lie somewhere in the amplicon indicated. The AZFc (b2;b4) deletion removes the entire region 
containing aU the members of seven testes-specific gene families, and ahnost always results in 
reduced spermatogenesis. The gr/gr (g l-r2/g2-r4) deletion eliminates half of AZFc and is 
associated with an increased risk of spermatogenic failure. Adapted from Tyler-Smith and 
McVean (2003). 
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Surprisingly, the gr/gr deletion persists in the population at 2% and has arisen 
independently fourteen times (Repping et al. 2003). Although the deletion confers 
increased risk of reduced sperm production it was inherited from the father in at least four 
of those screened suggesting the deletion has low penetrance and/or severity (Repping et 
al. 2003). 
Breakpoint analysis in four AZFb patients indicates that a common deletion mechanism is 
operating with AZFb deletions also; however, lack of flanking repeat sequences suggests 
the mechanism is different to that of AZFa and c. Other near identical repeat sequences 
to one found in AZFb have been identified within AZFc, suggesting that some AZFb and 
AZFc deletions extend over the boundary between them (Ferlin et al. 2003). 
3.1.2.2 Spermatogenesis Genes within AZF 
It is assumed that there is at least one spermatogenesis gene encoded within each AZF 
region (Vogt 1998). DNA sequencing and expression analysis suggests there are a variety 
of candidate spermatogenesis genes encoded within the three AZF regions, many of which 
have unknown function and importance in fertility (Lahn and Page 1997; Vogt 1998). 
These seem to fall into two categories: Y-specific genes in multiple copies, or Y-linked 
genes with X-linked homologs. The Y-specific genes have testis-specific expression and 
are predicted to play in spermatogenesis, while X-Y linked genes are expressed in a variety 
of tissues are thought to have a housekeeping role (Vogt 1998). The wide variability in 
semen quality over similar deletion intervals has made assigning particular AZF genes 
with particular semen characteristics difficult (Table 3.1). 
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Table 3.1. Candidate spermatogenesis ~enes within Yq11. 
Gene Gene Name Protein Homolog Expression Yqll Homolog" Symbol location 
BPYl Basic protein Y, pI 9 Novel Testis only D8* ? 
BPY2 Basic protein Y, pI 10 Novel Testis only AZFc No 
CDY Chromo domain Y Chromatin Testis only D1O-ll, (6) package protein 23-24* 
DAZ Deleted in RNA binding Testis only AZFc DAZL(3p32) AZoospermia RRM proteins 
DDX3 
DBY DEAD BoxY RNA helicases Multiple AZFa (Xpl1.3-
pl1.23) 
Eukaryotic translation Translation Multiple plus EfF1AY initiation-translation AZFb EfF1AX(X) 
factor lA Y initiation factor tes tis specific 
Heat shock Heat shock 
HSFY transcription factor2, Y element DNA unknown AZFb HSF2(6) 
chromosome binding domain 
PRY PTPN -13 like on Y Protein tyrosin Testis only AZFb No phosphatase 
RBMY RNA binding motif RNA binding Testis only AZFb, c RBMX(X+ RRM proteins autosomal) 
SMCY Selected mouse cDNA H-Y antigen HLA Multiple AZFb SMCX(X) Y B7 
Testis-specific protein SET/NAP-l !Spy regulated cell Testis only AZFb No Yencoded proliferation 
T7Yl Testis transcript Yl No-protein Testis only AZFc No 
encoded RNA 
77Y2 Testis transcript Y2 No-protein Testis only AZFc No 
encoded RNA 
USP9Y Drosophila fat facets C-terminal USP9X Multiple AZFa (DFFRX) (DFFRY) related Y ubiquitin hydrolase (Xpl1.4) 
U7Y Ubiquitous transcribed H-Y antigen HYD Multiple AZFa UJX(X) Y 
Putative 
XKRY XK related Y membrane Testis only DlO-ll * No 
transEort protein 
Table adapted from Vogt (1998) based on information given in Brown et al. (1998), Foresta et al. (2000), 
Ferlin et al. (2003), and Stouff's et al. (2004). a Parentheses indicate the chromosomal location of 
spermatogenesis gene homo logs. *Yq 11 locations with an asterisk indicate the reference is to the Vogt et al. 
(1996) deletion map; D8 corresponds to 5G (sY94), D1O-ll to 5H-K (sy97-sY109) , and D23-24 to just 
distal to RBMl (Vollrath et al. (1992); Reijo et al. (1995); Vogtet al. (1996)). 
3.1.2.2.1 Candidate Spermatogenesis Genes for AZFa 
AZFa deletions are associated with the most severe infertility pathologies suggesting that 
there may be several genes within AZFa that are crucial for normal germ cell 
development (Foresta et al. 2000). The proximal half of AZFa contains pseudogenes with 
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homology to Xp22, the remainder consists of three genes designated USP9Y, DEY and 
UTY. All three genes have some elements consistent with that of spermatogenesis genes 
(Foresta et a1. 2000). 
USP9Y(also known as DFFRY) is a homolog of the X-linked gene USP9X (DFFRX), and 
both are related to the Drosophila developmental gene fat facets (fa!); a member of a 
protein family that prevents protein degradation by removing ubiquitin markers. While 
deletion of fa!, USP9X, and USP9Y commonly results in severe disruption to fertility, the 
ubiquitous expression of USP9Yis inconsistent with a specialised role in spermatogenesis. 
It is possible that USP9Y functions indirectly, preventing protein degradation of 
important testes-specific gene products expressed in spermatogonia or early spennatocytes 
(Brown et a1. 1998). 
DEY encodes two transcripts, one large ubiquitously expressed transcript and a smaller 
testes-specific transcript. The protein encoded by DEY, DDXY belongs to the DEAD box 
family of proteins that are predicted to function as ATP-dependent RNA helicases. UTY 
is largely uncharacterised and rarely included in the deletion interval (Foresta et a1. 
2000). 
Typically, AZFa deletion genotypes do not match well with phenotype; a study of nine 
individuals indicated that elimination of DEY did not always produce a sea phenotype, 
nor did deletion of USP9Y(Figure 3.7) (Sargent et a1. 1999; Foresta et a1. 2000). 
USP9Y DEY mY 
Figure 3.7. Schematic representation of AZFa spennatogenesis genes and deletion intervals. The 
three AZFa genes are indicated at the top, and Yq STS markers below them. The "Hypo" deletion 
intervals resulted in hypospennarogenesis (severely reduced sperm production); "SeQ" deletion 
intervals resulted in Serroti-cell only syndrome. Figure reproduced from Foresta et al. (2000). 
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3.1.2.2.2 Candidate Spermatogenesis Genes for AZFb, 
The RBMY (RNA-binding motif) family of genes are widely thought to be the most likely 
candidate spermatogenesis genes for AZFb. They are expressed only in the testis, 
throughout all developmental stages except mature spermatozoa, and are homologous to 
the mouse gene rbm which causes infertility when deleted. Yet, AZFb deletion breakpoint 
analysis indicates that some deletions of AZFb that result in reduced sperm production do 
not remove either RBMYJ or RBMY2. 
Of other AZFb genes, SMCYand PRY are thought to be unlikely candidates. SMCY is 
ubiquitously expressed, encodes a histocompatibility antigen, and transgene expression 
does not restore sperm production in XSxrbO male mice. The two active PRY genes 
(PRYJ and 2) are more likely to be involved in the apoptosis of sperm cells than 
spermatogenesis (Mazeyrat et a1. 200li Stouffs et a1. 2004). 
Three other AZFb genes show more promising features consistent with spermatogenesis 
genes. EIFJAYis expressed exclusively·in the testis and encodes the Y-linked isoform of 
elF-lA, an essential translation initiation factor (Ferlin et a1., 2003). The role of ElFJAY 
in spermatogenesis is not known, nor have any individuals with a specific elimination of 
this gene been reported, yet the abundance of testis-specific transcripts suggest some role 
in spermatogenesis (Foresta et a1. 2001). 
The two CDY2 genes that have testis-specific expression, lie within the AZFbdeletion 
interval, and function in the replacement of histone proteins with protamines during 
spermiogenesis (FerHn et a1. 2003) 
Although the function of the novel candidate spermatogenesis gene HSFYin vivo has not 
been elucidated, expressed sequence tags (ESTs) associated with it are expressed in the 
testis. HSFYis a homolog of the HSF2 gene on chromosome 6 and contains a heat shock 
factor DNA binding domain, for this reason it is predicted to function as a transcriptional 
activator specifically binding to heat shock promoter elements (Ferlin et a1. 2003). 
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3.1.2.2.3 Candidate Spermatogenesis Gene for AZFc 
The best candidate spermatogenesis factor for AZFc is the DAZ gene family, located in 
two clusters each of two genes, one in each orientation (3'-5',5'-3') (Figure 3.8). All four 
genes are exclusively expressed in the testis and encode varying numbers of RNA 
recognition motifs; it is not known whether this confers different functions (Foresta et a1. 
2001). 
Cluster 1 J' D/1// 5' 
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Figure 3.8. Schematic illustration of the two DAZ gene clusters. Two STS markers targeted to 
sequence family variants (SFVs) distinguish between the two gene clusters (sY587T or C ), 
between genes within each cluster (sY581C* and T *), and between DAn and the other three 
DAZgenes (sY586C and T ). From de Vrieset a1. (2002) . 
Initially, seven DAZ genes were proposed but more recent research suggests there are 
only four, virtually identical (99.9%) gene copies (Szmulewicz et a1. 2002). Research 
suggests that at least three of the four DAZ genes are transcribed in the testis during 
spermatogenesis and that the extent to which spenn production is impaired might depend 
on the number of DAZ genes deleted, and which cluster, in a gene dosage effect (de Vries 
et al. 2002; Fernandes et at. 2002). 
DAZ family proteins are found in human germ cells at many developmental stages. In 
gonocytes, DAZL and DAZ proteins are distributed throughout the nucleus and 
cytoplasm, but predominate in the nuclei of spen11atogonia. In early (round) 
spermatocytes the proteins are found exclUSively in the cytoplasm, but only DAZL is 
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observed in the cytoplasm of elongating spermatids (Reijo et al. 2000). This suggests that 
DAZ proteins have multiple roles during gametogenesis, most likely during meiosis and in 
the establishment of spermatogonial stem cell populations (Reijo et al. 2000). The similar 
but not identical expression patterns of DAZ and DAZL suggests they have different 
functions (Reijo et al. 1995; Reijo et al. 1996; Reijo et al. 2000). 
3.1.3 Y Chromosome Micro-deletion Analysis 
Commonly, analysis of the AZF regions in population studies, and even fertility testing at 
reproductive health centres, has taken the form of sequence tagged site (STS) micro-
deletion detection by peR. Micro-deletions do not necessarily represent deletion of a 
entire gene, some STS markers tag DNA sequences whose function is unknown but 
assumed to be important to male fertilising potential (Foresta et al. 2001). 
However, the presence of other identical gene copies or sequences (pseudogenes) suggests 
that peR results are in fact more complicated than first realised. In the case of the DAZ 
gene family, if the STS marker sequence is present in all four gene copies, a positive peR 
result indicates between one and four gene copies is intact, yet if DAZ dosage is important 
the presence of only one copy may actually res~lt in reduced sperm production. A 
negative peR result indicates that all four copies are deleted (Foresta et al. 2001). 
Recently, more sensitive STS markers have been developed that distinguish between 
individual DAZ clusters, and genes (Figure 3.8) (de Vries et al. 2002; Ferlin et al. 2002). 
Thus the methods used to study Yq micro-deletion impact on the research outcome and 
conclusions that can be drawn from it. The association between deletions of particular 
spermatogenesis genes and identifiable semen characteristics is strengthened when study 
populations are selected based on testicular phenotype. However, depending on the 
screening method employed, seemingly similar deletion intervals can be observed among 
varied testicular phenotypes because deletions in some men might extend beyond the 
particular interval analysed in the study (Foresta et al. 2001). 
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Additionally, it is not fully understood whether X-linked or autosomal homolog 
expression alleviates or changes the pathology resulting from deletion of the Y-linked 
copy. This may be particularly true for the DAZ gene family, since DAZL is the only DAZ 
protein expressed in mature spermatids. Furthermore, without DNA analysis of male 
relatives it is difficult to distinguish natural polymorphisms from those that cause impaired 
spermatogenesis (Foresta et al. 2001). 
3.1.4 Aim of Research 
The Yq micro-deletion analysis aims to establish whether deletions within the three ~f 
regions contribute towards defective spermatogenesis in this study population. It is 
probable that mutations within more than one region, or multiple mutations in one region 
create more severely impaired spermatogenesis; this will be determined and then 
examined alongside the androgen receptor and POLr data to further ascertain what 
mutations are present together in relation to semen quality (Chapter Six). 
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Table 3.2. Yq STS primer pairs. 
STS Locus Left Primer Right Primer ProduCt Size (bp) 
sY14 SRY gaatattcccgctctccgga gctggtgctccattcttgag 472 
sY84 DYS273 agaagggtctgaaagcaggt gcctactacctggaggcttc' 300 
sY86 DYS148 gtgacacacagac tatgc ttc acacacagagggacaaccct 290 
sY127 DYS218 ggctcacaaacgaaaacaaa ctgcaggcagtaataaggga 280 
sY134 DYS224 gtc tgcc tcacca taaaacg accactgccaaaac tttcaa 290 
SY146 DYF52S1 acaaaaatgtggctcaggga aaatagtgtgcccacccaaa 173 
SY149 DYS1 tgtcacactgccctaa tcct tggtcatgacaaaagacgaa 132 
SY156 DYS239 aggaactggcaggattagcc atgtcagggtttcctttgcc 950 
SY157 DYS240 cttaggaaaaagtgaagccg cctgctgtcagcaagataca 285 
SY158 DYS241 c tcagaagtcc tcc taa tagttcc acagtggtttgtagcgggta 231 
SY239 cattca tcttccc ttttgaagg atgcaagtcgcaggaaatct 201 
SY254 DAZ gggtgttaccagaaggcaaa gaaccgta tc taccaaagcagc 380 
SY269 c tc tgggacaagtgttcc ttg cattggcatgaatgtgtattca 94 
SY277 gggtttts:cctgcatacgtaatta cc taaaa~caa ttc taaacctccag 300 
All primer sequences are given in the 5' to 3' direction. 
Table 33. Yq STS multiplex groups. 
Group STS Product Size (bp)' AZFRegion 
sY269 94 AZFc 
sY146 173 AZFc 
1 sY158 231 AZFc 
sY277 300 AZFc (DA2) 
sY156 950 AZFc 
sY149 132 AZFc 
sY239 201 AZFc 
2, 
. sY157 285 AZFc 
sY254 380 AZFc (DA2) 
, sY14 472 SRY 
3 sY84 300 AZFa 
sY134 290 AZFb 
4 
sY86 290 AZFa 
sY127 280" AZFb 
aMultiplex product sizes are given in base pairs (bp) and in ascending order of size. 
3.2.1.2 Yq Multiplex PCR Conditions 
PCR conditions ~ere based on multiplex conditions published in Kent-First et al. (1999). 
The four multiplex PCR's followed the same cycling programme which consisted of an 
, " 
initial denaturation at 96°C for 2 min, followed by 34 cycles of denaturation at 94°C, 
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primer annealing at 61°C, and primer extension at 72°C, all at 1 min cycles, and a final 
extension at 72°C for 10 min. This programme was later trimmed back to 30 s 
denaturation and annealing, and a 40 s extension for 30 cycles, and a 5 min final 
extension. Since the PCR product was not required for sequencing, and in order to 
conserve DNA, the PCR reactions were conducted in 6.25 J.LI n~actionvolumes, and 6 J.LI 
electrophoresed through an agarose or a polyacrylamide gel. 
3.2.1.3 Yq Multiplex PCR Visualisation 
Size differences within groups 1 and 2 (AZFc) (Table 3.3) were not less than 20 bp and 
could be visualisedas distinct bands after electrophoresis through a 2% (w/v) agarose gel 
with 1 x T AE buffer for 75 min at 8 V Icm. 
Groups 3 and 4 (AZFa and b) (Table 3.3) were more similar in size and therefore, to 
avoid conducting four individual PCR's, the products were visualised by electrophoresis 
through a 5% non-denaturing polyacrylamide gel (5% acrylamide, 1 x TBE, 0.07% APSj 
10 cm x 7 cm x 0.75 mm; Mini PROTEAN 3 (Biorad)) with 1 x TBE running buffer 
(0.045 M Tris-borate, O.OOlM EDTA (pH 8.0))(Appendix F) and 1 x loading dye III 
(0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol FF, 30% (v/v) glycerol in 
water). Gels were stained and visualised as described in Chapter Two Section 2.3.1.1. 
3.2.1.4 Yq Multiplex PCR Reactions 
Each multiplex PCR was run with a sY14 (SKY) positive control. Individual products 
were scored for a positive or negative result. The presence of a band indicated the STS 
marker was intact, while the absence of a band indicated a possible deletion. STS primers 
that gave a negative' PCR result were repeated three times with controls for DNA 
concentration and the primer pair. If the band failed to be detected on all three occasions 
the product was probed with a labelled primer in a Southern blot hybridisation. 
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3.2.2 Southern Blot Hybridisation of Negative peR Results 
A total of thirty samples were analysed in four Southern blot hybridisations (Table 3.4). 
Table 3.4. Samples analysed by Southen blot hybridisation. 
Sample" ProbedSTS ControlSTS 
1469 157 SRY 
2275 157 SRY 
2307 156 &254 SRY & 149 
Southern blot 1 b 4646 156 149 & 157 
8055 156 149 & 157 
95-22 156 &254 SRY 
RS 156 &254 SRY, 149 & 157 
SM 156 &254 SRY & 149 
Probe 1 2050 SRY, 149,156,157,254 
2307 254 
3002 156 
4646 156 
Southern blot 2 8055 156 
95-22 156 &254 
RS 156 
SM 254 
Probe 2 4020 
2696 156 
3047 149 
4071 149 
4290 149 
4449 158 
Southern blot 3 5544 149 
BT 146 & 158 
CP 146 & 158 
SF96-283 156 
WT 156 
ZC 146 
Probe 3ac SF95-590 
Probe 3b" TP 
6290 146,149 & 157 
Southern blot 4d AM302J 146 & 158 
CP 146 & 156 
SF94-380 149 
• Some samples were repeated by probing several PCR reactions. 
bMembrane 1 was reprobed with probe 2. 
cSouthen Blot 3 had two probes added to the hybridization. 
dSouthern Blot 4 was probed with probes 3a and 3b. 
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To set up the Southern blot experiments PCR samples were electrophoresed through a 
1.5% (w/v) agarose gel (10 cm x 7 cm x 0.5 cm) with 1 x TAE buffer at 7 V/cm for 75 
min. To assist transfer of DNA to the nitrocellulose membrane, the gel was illuminated 
under UV for 2 min after visualisation to shear the DNA into smaller fragments. 
3.2.2.1 DNA Transfer 
After UV irradiation the gel was depurinated by treatment with 0.125 M HCl. The gel 
was placed in a container, covered in 0.25 M HCl (~200 ml) and gently shaken for 15 
min to break up the two-ringed purine nucleotides of the DNA. This solution was then 
decanted off and replaced with a denaturation solution (1.5 M NaCl, 0.5 M NaOH) for 
30 min (shaking). This solution hydrolyses the phosphodiester backbone at sites of 
depurination, denaturing the double-stranded DNA into single-stranded. The gel is then 
placed onto the transfer apparatus, lying wells-down onto a wick of three long strips of 
3MM paper (Whatman chromatography paper) (pre-wetted in the transfer solution (1.5 
M NaCl, 0.25M NaOH)). After eliminating air bubbles from undemeath the gel, the 
nitrocellulose membrane (Hybond XL (Amersham Biosciences)) was placed with forceps 
on top of the gel. Three pieces of 3MM were placed on top of the membrane (both the 
membrane and 3MM are cut to the size of the gel) followed by a stack of tissue paper and 
a weight. Plastic (Gladwrap) was placed around the gel, touching its sides to prevent 
'short circuiting' where solution is pulled past the gel and membrane by the paper above 
touching the wet wick. The system was left to transfer DNA onto the membrane 
overnight. 
3.2.2.2 Pre-hybridisation of the NitroceUulose Membrane 
At all times the nitrocellulose membrane was handled with forceps to avoid 
contamination and dirty smears. The transfer system is first disassembled keeping the gel 
and membrane together. The locations of the well spaces are marked through the gel onto 
the membrane with a soft pencil, as is the location ofthe marker lane. The membrane is 
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briefly illuminated under UV (300 nm) to fix the DNA, then left to air dry between 
sheets of clean 3MM for 60 min while the pre-hybridisation solution (6 x SSC, 5 x 
Denhardts (2% Ficoll Type 400, 2% polyvinyl pyrrolidine, 2% bovine serum albumin), 
0.5% SDS, 0.5% blocking agent) is prepared. Once dry the membrane was washed in 2 x 
SSC (0.3 M NaO, 0.3 M (tri) sodium citrate) rolled up lengthwise and placed into a 
preheated (65°C) bottle (Hybaid, SciTech). Pre hybridisation solution was added (0.1 
m1!cm2) and the membrane was pre-hybridised in an oven (Hybaid, SciT ech) at 65°C, 
turning for 1 hr. 
3.2.2.3 Preparation of32P-labelled Hybridisation Probe 
The PCR products to be used as hybridisation probes were first precipitated to remove 
unincorporated dNTP's and non-annealed primer pairs. The pUrified PCR products were 
then labelled with 32p_dCTP using the Random Primed DNA labelling Kit (Boehringer 
Mannheim). The 9 III of precipitated PCR reaction was denatured for 10 min at 97°C 
then added to the labelling mixture which consisted of3 III of dNTPs (1:1:1 mix of dATP, 
dGTP and dTTP; all 0.5 mM), and 2 III ofhexanucleotides (random 6 bp primers in 10 x 
reaction buffer). The 32p_dCTP (3000 Ci/mmol; 5 J-LI) and 1 J-LI ofklenow enzyme (2 ulJ-LI 
in 50% glycerol (w/v)) were added last. The tube was then covered with a boiling hat, and 
heated at 37°C in a heating block for 10 min. The reaction is stopped by boiling for 10 
min and then stored on watery ice until required. 
3.2.2.4 Probe-Membrane Hybridisation 
The labelled probe was added to 15 ml of the pre-hybridisation solution (Appendix F) and 
poured gently into the hybaid bottle avoiding the membrane. The probe is allowed to 
hybridise to DNA on the membrane overnight at 65°C. 
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3.2.2.5 Washing of the Radioactively Labelled Membrane 
The radioactive hybridisation mix was poured off into a 50 ml falcon tube and stored at 
-20De for future use. Excess, unbound probe was washed off the membrane in 2 x sse for 
5 min at 65 De, with agitation. This solution was discarded and washing was repeated with 
2 x sse for a further 15 min. A final wash in 2 x sse, 0.1% SDS was conducted for 30 
min. The membrane radioactivity was then measured on a Geiger counter' (T echnical 
Associates, eA, USA), to establish whether a further, more stringent wash (1 x SSC) was 
required. If the background count was low and count over the DNA was between 10,000 
and 20,000 counts/rninute/cm2 (cpm) the third wash was ol:nitted. The m~mbrane was 
r ';,' I 
then wrapped in gladwrap for autoradiography. 
3.2.2.6 Southern Blot Visualisation by Autoradiography 
X-ray fHm (Kodak Biomax MR) was exposed to the membrane in an autoradiography 
cassette, with an amplifying screen. A membrane that read 10,000 to 20,000 cpm was 
exposed for 1 hr before developing, readings less than thatrequired longer exposure. After 
developing the presence or absence of a band was scored. 
3.2.3 Statistical Analysis of Micro-deletion Prevalence 
A G-test of independence was performed to test the null hypothesis that semen quality is 
independent of the presence ofYq AZF micro-deletions, against the alternate hypothesis 
that semen quality is related to the presence of Yq AZF micro-deletions (Sokal and Rohlf 
1995; Zar 1996). 
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3.3 Results 
Y chromosome AZF micro-deletions were only observed in men with poor semen quality 
(P<O.OOl) (Table 3.5) and only within the AZFc locus; no micro-deletions of men with 
normal semen parameters, or of AZFa or b were identified. Y chromosome micro-
deletions predominated in men with the most severe classes of spermatogenic failure 
(azoospennia or severe oligoasthenozoospennia; 10/15 observed micro-deletions). 
3.3.1 Yq Multiplex PCR Analysis 
A total of 292 individuals were screened for deletions of 14 Y chromosome STS markers, 
spread throughout the three AZF regions, two each in AZFa and b, and nine in AZFc, 
plus SRY (sY14) as a positive control. An additional 23 samples were screened for 
deletion in the AZFc region only, because DNA quantity was insufficient for analysis of 
AZFa and b also. Mulitplex PCR reactions of groups 1 and 2 (AZFc STS markers) were 
visualised on 2% (w/v) agarose gels, any indistinct or absent bands were amplified by PCR 
again (Figure 3.10). 
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Figure 3.10. Electrophoresis images of Yq multiplex PCR groups 1 and 2. Multiplex PCR group 1 
STS markers are indicated to the right of the left-hand agarose gel image with band size in 
basepairs. M signifies the molecular weight marker lane; pBS (HaeDJ). Individuals 1-6 have semen 
classifications of N, As, 0, SOAs, SO, and SOAs. The red asterisks by individual 4 and sY156 
highlight the absence of the STS marker band in that sample. Group 2 STS markers and band size 
are indicated in the right-hand image. The size marker is as per group 1. Individuals 1-8 have N, 
As, N, As, N, N, N, N, semen classifications. Red asterisks beside individuals 1 and 8, and sY149 
indicate two samples with indistinct bands in the sY149 STS marker position. 
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Separation of multiplex PCR bands of groups 3 and 4 (AZFa and b) was achieved by 
electrophoresis through 5% PAGE (Figure 3.11) . 
• Y84 (300 bp) sY86 (290 bp) 
.Yl34 (290 bp) sY127 (280 bp) 
M 1 2 3 4 5 6 7 89M 1 2 3 4- 5 6 7 8 
Multiplex primer group 3 MultipleX pruner group 't 
Figure 3.11. Electrophoresis images ofYq multiplex peR groups 3 and 4. Both groups have one 
STS marker from AZFa (sY84 or sY86) and one from AZFb (sY127 or sY134). The marker lane is 
pBS (Hae/lI) as per Figure 3.14. Individuals depicted in the gel image of group 3 have the 
following semen classifications, N, Az, N, As, SOAs, SO, SO, As, and N (1-9). Individuals in the 
image of group 4 are SOAs, As, OAs, N, OAs, F, OAs, and N (1-8). The asterisk beside 
individual 4 is indicative of a sample whose sYI27 band is indistinct and would be repeated. 
Group 4 primers amplified additional non-specific bands approximately 580bp in size, these are 
likely to be the result either of a comb ina tion of the two primer pairs sY86 and s Y 12 7, or a second 
priming site in the genome. 
Of the total 315 samples analysed for Yq 11 micro-deletion, 23 displayed three 
conSistently negative PCR results, including one individual who had three possible AZFc 
micro-deletions. These samples were further analysed by Southern blot hybridisation. 
3.3.2 Southern Blot Analysis 
Southern blot hybridisation analysis con-firmed that 14 of the 23 individuals did have 
deletions of AZFc STS' (Table 3.5) (Figure 3.12), including one individual who had two 
non-adjacent STS deletions within AZFc, and a third marker confirmed as intact (CP, 
Table 3.5 and 3.6); this total includes three individuals who were only screened for AZFc 
deletions (asterisked Table 3.5). 
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Table 3.5. Samples identified with Yq micro-d.e1etions. 
Semen STS Deleted Sample Classification Frequency" Comments 
sY149 4071 Az Vasectomy Reversalb 
sY158 4449 Az 
sY149' 5544 Az 3/20(15%) -
sY156* 2696 SOAs 
sY149 4290 SOAs 
sY149 6290 SOAs 
sY146 BT SOAs 
sY146 & sY156 CP SOAs 
sY146 Zc SOAs 6/52 (11.5%) 
sYl56 SF96-283 OAs 1/29(3.4%) 
sY149 SF96-380 0 
sY158* AM302J 0 2/28(7%) 
sY149 3047 As 
sY156 WT As 2/56(3.6%) 
"Frequencies are displayed as the proportion of the total number of individuals in the semen 
classification. The asterisked* micro-deletions indicate samples for which the extracted DNA 
volume was not sufficient tor screening in all three AZF regions; they have only been screened for 
deletion of the nine AZFc STS'. "The semen quality of this individual was analysed after his 
vasectomy reversal; his semen quality prior to that is unknown. Neither the SO nor N semen 
classification groups had any micro-deletions identified (0/21 and 0/104, respectively). For more 
derail refer Appendix D. 
sY254 
sYI58 
M 1 2 3 4 5 6 7 8 9 1011 
sYl56 
sY157 
sY254--". 
M1 234567891011 
sY156 
sY157 
sY149 
Figure 3.12 Southern blot hybridisation 3. On the left is the agarose gel image before transfer to 
the nitrocellulose membrane. Various STS marker bands of note are indicated. The right-hand 
image is a scan of the autoradiography film after developing. The red box highlights a very faint 
possible band in lane 10 that was being probed tor, although the sY157 positive is much darker. 
Southern blot 4 indicates this is not a real band (Figure 3.13). Mis AH/E (lamba DNA digested 
with HindIIl and EcoRl restriction enzymes). All bands apparent on the Southern blot represent 
positive control bands; however the sample with the red box was repeated in Southern 4 below. 
52 
sYl58 
MJ2345 
Chapter Three - V-Chromosome Micro-deletion 
o l- sYl56 
O'L--_ sY254 
+-- sY277 
MJ 2345 
Figure 3.13. Southern blot hybridisation 4. The agarose gel image on the left shows additional 
non-specific bands that are not detected by the probe in the autoradiography image on the right. 
The red box indicates where a sY 156 band was probed for; its absence suggests that the band-like 
smudge in Southern blot 3 was not a real band. There is a band in sample 2 that looks like a 
sY277 band although it does not appear with ethidium bromide staining (left), it may be a well 
placed spot like the one near the top of the gel since no sY277 primers were added to that sample. 
Mis A.HIE. 
The remaining nine samples had the presence of DNA corresponding to the STS marker 
band confirmed by Southem blot hybridisation. This indicated that DNA, albeit at a very 
small concentration was present due to successful primer binding and amplification 
through the STS during the multiplex peR reaction (Table 3.6). 
Table 3.6. Samples with STS band presence confirmed by Southern blot. 
Sample Southern blot Number STS confirmed Semen Classification 
8055 1 156 Az 
4646 1 156 SOAs 
2275 1 157 OAs 
2307 1 156 & 254 0 
SM 1 156 &254 0 
RS 1 156 &254 As 
1469 1 157 N 
8055 2 156 Az 
4646 2 156 SOAs 
2307 2 254 0 
95-22 2 156 & 254 0 
SM 2 254 0 
RS 2 156 As 
3002 2 156 N 
CP 3 158 SOAs 
Sample CP appears in both Tables 3.5 and 3.6 because it had some deletions confirmed (Table 
3.5) and one STS band verified as present (Table 3.6). Semen classification is abbreviated as per 
Table 3.5. 
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Exactly two-thirds (10/15) of the observed micro-deletions were identified in the two 
semen classification groups with the most severely affected spermatogenesis; azoospermia 
and severely oligoasthenozoospermia, characterised by the complete absence of sperm 
cells, or extremely low sperm count «5.0 million sperm/nil) combined with reduced 
motility «50%). Both azoospermia and severely oligoasthenozoospermia groups showed 
markedly higher micro-deletion frequencies than other semen classifications (15% and 
11.5% respectively; Table 3.5). In total, 14 of the 211 (6.6%) men with poor semen 
quality were identified with micro-deletions; none of the 104 normozoospermic 
individuals were identified with any AZP micro-deletions. 
3.3.3 Statistical Analysis 
The difference in Yq micro-deletion frequency between normozoospermic and non-
normozoospermic groups was statistically tested using a G-test of independence. A 2x2 
contingency table (Table 3.7) was created in order to evaluate the relationship. 
Table 3.7. Yq rnicro-de1etion contingency table. 
NormolS Non normolS Total 
Yqril~d* oOs. .. Dlf. 
4.62 9.38 
)4 
exp 
NoYqm-d* obs 104 197 99.38 201.62 
301 
exp 
Total 104 211 315 
*Yq mod refers to samples identified with AlF STS micro-deletions; the "No Yq m-d" row 
indicates nlllllbers of samples that did not have any micro-deletions. "obs" is observed numbers of 
individuals and "exp" is expected frequencies. 
The null hypothesis is that semen quality is unrelated to micro-deletion presence; against 
the alternate hypothesis that they are related. A William's correction was used as 
recommended by Sokal and Rolhf (1995). 
At an a; level of 0.05, Gadj = 1U)9, a~d therefore, because X2~.05.1 =3.841 is less than 11.09, 
the null hypothesis is rejected; semen quality is related to the presence ofYq AZP micro-
deletions (P<O.OOl). 
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3.4 Discussion 
3.4.1 Comparison with Published Yq Micro-deletion Frequencies 
Screening of the Yq AZF region identified 14 individuals with Yq micro-deletions. These 
were restricted to men with poor semen quality (6.6%) and were most commonly 
observed in men with severe spermatogenic defects. Not surprisingly this difference in 
deletion frequency between nonnozoospermic and non~normozoospem1ic individuals was 
statistically significant (P<O.OOl). A comparison of other Y chromosome micro-deletion 
studies suggests that the deletion frequency commonly ranges from three to seven percent 
among men with poor semen quality (Vogt et al. 1996; Girardi et al. 1997; Pryor et al. 
1997; Kent~First et al. 1999), but is significantly higher if the study population is 
intentionally selected based on semen characteristics (Kent-First et al. 1999). This 
suggests that more meaningful conclusions regarding particular male semen 
characteristics and the genetic mutations that cause them would come from analysis of 
highly selected study populations. While this seems rather obvious, it is harder to put into 
practise since gathering enough individuals of a particular phenotype so that results have 
significance can be difficult. 
Nevertheless, while studies such as this one may not necessarily highlight which Yq 
chromosomal regions are associated with particular phenotypes, the fact that Yq deletions 
are consistently found in 5-10% of men with impaired spermatogenesis suggests they play 
an important role in the predisposition to reduced sperm production (Qureshi et al. 1996; 
Pryor et al. 1997; Grimaldi et al. 1998; Liow et al. 1998; Kent~First et al. 1999; Krausz et 
al. 1999; Kerr et al. 2000; Dohle et al. 2002; Madgar et al. 2002; Erasmuson et al. 2003). 
Yq micro-deletions are extremely rare in men with normal semen parameters. Of the 
published data analysed only three studies have reported finding any deletions within 
normozoospermic controls; 41200 (2%) (Pryor et al. 1997)),8/920 (0.87%) (Kent~First et 
al. 1999) and 1/141 (0.71%) (Kerr et al. 2000). While several deletion intervals are 
associated with azoospermia, JOLAR in AZFa, and KLARD in AZFc, the presence of 
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small deletions of the Y chromosome's AZF region do not preclude the possibility of 
fathering offspring. However, many of the fathers found to harbour micro-deletions 
reported having trouble conceiving and several choose to utilise alternative means of 
having children (Vogt et a1. 1996; Pryor et a1. 1997). Spenn from men with Y 
chromosome micro-deletions are capable of achieving fertilisation through ICSI 
(intracytoplasmic sperm injection) although as expected sons inherited the AZF deletions 
present in their father (Jiang et a1. 1999; Kamischke et a1. 1999; Page et a1. 1999). 
3.4.2 Micro-deletion within AZFc. 
Of the 15 micro-deletions identified, the majority of deletions were of the sY149 marker 
(6/15). This STS falls close to the DAZ marker (s Y254), but has no sequence homology 
with the DAZ sequence (Entrez accession numbers NM_004081.3 and NM_020420.1, 
National Centre for Biotechnology Information (NCBI) www.ncbLnlm.nih.gov) 
according to BLAST masic local ~lignment ~earch 1001; NCBI, (Altschul et a1. 1990)). 
Interestingly, although the sY277 marker has been reported to be an additional marker for 
the DAZ gene family (Reijo et a1. 1996) it did not align with either of the DAZ gene 
sequences submitted to the Entrezdatabase (given above), while sY254 aligned with both. 
The four deleted AZFc markers (sY146, sY149, sY156, and sY158) do not have sequence 
similarity to any of the favoured AZFc spermatogenesis genes, and are therefore presumed 
to bind to intervening regions, pseudogenes and introns within AZFc (Skaletsky et a1. 
2003). Given that most deletions of AZFc are larger than 1Mb and remove all five gene 
families (BPY2, CDY1, DAZ, PRY, and RBM2) this suggests that the majority of the 
individuals in the study population did not have large deletions of that nature, since STS' 
dispersed between the AZFc spermatogenesis genes were amplified successfully. However, 
it is possible that the deletions observed may extend into spermatogenesis genes on their 
boundaries and result in reduced spennatogenesis. 
S6 
Chapter Three - Y -Chromosome Micro-deletion 
The locations of the AZFc STS markers used in this study given on the NCBI website 
(www.ncbi.nlm.nih.gov) suggest that the individual identified with two AZFc micro-
deletions (CP, Table 3.5) appears to have two adjacent deletions (Figure 3.14). However, 
these are separated by thousands of base pairs and may not necessarily represent a large 
deletion. Analysis of the father's and brother's AZF region would indicate whether the 
deletions were inherited or are the result of a single or two separate de novo deletion 
events. Notably the gene positions of the DAZ and RBMY gene families, BPY2, and CDY 
are different between the NCBI website, de Vries et a1. (2002), and Skaletsky et a1. (2003) 
making definitive conclusions difficult. 
Mbp 
24.0 
24.1 
24.2 . 
24.3 
24.4 
24.5 -
24.6 
24.7 * 
24.8 
25.6 
25.7 
25.S 
25.9 
26.0 
26.1 
26.8 
26.9 
27.0 
* 27.1 
27.2 
DAZ4 
RBMY2CP 
CDY 
TTTY 
RBMY2DP 
DAZ 
DAZ2 
DAD 
Figure 3.14. Schematic map of AZFc showing 
location of 5TS markers. STS marker locations 
were identified lIsing the Reverse e-PCR web-based 
programme ((Schuler 1997) NCBI website 
www.ncbi.nlm.nih.gov). All potential binding 
sites are given within the Homo sapiens genome 
sequence (taxon reference 9606). Other Y 
chromosome genes or pseudogenes located on the 
Y chromosome 5TS map viewer are noted. The 
approximate nucleotide location along the Y 
chromosome is given on the left hand side and 
corresponds to Yql1.22-23. RBMY2CP and DP are 
RBMY family 2 C and D pseudogenes. 
• sY156 
sYl46 
sYl49, sY254, and sY277 
sY254 
* sYl57 
• sY269 
sYl58 
3.4.3 Absence of Micro-deletions within AZFa and h. 
The failure to identify micro-deletions of AZFa is not necessarily surprising since they are 
more often observed associated with very severe reductions in semen quality (10% of 
SCQ patients (Foresta et a1., 2000)) and only a single individual in the entire study 
population was noted as having this type of testicular pathology. Furthermore, the two 
STS' selected to screen for AZFa deletions fall proximal to all three candidate 
spermatogenesis genes so that only large deletions that eliminate all of USP9Yand 
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proximal to that would be detected (Figure 3.9). Perhaps use of sY87 which is located 
be tween USP9Yand DBY might detect deletion intervals corr~sponding to elimination of 
one or other, or both genes (Figure 3.7). 
As with AZFa, STS markers selected for AZFb did not actually bind to any candidate 
spermatogenesis genes, but to the DNA sequences surrounding them. However, deletions 
involving the AZFb STS' used in this study do occur in both AZFa and b deletion 
intervals. STS sYl27 was part of a common deletion observed in four men with severe 
spermatogenic failure that encompassed the EIF1AYand SMCY genes (Ferlin et al. 
2003). A further eight men in the same study had deletions of the entire AZFa interval 
encompassing both sYl27 and sY134. 
3.4.4 Yq STS Deletion Analysis by peR 
It is likely that deletion frequency of multicopy genes has been grossly underestimated 
since, PCR will·only detect a deletion if all copies are missing. The DAZ gene family for 
example, is pr~sentin two clusters each with two DAZ genes. It is thought that only one 
of the four DAZ copies needs be intact for the STS primer pair to bind and amplify a 
product by PCR, yet deletion of three DAZ copies is likely to have a profound impact on 
an individual's semen quality. Therefore, in the time since sequencing of the MSY more 
sensitive approaches have been developed. Alternatively, restriction digestion of two new 
STS', sY581 and sY587 which target subtle sequence differences located in the introns of 
some DAZ gene family members, is able to distinguish between the four copies. In this 
way it is possible by meaJ;1s of eli11!ination to, determine wl1.ichgene copies of the Jour are 
, . • .',' , I' , 
present, and which are deleted (Saxena et al. 2000; Ferlin et al. 2002). Notably this 
technique identified deletions of DAZ copies 1 and 2 in two men with severe 
spermatogenic failure that had previously been cleared ofDAZ deletions by standard 
sY254 STS deletion analysis (Ferlin et al. 2002). 
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It is possible therefore, that deletions of DAZ genes and other multicopy families such as 
RBMYwere missed in the AZF deletion screening conducted in this study, which might 
explain why no deletions of DAZ(sY254) were observed. 
3.4.5 Yq Deletion Analysis by Southern Blot 
Analysis of samples using Southern blot hybridisation verified both the presence and 
absence of DNA representing a PeR-amplified STS band (Tables 3.5 and 3.6). The 
significance of confirming the presence of an indistinct peR band using Southern 
hybridisation, may suggest one of several possibilities. Firstly, the peR reaction mix was 
inhibited in the same way, on at least three different occasions. Generally, problems with 
peR reactions occurred in samples with low sperm count, where DNA concentration was 
low and there is the possibility that reaction inhibitors were retained in the sample during 
DNA extraction in an effort to maximise DNA yield. Alternatively, low concentration 
peR products might suggest that the copy number for the Y chromosome gene is reduced, 
with the result that amplification is lower because there are less primer binding sites. This 
is less likely to be the answer in this case, since a BLAST alignment suggested that none 
of the STS' used corresponded to any of the candidate spermatogenesis gene families 
identified to date. 
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4.1 Introduction 
The androgen receptor (AR) is not essential for life, just for maleness. As a consequence, 
it is the most frequently mutated human steroid receptor, with over 300 different 
mutations documented (Yong et al. 2000). These changes fall into two classes: increases 
in length of a polymorphic CAO trinucleotide repeat in the transactivation domain, or 
missense mutations of the ligand~bindhlg domain; both reduce the transcription-
activating function of the AR. It is predicted that mutations of the androgen receptor 
gene cause up to 10% of idiopathic male infertility (Yong et al. 2000). 
4.1.1 The Androgen Receptor and Male Sexual Development. 
Human embryos follow the same developmental path until the sixth week of gestation 
when male embryos are prompted to differentiate down the male developmental pathway 
by members of the SOX (SRY-like HMO box) gene family on the Y chromosome, which 
stimulate a cascade of gene activities resulting in male sexual development (Yong et al. 
2000). 
At puberty a surge of male androgen (the steroid sex hormones; testosterone and 
dihydrotestosterone (DHT)) triggers the differentiation of male secondary sexual organs 
and initiates spermatogenesis (MifSud et al. 2001). This response of the male body to 
androgen is mediated by the AR. Binding of androgen to the ligand~binding domain 
(LBD) in the cytoplasm of the cell stimulates a conformational change in the AR in a 
region of the LBD that is made up of twelve a.-helices. Folding of this region prevents 
further androgen biridingand results in the dissociation of other proteins bound to the 
AR to reveal functional domains where transcriptional co-activators can bind. The 
androgen:-bound AR translocates into the nucleus where it forms a dimer complex with 
another androgen-bound AR (Wong et al. 1993; Roy et al. 2001). The DNA~binding 
domain (DBD) facilitates binding of the androgen~AR homodimer complex to androgen~ 
response elements in the regulatory regions (promoter and enhancer sequences) of target 
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genes. Co~activator proteins (transcription factors) bind to the transactivation domain 
(TAD) of theAR and fine~tune the amount of target~gene transcription activated by the 
AR (Gottlieb et a1. 1999). 
Male sexual development is not an androgen-driven process, but androgens are required 
for normal development; differentiation of Wolffian Ducts, inhibition of female sexual 
organ development (Quigley et a1. 1995). Speml production also requires high 
concentrations of androgen and a functional AR (Quigley et a1. 1995). 
4.1.2 The ARGene 
The AR gene is a single copy gene located on the long arm of the X-chromosome (Xqll). 
The coding region comprises nearly 2760 base pairs of DNA spread over eight exons. The 
AR protein is derived from a single polypeptide that varies in length depending on the 
number of trinucleotide repeats present in two polymorphic repeat regions within exon 
one (Figure 4.1) (Lubahn et a1. 1988; QUigley et al. 1995). 
23 4567 B 
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a. (CAG) 11.31 (CCN). (GGC)8-24 
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Figure 4.1. Schematic representation of the AR gene and protein. (a) The AR gene. Exons are 
colour-coded to protein domains. (b) The protein has three functional domains: the 
transactivation domain (TAD) from exon 1, the DNA-binding domain (DBD) from exons 2 and 
3, and the ligand-binding domain (LBO) from exons 4 to 8. The protein is approximately 919 
amino acids in length but varies depending on repeat number within two polymorphic repeat 
tracts; a polyglutamine (Q) (CAG) 11-31 and polyglycine (G) (GGC) ,S-24 (blue boxes). The third 
trinucleotide repeat is an eight-unit proline repeat tract (P) (CCN)s. Arrows indicate mutation 
hot-spots (Wang et al (l998b); Yong et a1. (2000». The hinge region containing the nuclear-
targeting sequence is indicated by the red box. (c) AR protein domains. Adapted from Quigley et 
a1. (1995). 
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The AR belongs to the steroid-receptor superfamily which also includes receptors for 
oestrogen, adrenal and thyroid hormones, retinal acid and vitamin D. All of which 
encode the three functional domains plus the hinge region (Figure 4.1) (Quigley et a1. 
1995). 
The TAD is the largest AR domain comprising more than half the protein (~53 7 amino-
acids (aa». It has the least conserved DNA sequence and is the most variable in size 
between members of the steroid receptor family. Within the TAD are three trinucleotide 
repeat DNA regions; two polymorphic homo polymeric repeats; the CAO-encoded 
glutamine repeat (11-31 repeats; approximately Q58_Q79), and the OOC-encoded glycine 
repeat (8 to 24 repeats; roughly 0 449_0472), and a single eight-unit heteropolymeric (CCN) 
proline repeat (pJ72_p379) (Simental et a1. 1991; Jenster et a1. 1992). 
The central, cysteine-rich DBD is 90 aa long and has the most highly conserved amino-
acid sequence among steroid receptor family members. This region folds to create two 
loop structures that together form a single unit comprising two zinc finger motifs. Each 
motif is created by the binding of a zinc ion to four cysteine residues in each of the two 
exons. Three residues at the base of the first zinc finger (exon 2), glycine 557 , serine578, and 
valine5Bl determine the DNA specificity controlled ,by the DBD of the AR by interacting 
with enhancer sequences in 5' regulatory regions of target genes. The second zinc finger is 
basic and functions to stabilise the DNA/AR association by interacting with the 
phosphate backbone and mediating receptor dimerisation (Lubahn et a1. 1988; Marcelli et 
a1. 1990; Jenster et a1. 1992; Quigley et a1. 1995). 
The hinge region is encoded by the 5' end of exon four, and contains all but two of the 
amino-acids that make up the nuclear-targeting sequence (arg629 -lys-leu-lys-lys633) which 
directs the transportation of the AR from the cytoplasm to the nucleus upon androgen 
binding. The first two amino-acids of the targeting sequence are encoded at the 3' end of 
the TAD (arg-lys) Oenster et al. 1992; Quigleyet a1. 1995). 
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The ligand-binding domain (LBD; 250 aa) facilitates the specific, high-affinity binding of 
male sex steroids to the receptor. This domain is also predicted to be the binding site of 
inhibitory proteins that prevent AR transcription activation in the absence of ligand and 
is involved in dimerisation of receptors (Housley et a1. 1990; QUigley et at. 1995). 
4.1.3 Co-activator Proteins Enhance AR T ransactivation 
A number of proteins form complexes with the AR and enhance its transactivation 
activity. Androgen receptor-associated protein 24 (ARA24, also known as GTP-binding 
nuclear protein RAN) is a member of the Ran (Ras-related nuclear protein) family of 
proteins. It functions as a GTP-binding protein and is predicted to be involved in the 
transport of proteins out of the nucleus, cell-cycle progression, and chromatin 
condensation (Hsiao et a1. 1999) . ARA24 enhances AR-mediated transcription 
activation by binding to the polyglutamine region. The binding affinity of ARA24 for the 
AR is inversely related to the number of CAG repeat units encoded in the polyglutamine 
region; interactions become stronger as glutamine number decreases resulting in 
enhanced AR transactivation capability, and are weakened with increasing numbers of 
CAG repeat units redUcing transactivational activity (Hsiao et a1. 1999). 
Research indicates that co-activators bind at several different places on the AR (Irvine et 
a1. 2000). The TAD contains a ligand-independent transcription-activation functional 
domain (AFl) that is repressed by the LBO when no androgen is bound. The AF1 region 
comprises two overlapping, but distinct transcriptional activation units: TAU1 and TAU5 
at amino-acid residues 101-370 and 360-528, respectively (Figure 4.2). Both AF1 and 
AF2 are required for optimal transactivation activity of the AR (Irvine et a1. 2000). 
TAD P G DBD LBD I. I 
TAUl (101·370) T AU5 (360·528) AF2 
I 
AFI 
Figure 4.2. The location of transcription-activating functional domains within the TAD. 
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The LBD also contains an activation function region, AF2, where ligand binding induces 
a conformational change that repositions AF2 so that it can interact with AR 
transcription co-activators (Figure 4.2). TransCription activation of androgen-target genes 
requires both AF1 and AF2; however elimination of virtually any stretch of the TAD 
results in a dramatic reduction (80%) in ligand-dependent transactivation activity by the 
AR (Irvine et a1. 2000). 
4.1.4 Androgen Insensitivity Syndromes. 
Normal function of the AR is essential in the developing embryo to ensure proper 
differentiation of the male genitals both internally and externally. Mutations that alter 
the ligand- or DNA-binding activity of the AR are associated with a subtle reduction in 
AR target gene activation and cause "androgen-insensitivity" syndromes (AIS). At its 
most severe, AR dysfunction results in complete androgen insensitivity syndrome (CAIS), 
characterized by sex reversal in otherwise healthy 46XY individuals; patients with CAIS 
have normal testosterone levels but entirely feminine reproductive phenotype. Mutations 
of the AR gene that result in a less severe impairment to AR functioning result in partial 
androgen insensitivity syndrome (PAIS) where the physiology of male genitalia can 
appear anywhere from the normal male phenotype to almost completely feminine 
genitalia. PAIS patients commonly experience defective spermatogenesis and male 
infertility (Marcelli et a1. 1990; McPhaul 1999; Lim et a1. 2000). 
Malfunction of the AR is associated with many androgen-related conditions, such as 
abnormal genital development, spinal bulbar muscular atrophy, breast, ovarian and 
postate cancer, and even baldness and acne (Yong et a1. 2000). 
Most studies of AR mutation have identified defects in androgen- and DNA-binding 
domains because these changes produce characteristic AIS phenotypes in affected males 
(Puscheck et a1. 1994). Mutations range from single nucleotide changes that cause 
missense amino-acid substitutions to large deletions of the gene (Loy and Yong 2001). 
Substitutions within the DNA-binding domain impair the capacity of the receptor to bind 
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to target DNA sequences within promoter and enhancer regions. Substitutions within the 
LBD have more varied effects on receptor function but often result in disruption of 
associations between the transcription co-activators and the TAD (Loy and Yong 2001). 
Both types of mutation result in reduced DNA binding by the AR, leading to diminished 
transcriptional activation and reducing AR regulation of target gene activity during 
sexual development (Lim et al. 2000; Loy and Yong 2001). Two regions within the LBD 
are 'hot-spots' for amino-acid substitutions, these regions; spanning residues 726-776 and 
828-886 (Figure 4.1) are often found associated with AIS phenotypes. A single 
substitution within this region is sufficient to impair receptor functioning and drastically 
alter the sexual appearance of individuals (Puscheck et al. 1994; Wang et al. 1998a; 
Wang et al. 1998b; Loy and Yong 2001). 
Although almost the entire TAD region is important for normal receptor transactivation, 
few deleterious mutations have been characterised; only 18 mutations have been observed 
in AIS patients. Most of these mutations produce a premature stop codon resulting in a 
severely truncated and non-functional AR protein. The remainder results in a reduction 
in transactivation; deletion of amino-acid residues 101-370 reduces transactivation 
activity to 50% of wild-type. While these mutations are predicted to be the cause of the 
reduced spennatogenesis in these men, they do not always result in infertility. At least 
one of the substitutions has also been observed in normozoospermic controls, and many 
more produce varying degrees of AIS phenotypes between different individuals (Wang et 
al. 1998b; Mifsud et al. 2001). This suggests that genetic background is important in the 
determination of fertility. The lack of TAD mutations identified in AIS individuals 
suggests this domain does not contribute significantly to this pathology. It does not 
necessarily follow however, that the domain is infrequently mutated since genetic studies 
of the AR have largely comprised screening for mutation in individuals with some degree 
of androgen insensitivity symptoms (Loy and Yong 2001). Alternatively, it is hypothesised 
that mutation of the TAD might alter expression patterns of genes essential for aspects of 
male sexual development not necessarily associated with outward appearance, for 
example, sperm production (Puscheck et al. 1994). 
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4.1.5 The ARGene and Trinucleotide Repeat Expansion 
The polymorphic polyglutamine region encoded by the CAG trinucleotide repeat varies 
nonnally between members of the population (11 to 31 repeat units), and between 
ethnicities (Edwards et a1. 1992). Men of African descent tend to have shorter CAG 
repeat alleles, with an average of 18 repeats, Asian men have on average, 23-24 repeats 
(Mifsud et a1. 2001), and Caucasian men fall in between with an average of 21 repeats 
(Quigley et a1. 1995; Hardy et a1. 1996). Glutamine-rich regions enhance transcription 
factor binding, therefore, the AR polyglutamine region is predicted to function by 
regulating the amount of gene transcription initiated by the AR, through its interaction 
with co-activators such as, TIF2 (transcriptional intermediary factor 2), ARA24 
(androgen-receptor associated protein 24), and P160-coactivators (Gerber et a1. 1994; 
Hsiao et a1. 1999; Irvine et a1. 2000; Yong et a1. 2000). 
The AR polyglutamine region, like other trinucleotide repeat tracts, can undergo either 
expansion or contraction in repeat number during DNA replication. Gross expansion 
(>36 CAG repeats) of the repeat tract results in spinal bulbar muscular atrophy (SBMA; 
commonly known as Kennedy's Disease) (La Spada et a1. 1991). Kennedy's disease is a 
severe, progressive, adult-onset neuromuscular disease that causes weakness of the 
muscles in the extremities, and those controlling speech and swallOwing. Secondary 
symptoms commonly include AIS gynecomastia (the development of breast tissues in 
men, often during adolescence), testicular atrophy and severely reduced spermatogenesis 
(oligozoospennia or azoospermia) (Yong et a1. 2000). Due to the X-linked nature of the 
disease it is maternally inherited and only affects men; female carriers are usually 
phenotypically nonnal (Yong et a1. 2000). 
In contrast, a reduction in glutamine repeat number increases the risk of androgen-driven 
cancers, speCifically prostate, breast, and ovarian; less than 20 AR CAG repeats doubles 
the risk of developing prostate cancer (Sartor et a1. 1999). Contraction of the ARrepeat 
disrupts receptor specificity so that it becomes activated by ligands other than male 
androgen, resulting in hyperstimulation and prolific growth of target tissues. The X-linked 
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and maternally inherited nature of AR mutation correlates with genetic features of cancer 
heredity, where history in a brother indicates greater risk than in the father (Giovannucci 
et a1. 1997). Interestingly, breast cancer risk is heightened in women who carry the 
BRCA1 gene mutation and have long AR polyglutamine regions (>28 CAG repeats) 
(Rebbeck et a1. 1999). 
4.1.6 Mechanism of Trinucleotide Repeat Expansion 
The AR CAG trinucleotide repeat is a member of a class of DNA called microsatellites; a 
stretch of DNA made up of units, 1-6 bp in length, repeated multiple times in a head to 
tail orientation; in this case CAGCAG ... (CAG)11-31. Most microsatellites are polymorphic 
in unit copy number between individuals, differing by small increases and decreases in 
repeat number within the nonnal range, and are not associated with disease (Kovtun et 
a1. 2001). The dramatic increase in trinucleotide repeat number associated with disease 
often occurs during transmission from parent to offspring, and repeat number correlates 
with both disease severity, and age of onset; the longer the allele the earlier the age of 
onset and more severe the disease symptoms (also known as anticipation) (Kovtun et al. 
2001). 
Although the mechanism of micro satellite expansion is not fully understood it is thought 
to be due to misaligned pairing of repeat stretches and formation of secondary structures 
(Kovtun and McMurray 2001). Of the ten possible trinucleotide repeat sequences, three 
are especially prone to expansion: CAG, CGG, and GAA. These three sequences have an 
enhanced ability to fonn stable secondary structures through nucleotide base-pairing 
(McMurray 1999). For example, the CAG-CTG repeat forms a hairpin structure through 
G-C base-pairing with one mismatch base, A-A or T-T (Figure 4.3). In contrast, repeat 
stretches that rarely undergo expansion in repeat number contain base interruptions to 
the triplet repeat sequence that inhibit the formation of hairpin structures by increasing 
the number of mismatched bases (Chung et a1. 1993; Kovtun et a1. 2001). In yeast, CAG-
CTG repeat stretches with two interruptions were repaired better, and were more stable 
than repeats with only one interruption (Kovtun et Qt. 2001). 
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Figure 43. Hairpin structure formed by CAG trinucleotide 
repeat DNA sequences. The hairpin structure is stabUised 
by additional hydrogen bonding between C-G base pairs, the 
interruption of a trinucleotide repeat DNA stretch by a 
different base increases the proportion of mismatched bases 
and reduces the stability of the structure. Adapted from 
Kovtunet al. (2001). 
The longer the trinucleotide repeat region becomes the more likely it is to undergo 
further expansion (Leeflang et aI. 1995). Analysis of the Huntington's disease (HD) CAG 
repeat observed that repeat lengths in the normal range had a mutational frequency of 
0.6%, while moderately expanded HD alleles (30 and 36) had a mutation rate of 11 % and 
53% respectively, and disease-causing repeat lengths (38-51 CAG repeats) mutated 92%-
99% of the time (Leeflang et aI. 1995; Kovtun et aI. 2001). It is thought the propensity for 
higher mutation frequencies with increasing repeat length is due to the greater stability 
conferred by the higher level of hydrogen bonding; thus while long repeat regions (>25 
units) form hairpin structures as quickly as shorter repeats they unpair more slowly, and 
remain looped for longer to be trapped into DNA or inhibit replication and repair 
enzymes (Kovtun et aI. 2001). 
Research in bacteria and yeast suggests that trinucleotide repeat expansion occurs in 
these organisms via the incorporation of DNA loops after replication slippage or DNA 
strand break repair (Kovtun et aI. 2001; Mirkin and Smimova 2002). Replication slippage 
occurs when the polymerase enzyme has difficulty replicating the trinucleotide repeat 
region, the enzyme briefly dissociates itself from the replication fork and the template 
strand, and re-attaches at an earlier repeat dragging the nascent strand with it, forming a 
loop of extra DNA. Resumption of DNA synthesis results in an increase in repeat number 
equal to the number of repeats the enzyme travelled back (Figure 4.4a) (Kovtun et aI. 
2001; Mirkin and Smirnova 2002). 
Breaks in DNA can be created by the formation of DNA loops at the single- or double-
strand breakpoint. Repair then; occurs either by gene conversion; non-reciprocal 
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homologous recombination where DNA is copied but not exchanged, or complementary 
"fill-in" by repair enzymes (Figure 4.4b) (Kovtun et al. 2001). 
Alternatively it is hypothesised that incorporation of RNA primers by the flap-
endonuclease enzyme could result in microsatellite expansion. The removal of RNA 
primers from Okasaki fragments is inhibited when the RNA primer is composed of 
trinucleotide repeat DNA sequences; instead of being removed the primers are displaced 
and form loops that are then ligated to the 3' end of the adjacent Okasaki fragment and 
are replicated into DNA during the following replication round (Figure 4.4c) (Kovtun et 
a1. 2001; Mirkin and Smirnova 2002). 
A. 
B. 
a. 
~..--- Pol 
Loop formation 
SSBBreak 
Msh2 
bI. 
~ 
Loop formation and 
5 rabilisation 
hZ. 
Pol begins svnthesis again 
Gene conversion 
Complementary 
illlin 
c:::::> c. 
Ligation and 
expansion 
_L.--
1NR RNA primers not removed from 
Okasaki fragments rorm loops 
5' end of RNA primer is ligated to 
adjacent Okasaki fragment 3' end 
Figure 4.4. Three models of trinucleotide repeat expansion. A. Replication Slippage, the 
Polymerase enzyme (Pol; yellow) disassociates itself from the template strand when it encounters 
difficulty replicating the trinucleotide repeat (1NR); the nascent strand fonus a loop (blue) that 
expands the 1NR by the number of repeats pol moved back. B. Break repair at single- (SSB) or 
double-strand breaks (DSB) by either gene conversion, using a non-homologous template, or 
complementary fin allows expansion of the 1NR of the disassociated strand (blue). Other TNR 
loops (black) that form as synthesis proceeds may be inc'oi'porated at this time too. C. Okasaki 
fragment RNA primers (orange) can form loops when they consist of1NR sequences. These are 
not removed by the flap-endonuclease and are incorporated into the DNA by ligation. Adapted 
from Kovtun et al. (2001), Kovtun and McMurray (2001), Mirkin and Smimova (2002). 
74 
Chapter Four - The Androgen Receptor 
Research aiming to establish the mechanism and timing of expansion in mammalian cells 
has been more difficult. Transgenic mouse models suggest that expansion takes place in 
both somatic and germ cells, and that both occur in a cell developmental-stage dependent 
manner (Kovtun et al. 2001). Expansion in germ cells was observed in post-meiotic cells 
through the incorporation of repeat hairpin structures during DNA break repair (Kovtun 
and McMurray 2001). The expansion mechanism in both somatic and geml cells appears 
reliant on the presence of a mutS homolog-2 (Mshl) protein suggesting microsatellite 
expansion in somatic cells occurs via a mechanism similar to germ cells (Kovtun and 
McMurray 2001). 
4.1. 7 AR CAG Repeat Tract Expansion and Male Infertility 
It is predicted that mutations of the androgen receptor gene cause up to 10% of idiopathic 
male infertility (Yong et al. 2000). Normal spermatogenesis requires high levels of male 
androgen, yet many men with reduced sperm production have normal hormone levels and 
do not display AIS symptoms suggesting the cause lies elsewhere in the pathway. The AR 
mediates the transcription of genes involved in male sexual development and sperm 
production through its interaction with co-activators which bind to the polyglutamine 
region of the TAD in a CAG repeat number dePendent manner. High-normal CAG 
repeat numbers weaken the interaction and reduce transactivation while very long CAG 
repeat alleles cause Kennedy's disease where onset is accompanied by dramatically 
reduced spenn production. Therefore, it is predicted that moderate expansion might be 
sufficient to reduce AR transcription activation of male genes such that spenn production 
is significantly decreased but remains beneath the threshold for pathological protein 
activity and androgen insensitivity phenotypes (Figure 4.5). 
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Prostate Cancer Risk 
Less Than 20 21 High 20's 36 
AR CAG Repeat Length 
Figure 4.5. Schematic graph Ulustrating the inverse relationship between AR CAG repeat length 
and the transactivation capability of the AR. Long alleles (>26 CAG units) results in low 
tmnsactivation and increased risk of decreased sperm production. Very long AR CAG repeat 
lengths above the double line cause SBMA and reduced sperm production. Short repeat lengths 
increase the transactivation potential of the AR resulting in hyperstimulation of tissues increasing 
the risk of cancer. Adapted from Yang et al. (2000). 
Research in a number of populations in the wake of this hypochesis suggests that indeed 
moderate increases in repeat size (226 CAG repeats) are significantly associated with 
reduced sperm production. Moreover, the greatest difference in repeat number from 
normozoospermic controls is observed in men with the most severely impaired 
spermatogenesis (azoospermia) (Tut et a1. 1997; Dowsing et a1. 1999; Yoshida et a1. 1999; 
Lim et a1. 2000; Mifsud et a1. 2001). However, not all studies of male populations have 
observed a statistically significant associacion between AR polyglutamine number and 
semen quality (Giwercman et a1. 1998; Dadze et a1. 2-l}OO) , and criticism of the findings 
has centred on the fact that significant risk of decreased sperm production might result 
from an increase in CAG repeat number of only one to two repeats above the mean. The 
results of my own research indicated there was no association between AR CAG repeat 
length and reduced sperm production in the population studied (Erasmuson et a1. 
2003) (with Appendices). Furthermore, experimental and control populations often 
display significant overlap in CAG repeat number distribution. This means there are 
normozoospermic men with high numbers of glutamine repeats for whom diminished AR 
activity is not causing a decrease in sperm production, and men with reduced sperm 
production with low numbers of repeats for whom a different mechanism is the cause of 
their impaired spermatogenesis, suggesting that AR m4tation causes only rare cases of 
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reduced sperm production. The question remains whether the correlation is merely 
statistical or a true physiological effect built up by a small change in AR activity over the 
course of the male's lifetime? 
Support for the hypothesis has come from in vitro studies of the transactivation activity of 
AR's with low-normal «20), normal (20-21) and high-normal (>26) numbers of 
glutamine repeats (Puscheck et aL 1994; Kazemi~Esfarjani et aL 1995; Tut et aL 1997; 
Dowsing et aL 1999; Irvine et al. 2000; Mifsud et al. 2001). A 6% reduction in AR 
transactivation activity was noted with an increase in repeat number from 21-29 repeats 
(Irvine et aL 2000). Surprisingly, these expression assays indicated that while repeat 
numbers in the higher end of the normal range did indeed have significantly lower levels 
of transcription activation, deletion of the entire polyglutamine repeat did not eliminate 
transactivational activity (Kazemi~Esfarjani et aL 1995). In fact, AR's with no CAG 
repeats had higher levels of transcription activation than those with 'normal' numbers of 
CAG units (20-21) (Kazemi~Esfarjani et al. 1995). On the basis of this research a second 
hypothesis was proposed which suggests that instead of decreasing transactivation, AR 
trinucleotide expansion instead increases an· inhibitory effect of glutamine. units on 
transactivation activity. Hence, the loss of transactivation function in the expanded AR's 
of Kennedy's patients and infertile men might be the result of an exaggeration of the AR's 
ability to bind protein, leading to the reduction in gene transcription activation of male 
target genes (Kazemi~Esfarjani et al. 1995). It is likely that X chromosomes with very low 
numbers of AR CAG repeats would be lost from the gene pool by the reproductive death 
of individuals from aggressive androgen-driven cancers. 
One final controversy is that while Kennedy's disease patients commonly experience some 
fertility problems during puberty and adolescence most do not develop oligo-or 
azoospermia until disease manifestation at 40 or 50 years of age, and so, for most of the 
patient's life their reproductive capacity is normal, but they have massively expanded AR 
polyglutamine tracts. Moreover, foetal sexual differentiation and development of 
Kennedy's patients is nomal, androgen-insensitivity appears rather suddenly at disease 
onset (La Spada et al. 1991). 
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Most likely the reduction in transcriptional activation in expanded AR CAG repeat tracts 
acts to compound effects of mutations in other fertility genes, so that men can have 
increased numbers of CAG repeats but not experience reduced sperm production if all 
other fertility genes are intact. It is widely appreciated that men with poor semen quality 
are likely to harbour more than one mutation of genes involved in sperm production and 
sexual development. Once a threshold of mutations is surpassed severe defects result in 
severely impaired spermatogenesis: awospermia (a form of truncation selection by 
reproductive death) (Vogt 1995). However, few if any studies have analysed the same 
population of men for mutations in a variety of recognised fertility genes, to examine if 
synergistic effects exist. In any case, since the AR is vital to the proper establishment of 
fertility it is likely to be the causal factor in at least some cases of male infertility. The 
concern is then the ability of men with poor semen quality to conceive children via 
intracytoplasmic sperm injection (lCSI) and pass on genetic changes that cause impaired 
spermatogenesis to their children (Vogt 1995). In the case of expanded AR CAG alleles, 
ICSI daughters will be 'carriers' passing the unstable allele to SOIlS in whom further 
expansion might occur, leading to a higher frequency of Kennedy's disease in succeeding 
generations (Hawkins et al. 1999; Vogt 1999; Cram et al. 2000). 
Transmission of extremely expanded alleles with 46 CAG repeats was examined over four 
generations in one family where six males had Kennedy's disease. All normal alleles 
segregated stably, in contrast, the expanded allele was markedly unstable, increasing 
seven times and decreasing once in a total of 17 transmissions. The increase was usually 
by one CAG unit; however, expansion by five repeats was noted once (Takiyama et at. 
1995). 
Further evidence for the largely stable nature. of CAG allele inheritance was observed in 
analysis of CAG number in 92 fathers and their 99 ICSI conceived daughters. Only four 
of the 99 daughters showed expansion or contraction of the original paternal AR CAG 
allele (20-24,22-23,26-18, and 26-22). This mutation frequency is thought to be 
consistent with the low level of mosaicism in CAG number between gametes of a normal 
healthy individual. Therefore, a child conceived by ICSI is not more likely to inherit an 
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AR CAG allele with a greater number of repeats than one from a healthy father who falls 
within the 'normal' range, 11-35(Vogt 1999). Nonetheless, the actual risk of transmitting 
impaired spermatogenesis is dependent on how significant slight differences in CAG 
number are to receptor function. 
4.1.8 Aim of Research 
By analysing AR CAG repeat variation I aim to establish whether moderate expansion of 
the AR polyglutamine region is a significant risk factor of poor semen quality in this study 
population. There is evidence for reduced transcription activation by the AR in vitro and 
in several other populations but the relationship remains controversial. Trinucleotide 
repeat expansion is an acknowledged mechanism leading to pathological protein activity, 
but it is less widely accepted that the small increases in AR CAG repeat length postulated 
to cause reduced transcription of fertility genes will produce a large enough effect to result 
in impaired spermatogenesis even over the lifetime of an individual. These results will be 
evaluated alongside Y chromosome micro-deletion and POLy data to assess the 
contribution of these three regions to semen quality (Chapter Six). 
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4.2 Method 
A total of 2 n individuals were analysed for variation in the AR CAG repeat region, 251 
of these formed the basis for a peer review paper (with Appendices). 
4.2.1 peR Analysis 
Specific PCR primers were designed to border the AR CAG repeat region and amplify 
through it. Primer sequences were derived from previously published research (Sartor et 
al. 1999) and confirmed by PCR simulation assessing the specificity of priming within the 
androgen receptor gene sequence published on the NCB! web site (version number 
NM _000044.2) using the computer programme Amplify 1.2 (Engels 1993). Primer 
sequences and parameters are specified in Table 4.1 below. 
Table 4.1. AR CAG trinucleotide repeat PCR primer characteristics. 
Primer Nucleotide GC Tm Product 
Name location Sequence (1M Na+) Size content (bp) 
AndroRFl 1183-1206 tccagaatc tgttccagagcgtgc 54% nAoC 
288 
AndroRRZ 1447-1470 gc tgtgaaggttgc tgttcc tcat 50% 69,4°C 
AndroRFl is the forward primer and RR2 the reverse. Primer sequences are given in the 5'-3' 
direction. Refer Appendix G for nucleotide sequence. 
The PCR reaction mix used standard concentrations of each additive (as per Chapter 
Two). PCR analysis was conducted in a MJ Research Inc. PTC-lOO thermo-cycler. The 
PCR programme consisted of an initial denaturation at 94°C for four minutes, followed by 
30 cycles of 94°C, 58°C, and noc for one min each, and a final ten min extension at 
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Initially 5 J.LI of the PCR reaction was electrophoresed through a 2% (w/v) agarose gel 
with 1 x orange G, at 8 V Icm for 20 min, then stained and visualised under UV 
illumination; on later gels this volume was reduced to 3 J.LI to maximise product yield for 
DNA sequencing. 
4.2.2 DNA Sequencing 
Precise quantification of CAG repeat number was established by DNA sequencing of 
purified PCR products for 272 individuals. Direct DNA sequencing using dideoxy 
tennination dNTPs was conducted using either y 32p_dCTP 5'-labelled primer sequencing 
or internally labelled a 33p_dCTP with the Thennosequenase (Amersham Phannacia 
Biotech) or Amplicycle (Applied Biosystems) sequencing kit systems respectively. Both 
isotopes had specific activities of 3000 Ci/mM. Because one sequencing run was sufficient 
to read the entire CAG repeat region, sequencing reaction volumes were reduced to one 
quarter of the suggested volume given in the DNA sequencing kits. 
4.2.2.1 5' Y 32p_dCTP Labelled Primer Sequencing Reactions 
Both primers were tested to ascertain which produced the clearest s~quencing reads with 
the result that the AndroRR2 (reverse) primer was used for the majority of sequencing. 
The AndroRR2 primer was end-labelled with y 32p_dCTP (NEN, 3000 Ci/mmol) by 
mixing 0.625 J.Ll (approximately equal to 20 pMol) of AndroRR2 primer with 1 x T4 
polynucleotide kinase (PNK) buffer (0.5 M Tris-HCl, pH 7.6, 100 mM MgClz, 100 mM 2-
mercaptoethanol), 1.125 J.Ll (16 pMoles) ofy 32p_dCTP isotope, and 2.5 units ofT4 PNK 
enzyme (2.75 J.LI of 0.9 ulI1J) the final labelled primer volume was 5 J.LI (quarter reactions). 
The primer mixture was heated in a thennal cycler (MJ Research Inc. PTC-lOO) at 37°C 
for 30 mins, and then stopped by heating at 95°C for 5 min to inactivate the kinase 
enzyme. The primer was then stored in the radiation room at -20°C until required. 
81 
Chapter Four - The Androgen Receptor 
Cycle sequencing was carried out by combining 200 finoles of purified PCR product with 
1/11 of sequencing buffer (260 mM Tris-HCl (pH 9.5),65 mM MgClz) plus 2 pMoles of y 
3zP_dCTP labelled AndroRR2 primer (above), and 4 u of Thermo Sequenase DNA 
polymerase (4 u//11; 0.0006 U//11 Thermoplasma acidophilum inorganic pyrophosphatase; 
20 mM Tris-HCl (pH 8.5), 1 mM dithiothreitol (DTT) , 100 mM KCl, 0.1 mM EDTA, 
0.5% Tween®20, 0.5% Nonidet®P-40, 50% glycerol); these are half reactions with a total 
reaction volume of 9.25 /11 The reaction was thoroughly mixed before dispensing 2 /11 
aliquots into each of the individual ddNTP termination tubes (2 fLl; each consists of 150 
fLm of the three other dNTPs, 150 fLM deaza-termination nucleotide plus 1.5 fLM ddnon-
termination nucleotide), mixed again, and a drop of oil added. 
Sequencing reactions were cycled in a thermal cycler (Eppendorf Mastercycler® gradient)· 
in the following programme: 96°C for 2 min,30 cycles of 96°c 30 s, 58°C 30 s, noc 45 s, 
and a final 10 cycles of 95°C 30 s, and noc 45 s. Sequencing stop solution (2 fLl; 95% 
fonnamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF) was added 
as soon as the cycling was complete and reactions stored at 4°C in the radiation room 
until required. 
4.2.2.2 a 33p_dCTP Internally Labelled DNA Sequencing 
Internally labelled cycle sequencing reactions were prepared in half or quarter volumes. A 
bulk reaction mix was made up consisting of n + 1 (n= the number of samples) volumes of 
0.25 fLl of AndroRR2 (8 fLM), 0.25 fLl of a 33p_dCTP and finally 2 fLl of 10 x cycling mix 
(0.25 U/fLl AmpliTaq DNA Polymerase, CS, in 500 mM Tris-HCl (pH 8.9), 100 mM KO, 
25 mM MgCIZ, 0.25% (v/v) Tween®20). After thoroughly mixing, 2.5 fLlwas aliquoted to 
individual tubes containing 100-200 finoles of DNA (made up with ddHzO to 12.5 fLl) to 
make a. final DNA sequencing reaction volume of 15 fLL Finally, 3 fLl of each DNA 
reaction mix was aliquoted to one of four tubes each containing 1 fLl of a differentddNTP 
termination solutions (each contains 22.5 fLM c7dGTP (addition of 7-deaza-2' -deoxy-
guanosine-5'-triphosphate alters the base pairing of guanine residues enhancing migration 
of GC rich sequences through the gel), 10 fLM dATP, dCTP and dTTP, plus one of: 80 
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fLM of ddGTP, if G termination mix tube; 600 fLM ddA TP if A termination mix; 300 fLM 
ddCTP if e termination mix; or 900 fLM ddTTP ifT termination mix in 10 mM Tris-HO, 
0.1 mM EDTA (pH7.5)). 
The reaction mixes were overlaid with a drop of oil then cycled in a preheated (95°C) 
thermal cycler for an initial 2 min at 95°e followed by 35 cycles of 95°e, 68°e, noe each 
for one min. Once amplification was complete 2 fLl of stop solution was added, and the 
reactions stored at -20oe until required. 
4.2.2.3 Electrophoresis of Sequencing Reactions. 
All sequencing reaction products were electrophoresed through a 6% denaturing 
polyacrylamide gel (6% acrylamide, 1 x TBE, 8.3 M UREA; Appendix F) (40 em x 34 em 
x 0.4 mm; model S2 electrophoresis tank; BRL Life Technologies Ltd). Once polymerised, 
the gel was pre-run for 30 min to ensure an even heat throughout. Samples were thawed 
and denatured at 95°e for 4 min just before pre-running was complete, then placed on 
watery ice to prevent re-annealing. Before loading, well spaces were flushed of urea using 
the 1 x TBE buffer in the upper buffer tank, and then 3 fLl of each termination mix was 
added in the A, G, e, T nucleotide order. Gels were run for a total of 90 min with 500 ml 
1 x TBE (0.04 M T ris-borate, 0.001 M EDT A) electrophoresis buffer at a constant 70 W 
power (approximately 1500 V and 45 rnA), before being transferred to a piece of 3MM 
(cuHo-size), placed on a gel-drier (model 583; Biorad) and dried for 60 min at Booe 
under vacuum. 
4.2.2.4 Autoradiography 
Gels were checked for radioactivity with a Geiger counter then placed in close contact 
with an X-ray film (Kodak MR Biomax), secured inside an autoradiography cassette, 
black plastic, and Perspex. Films were left to expose for increasingly longer periods as the 
isotope lost activity, fo1' example, fresh sequences (> 1000 cpm) requires approximately 
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12-24 hr exposure but as activity decayed films required greater exposure times ezp films 
were left to expose at -80°C) . 
4.2.2.5 Statistical Analysis ofCAG Repeat Length Variation 
Multiple comparisons were performed to test whether groups of men with poor semen 
quality (grouped as non-noffi10zoospermia) had significantly greater mean AR CAG 
repeat lengths compared to normozoospermic men, using both one- and two-tailed two-
sample t-tests (Zar 1996). The null hypothesis was: 
* Ho:/-Lnon-norrnozoosperrnia::::;/-Lnorrnozoosperrnia against 
* HA:/-Lnon-nonnozoospennia > /-Lnorrnozoospennia (one-tailed) 
and 
* Ho:/-Lnon-nOffilozoosperrnia = /-Lnonnozoospermia against 
* HA:/-Lnon-norrnozoospermia7=/-Lnormozoosperrnia (two-tailed), P<O.05. 
There were two groupings of total non-normozoospermia individuals, one including 
asthenozoospermic men, and one excluding them. The majority of research investigating 
associations between long AR CAG repeat lengths and semen quality has excluded 
asthenozoospermic men on the basis that reductions in AR transactivation lower the 
expression levels of genes involved in spermatogenesis, whereas these men have normal 
sperm counts but lack normal levels of sperm motility. I have decided to include them in 
one grouping since presumably sperm motility requires gene transcription of structural 
elements involved in the organisation of mitochondria and filaments within the sperm 
tail, and nuclear proteins involved in energy production, some of which may be up-
regulated by the AR. 
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4.3 Results 
AR CAG repeat number varied between 8 and 38 repeat units in the total population 
(n=272).9 to 38 in normozoospermic controls (n=98). and from 8 to 31 in men with 
poor semen quality (n= 174) (fable 4.2). 
Men with normal semen parameters exhibited the lowest mean CAG repeat number 
(21.62 ±0.32 repeats). while men with the most severely impaired spermatogenesis; 
azoospermia had the highest mean CAG repeat number (22.13± 0.7 repeats). This was 
not a statistically significant difference (Table 4.2). 
Although mean AR CAG repeat number increased as the severity of reduced sperm 
production increased, from normozoospermia to oligozoospermia, severe oligozoospermia. 
and azoospermia, the difference was not statistically significant indicating that CAG 
repeat distribution was unrelated to semen quality. 
4.3.1 PCR Analysis 
A single pair of PCR primers was sufficient to amplify the AR CAG repeat region. A sole 
PCR product was obtained of approximately 300 bPI but varied depending on the number 
of CAG units encoded within the polyglutamine repeat region (Figure 4.6). 
Jt4b 
M N As As N N 
Figure 4.6. Electrophoresis of AR CAG PCR products. N signifies NonnoZS. As AsthenoZS, SO 
Severely OligoZS. and 0 OligoZS. Each PCR product migrates differently through the agarose gel 
in a size-dependent manner. The asterisked nonnozs sample has 38 AR CAG repeats, and the 
double-asterisked sample. nine; the remainder have between 19 and 24 CAG repeats. 
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4.3.2 DNA Sequencing Analysis 
All 272 AR CAG PCR products were DNA sequenced using either 32p_ or 33P-labelled 
DNA sequencing methods and CAG unit number directly counted from the 
autoradiography film (Figure 4.7). There was no obvious difference in sequencing clarity 
between the two methods. 
I leG AI 
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Figure 4.7. Autoradiography image of AR CAG 
DNA sequencing. Individual 1 has 13 CAG repeat 
units, 2 has 21, and 3 has 26. 
Mean CAG repeat number and distribution were remarkably similar among semen 
classifications; the mean AR CAG repeat number for each semen classification differed 
from the next by less than or equal to half a repeat. All mean repeat lengths were slightly 
higher than the reported average repeat number for Caucasian men (21 repeats). This 
similarity in CAG repeat number distribution among semen classifications is reflected in 
the mean and mode for most groups which centres around 21 repeats. The range of CAG 
repeat lengths observed in both normozoospennic men and men with poor semen quality 
(non-nomlowospemlic) were virtually identical (9-38 and 8-31 respectively) (Figure 4.8). 
In addition, both groups of men had members with repeat lengths in the very low an.d 
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very high range, in fact, one nonnozoospennic individual has an AR CAG allele close to 
the threshold associated wirh Kennedy's disease (38 CAG units). The nonnozoospennic 
group of men displayed both the highest (38) and lowest (9) AR CAG repeat alleles 
(Figure 4.8). 
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Figure 4.8. AR CAG repeat length distribution within the sample population. The graph 
compares AR CAG repeat length distribution between nonnozoospennic individuals (dark purple 
bars) and men with poor semen quahty (orange bars); CAG repeat number is indicated along the 
X axis, and the frequency observed in the IXlPulation up the Yaxis. 
Men with poor semen quality had a markediy greater proportion of individuals with long 
AR CAG alleles (:~26; 13% compared to 5% tor normozoospem1ic men) (Table 4.2; 
Figure 4.8). Apart from the azoospennic group, more than 10% of each subgroup of non-
nom10zoospemlic men had long AR CAG alleles; a marked difference to the proportion 
of those groups with shorter AR CAG alleles. In comparison, nonnozoospemlic men had 
low frequencies of both long and short repeat alleles (Table 4.2). 
4.3.3 Statistical Analysis of Mean AR CAG Length. 
Mean CAG repeat length of each group of men with poor semen quality, the total group 
of men with reduced spem1 production (excludes asthenozoospennic men), and the non-
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normozoospermic group as a whole, was compared to the mean length observed in 
normozoospermic men using a one-tailed and two-tailed two-sample t-testat an <x'level of 
0.05 (Table 4.2). There was no statistically significant difference in CAG repeat length 
distribution between semen classifications; men with reduced sperm production were not 
more likely to have long AR CAG repeat lengths than normozoospermic men and no 
inverse correlation was observed between length of AR CAG alleles and speml 
production (P>0.05). 
Table 4.2. Statistical characteristics of AR CAG repeat length variation. 
Semen 
Mean± SE Mode PValue" Range %::=;;16
b %~26b 
Classification n (Median) CAG's CAG's 
Total 272 21.79±0.20 20(21) 8-38 3% 10% Population 
NormoZS 98 21.62±OJ2 20(21) 9-38 3% 5% 
Total Low 119 21.87±0.29 21 (21) 0.289 13-31 2.5% 13% Count" 0.577 
Total Non- 174 21.9±0.25 21 (21) 0.260 8-31 3% 13% 
normozsd 0.520 
AZS 15 22.13± 0.7 21,24
d 0.258 18-27 0% 1% (22) 0.515 
Severely 49 21.90±0.51 21 (21) 0.323 13-31 6% 14% OligoZS 0.647 
OligoZS 55 21.76±OA1 20(21) 0.394 18-31 0% 11% 0.787 
AsZS 55 21.93±OA8 23(22) '0.299 8-28 4% 13% 0.597 
(a) The firstPvalue is the one~tailed t-test score, the second is the, two-tailed score. (b) These 
columns reflect the proportion of each semen classification that fall greater than or equal to five 
repeats either side of the mean (21); the high risk region for reduced spermatogenesis (~26 CAG 
repe.ats (Dowsing et at 1999» and greater riskof androgen-driven cancers (::=;;16 CAG repeats)~ 
(c) The combined 'low count' group includes all individuals with reduced sperm count «20 
million sperm/ml). The 'Total Non-normozs' group includes asthenozoospermic individuals.· (d) 
Both 21 and 24 CAG repeat~ are equally most common among azoospermic men. 
The addition of 21 samples did not alter the result of statistical testing comparing AR 
CAG repeat distribution between semen classifications .. 
88 
Chapter Four - The Androgen Receptor 
4.4 Discussion 
Since the suggestion that expanded, yet normal AR trinucleotide repeat lengths might be 
a significant risk factor for reduced sperm production was made by Tut et a1. (1997) and 
Dowsing et a1. (1999) many other studies have sought to examine this association in other 
populations. 
There was no significant association between poor semen quality and moderate AR CAG 
repeat expansion in this group of New Zealand Caucasian men. Comparisons of other 
such studies indicates that there is little variation in mean CAG repeat number 
(approximately half a repeat) between Caucasian populations of men with reduced sperm 
count where sample sizes are high (Dadze et a1. 2000; Mifsud et a1. 2001; Wallerand et a1. 
2001; Rajpert~De Meyts et a1. 2002; Van Golde et a1. 2002)(Table 4.3). This might 
suggest that for those Caucasian populations where the mean CAG repeat number is 
much greater than 22 repeat units the sample size is not large enough. Because the 
difference in mean AR CAG repeat length between non-normozoospermic and 
normozoospermic populations is commonly small (usually one to two repeats), large 
sample sizes are required to generate a normal population distribution in order to evaluate 
the significance of the association. It is possible that for some of these populations Type II 
errors are occurring. 
Table 43. Comparison of AR CAG repeat length variability !Ind association with reduced semen quality in 
other studies. 
Semen Population Mean ± SE (n) Range PValueo Rererence Classification Ethnicity 
AZS Cuucasian* 22.1 ±o. 70 (15) 18-27 Not significant TIlis Study 
Caucasian* 23.0±0.63 (16) 19-26 Not significant Patrizio et at. 2001 
25.4±0.77 (27) 20-39 p=0.0005 ( < 1x106 spm/m!) 
Caucasian* 23.9±0.50 (37) Significant Wallerand et al. 2001 
German 21.4±0.64 (18) 16-26 Not significant Dadzeet al. 2000 
21.9±0.34 (59) 16-29 Not significant « 1x106 spm/ml) 
Caucasian* 24.7 ± 1.0 (10) 20-29 .001 <p< .0025 D~wsing et al. 1999 
US (Texan) 22.9±0.73 (23) 17-31 p=0.019 Mifsud et al. 2001 Chinese 23.8±0.S2 (33) 18-33 p=0.043 
Japanese 23.4±0.52 (30) 19·30 Not significant Sasagawa et al. 2001 
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Severely 
OliogoZS 
OligoZS 
Japanese 26.5±0.54(41) 
Caucasian* 21.9±0.51 (49) 
Caucasian* 22.2±0,45 (26) 
German 22.3±0.80 (29) 
Caucasian* 23.0±1.20 (13) 
Caucasian'" 21.8±0,41 (55) 
German 23.0±0.94 (13) 
Caucasian* 22.0±1.00 (7) 
US (Texan) 21.7±0.34 (72) 
Chinese 22.9±0.33 (87) 
Japanese 21.2 ±0.55 (59) 
Caucasian'" 21.9±0.29 (119) 
Dane 
Total Dutch 
21.5±0.26 (119) 
22.2±0.36 (75) 
23.5±0,41 (69) 
22.0±0.29 (119) 
Subfertile Caucasian'" 
Populationb German 
Swedish 
US (Texan) 
Chinese 
21.9 (33) 
22.0±0.31 (95) 
23.8 (120) 
Caucasian'" 21.6±0.32 (98) 
NormoZS 
Dane 21.8±0.32 (110) 
Dutch 
Caucasian* 
Caucasian'" 
German 
Caucasian* 
Swedish 
US (Texan) 
Chinese 
Japanese 
Japanese 
Japanese 
21.7±0,41 (70) 
22.0±0,42 (45) 
22.2 ±0,40 (50) 
20.8±0.70 (22) 
20.5±0.30 (32) 
23.2 (294) 
20.7±0.52 (55) 
22,4±0.32 (87) 
23.7±0.44 (51) 
21.4±0.58 (36) 
13.9±0,42 (48) 
20-34 
13-31 
18,26 
16-34 
15-34 
18,31 
17-28 
20-27 
14-29 
14-32 
14-32 
13-31 
15-29 
13-36 
18-39 
16-34 
16-27 
17-31 
18-33 
9-38 
14-33 
15-31 
12-30 
15-26 
17"25 
8-30 
8-27 
11-29 
17-28 
16-31 
17-30 
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p=O.OO13 
Not significant 
Not signiflcant 
Not significant 
.025<p<.05 
Not signiflcant 
Not significant 
Not signiflcant 
Not signiflcant 
Not significant 
Not significant 
Not significant 
Not significant 
Not significant 
p=O.03 
Not significant 
Not significant 
p=0.034 
p=0.032 
Yoshida et a1. 1999 
This Study 
Patrizio et a1. 2001 
Dadze et al. 2000 
Dowsing et a1. 1999 
This Study 
Dadze et al. 2000 
Dowsing et a1. 1999 
Mifsud et a1. 2001 
Komori et a1. 1999 
This Study 
Rajpert-De Meyts et al. 
2002 
Van Golde et al. 2002 
Patrizio et a1. 2001 
Dadze et a1. 2000 
Gewercman et al. 1998 
Mifsud et a1. 2001 
This Study 
Rajpert,De Meyts et al. 
2002 
Van Golde et al. 2002 
Patrizio et al. 2001 
Wallel'and et a1. 2001 
Dadze et a1. 2000 
Dowsing et a1. 1999 
Giwercman et al. 1998 
Mifsud et a1. 2001 
Sasagawa et al. 2001 
Komori et a1. 1999 
Yoshida et a1. 1999 
'P Value is significant is p<O.OS. ~e total non-~onnozoospennic population does not include 
asthenozoospennic individuals. Caucasian* refers to a predominantly Caucasian sample 
population. (n) indicates the sample size of each semen quality classification in each study. 
On the other hand it may be that other factors are operating in populations where no 
association was found. For example, there is good evidence that AR CAG length varies in 
a race-dependent manner, and while most recent research has attempted to select 
ethnically homogeneous sample populations it is possible that genealogy has some affect 
on observed AR CAG repeat lengths in individuals who consider themselves Caucasian. 
90 
Chapter Four - The Androgen Receptor 
For instance our New Zealand population of men all identify themselves as Caucasian but 
some may have Polynesian ancestry that may affect AR CAG repeat distribution in some 
semen classification groups or the total population. 
In addition, genetic background may influence findings. Many studies seek to rule out 
other recognised causes of impaired spermatogenesis in the study population, such as Y 
chromosome micro-deletions, varicocele, hypogonadism and cryptorchidism, but we do 
not yet fully understand how non-hannfu1 po1ymorphisms operate to influence our 
physiology. The same mutations that lead to reduced spenn production in some men 
might reduce the semen quality of men with a fertility-enhancing polymorphism, but not 
to the point of oligo- or awospennia and so confuse associations between gene mutation 
and infertility (De Kretser and Baker 1999) 
The comparison between other studies such as this also indicates that different 
populations have different CAG repeat length distributions. For example, a Gennan 
Caucasian population of men with reduced sperm production who have a mean AR CAG 
repeat number of 22 is not statistically different from the nonnowospermic group mean of 
20.8 repeats (Dadze et al. 2000) but 21.95 repeats is significantly different to 20.72 
repeats in a Texan Caucasian population (Table 4.3.) (Mifsud et al. 2001). 
Furthemlore, as was observed in this study, AR CAG repeat length ranges are remarkably 
similar between nonnowospennic and non-nonnowospennic populations, usually 
spanning much of the normal polymorphic range (11-31 repeats). 
In light of these observations it seems unlikely that a small expansion in the AR CAG 
repeat number within the nonnal polymorphic range represents a significant risk factor for 
reduced sperm production in the majority of healthy men. In fact, several studies indicate 
that the population of men with poor semen quality are not always the group with the 
greatest proportion of long CAGrepeat lengths (;::28), proposed by Tut et al. (1997) as 
being at especially high risk of reduced sperm production (Giwercman et al. 1998; Komori 
et al. 1999). 
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Nevertheless there seems to be sufficient evidence to suggest that moderate expansion 
and contractions of the AR polyglutamine repeat affect AR functioning such that 
androgen-related disorders are more commonly found associated with long or short AR 
CAG alleles (Mifsud et a1. 2000). For instance, shorter AR CAG repeat tracts resulting in 
higher AR transactivation have been associated with Polycystic Ovary Syndrome (PCOS) 
characterised by irregular menstruation and anovulatory infertility. PCOS is usually 
associated with hyperandrogenism due to higher than nomlal levels of testosterone in 
women resulting in the inhibition offollicular development and anovuation. However, it 
seems that increased intrinsic AR activity as a result of short AR CAG allele lengths 
explains how PCOS occurs through hyperandrogenism in women that have low androgen 
levels (Mifsud et a1. 2000). Moreover, ARs with long AR CAG repeat regions are 
associated with undermasculinised male genitalia. Reduced levels of AR intrinsic action 
due to long AR CAG alleles were thought to cause moderate undermasculinisation by 
compounding the effect of other weak causal factors that on their own do not cause 
abnormalities (Lim et a1. 2001). This lends credibility to the idea that long AR CAG 
alleles might cause a small reduction in AR activity that over the reproductive lifetime of 
an individu:alincreases the risk of reduced sperm production in men with a particular 
genetic background. 
The rational behind an AR-mediated mechanism resulting in reduced sperm production 
seems reasonable; it appears to be the causal mechanism in other related disorders 
(PCOS, abnormal genitalia, AIS) and polyglutamine expansion has a noted in vitro effect 
on the ability of co-activators such as ARA24 and p160 transcription factors to bind and 
regulate transcription-activation by the AR. Therefore, it seems plausible that at the very 
least, reduced AR activity as a result of long AR CAG repeat regions exacerbates the 
effect of other weak mutations leading to reduced spermatogenesis in a proportion of men 
with poor sperm quality. Thus, although it may not represent a significant causal factor on 
its own, analysis of trinucleotide repeat expansion of the AR polyglutamine region might 
be of in terest if combined with screening of other fertility· genes perhaps using DNA 
micro-array technologies. 
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5.1 Introduction 
A reduction in cellular energy production as the result of an accumulation of 
mitochondrial DNA (mtDNA) mutation has been implicated in many disepses, it is also 
thought to be responsible for some cases of reduced semen quality; asthenozoospermia, in 
otherwise healthy males (Kao et a1. 1995; Lestienne eta1. 1997; Kao et a1. 1998; 
Holyoake et a1. 2001). As is the case with X-linked spermatogenesis genes, females can 
influence the fertility status of their male offspring yet remain unaffected, through 
transmission of her mitochondrial population in the cytoplasm of the oocyte. A 
heterozygous population of wild-type and abnormally functioning mitochondria· that 
produce a reduced level of cellular energy may not noticeably affect somatic cell or oocyte 
function, but might however impair the motility of a male offspring's sperm cells, which 
have significantly fewer mitochondria per cell. These mtDNA mutations .. can be 
maintained in the gene pool because they are transmitted through the female lineage and 
since they are not harmful to females are not subject to negative selection (Chinnery et a1. 
2000). 
5.1.1 The Mitochondrion. 
Mitochondria are bounded by a double membrane. The outer membrane protects the 
organelle, and contains specialized transport proteins, such as porin to facilitate the 
passage of molecules into the intennembrane space. The inner membrane is folded into 
cristae that fill the inner matrix. Arranged in clusters on the cristae are the energy 
generating complexes of the electron transport chain. Cells that have a high energy 
demand, such as the flight muscle cells of birds, have greater numbers of mitochondrial 
cells, each with more cristae and electron transport chain clusters, in comparison, skin 
cells have few mitochondria (Ross 1999; Spurger 2003). 
Most mammalian cells contain in the region of 103 to 104 copies of the same mtDNA 
genome (homoplasmY)j oocytes contain an average of 200,000 mtDNA copies while 
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spermatocytes contain between 22 and 100 (Lightowlers et a1. 1997; May~Panloup et a1. 
2003). 
5.1.2 The Mitochondrial Genome 
In most eukaryotes, mitochondrial DNA (mtDNA) is a small, 16-18kb circular duplex 
(Figure 5.1) arranged into structures called 'nucleoids', which usually contain four to five 
mtDNA copies, plus several associated proteins including the mitochondrial single-
stranded DNA-binding protein (mtSSB), mitochondrial transcription factor A (Ham), 
Twinkle (DNA helicase) and the mtDNA damage protection protein, Mgm101p 
(Meeusen et al. 1999; Garrido et at 2003; Korhonen et a1. 2003). Replication occurs 
semiconservatively beginning in the displacement (0) loop with the heavy-strand; light-
strand synthesis begins once replication has proceeded approximately two-thirds of the 
way around (Anderson et a1. 1981; Wallace 1999). Mammalian mtDNA encodes 13 
polypeptides that are essential subunits of electron transport chain complexes (also 
known as OXPHOS proteins because of their role in oxidative phosphorylation) (Table 
5.1). Dispersed amongst these genes are 22 tRNA genes and two rRNA genes (16S and 
12S). 
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Figure 5.1. The mitochondrial 
genome. The 16,569 bp human 
mitochondrial genome encodes seven 
of the 43 Complex I subunits (NADH 
dehydrogenase NDl, 2,3,4, 4L, 5 and 
6) shown in pink; one of the 11 
subunits of Complex m (Cytochome b, 
Cyt b) in orange; three of the 13 
Complex IV subunits (COl, II and Ill) 
in purple; and two of the 16 subunits 
~. of Complex V (A TPase 6 and 8) in 
yellow. The two rRNA genes are in 
green, and the tRNA genes are 
labelled with their amino-acid letter. 
The control region contains the heavy-
strand origin of replication (OJ, and 
the heavy- and light-strand promoters 
(PH and PL). The OL lies within several 
tRNA genes between ND2 and COl 
Adapted from Wallace (1999). 
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Even though the majority of the mitochondrial genome is devoted to producing 
OXPHOS proteins, a far greater number are produced by the nuclear genome and 
transported in (DiMauro and Schon 2003). This includes proteins required for 
mitochondrial protein synthesis, such as DNA and RNA polymerases, translation 
initiation and elongation factors, ribosomal proteins, amino acyl tRNA synthetases, 
regulatory proteins such as Tfam, and the remaining 77 OXPHOS proteins (Table 5.1) 
(Anderson et al. 1981; Klug 1997; Chinnery et al. 2000). In addition, 60 additional 
nuclear-encoded proteins are required for electron transport chain functioning and 
assembly (DiMauro and Schon 2003). 
Table 5.1. Mitochondrial and nuclear protein contribution to the electron transport chain. 
No. of Complex I Complex II Complex III Complex IV Complex 
subunits (NADH: (Succinate: (Ubiquinol: V (Cytochorome Total encoded ubiquinone ubiquinone cytochrome c C oxidase) (ATP by: oxidoreductase ) oxidoreductase) oxidored uc tase) synthase) 
mtDNA 7 a 1 3 2 13 
nuclear ~39 4 10 10 ~14 ~77 
Information from Wallace (1999) and DiMauro and Schon (2003). 
There are several distinct differences between nuclear and mtDNA genetics. Unlike 
nuclear DNA, the majority of mtDNA is protein-coding; only the D-loop (approximately 
lkb) is not, it is free of protective histone proteins, and is attached to the inner membrane 
(Chinnery et al. 2000). 
5.1.3 Mitochondria are Maternally Inherited 
Despite the fact that between 75 and 100 normally functioning paternal mitochondria 
enter the oocyte at fertilisation only maternal mtDNA is easily detectable in the 
developing embryo (Sutovsky et al. 2000). There is some evidence to suggest that 
patemal mtDNA is actively excluded from populating the developing embryo. 
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Sperm lose 90% of their mtDNA during spermatid elongation resulting in an average of 
1.4 mtDNA copies per mitochondrion (Sutovsky et al. 2000; May-Panloup et al. 2003), 
This reduction is due to the down regulation of the mitochondrial transcription factor 
(Tfam) gene, that controls mtDNA copy number in mitochondria (Rantanen and Larsson 
2000; Sutovsky et al. 2000). Thus, the number of paternal mtDNA received by the oocyte 
is a fraction of the estimated 100,000 maternal copies present (Ankel-Simons and 
Cummins 1996). Furthermore, this tiny paternal pool of mitochondria is then subjected to 
a mighty selection pressure as the number of mitochondria per cell is dramatically reduced 
before implantation in the uterus (Chinnery et al. 2000). Hence the chances of paternal 
mtDNA copies persisting are slim. However, should a paternal mitochondrion survive the 
bottle-neck it could potentially make up a significant proportion of the developing 
embryo's mitochondrial population. 
Alternatively, or in concert with the above, paternal mtDNA may be targeted for active 
destruction before mtDNA replication resumes in the implanted embryo. Research 
suggests that a component of the spenn mitochondrial membrane is ubiquinated early in 
spennatogenesis (secondary speffi1atocyte or round spermatocyte stage) targeting the 
organelle for destruction by the oocytes 26S proteolytic machinery (Sutovsky et al. 2000; 
Thompson et al. 2003). This tag must be masked during passage through the epididymus 
since this is where abnormal sperm cells and histone proteins are ubiq uinated and 
destroyed, and then uncovered in the oocyte (Sutovsky 2003). As yet is it unclear how 
paternal mitochondria are destroyed since they are significantly larger than the 26S 
proteasome. It is possible that only a few membrane proteins are degraded exposing 
signals that trigger a separate mechanism, such as autophagy of the entire paternal 
mitochondrion (Wojcik 2003). 
It is hypothesised that the elimination of paternal mtDNA from embryos has developed as 
an evolutionary adaptation to prevent heteroplasmy and the inheritance of a potentially 
DNA-damaged mitochondrial genome (Cummins 2000; Sutovsky et al. 2000). Like the Y 
chromosome, mtDNA is su~ect to Milller's ratchet, hence the bottleneck in the pre-
implantation embryo either removes highly mutated mtDNA genomes, or generates 
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individuals with them at high frequency, in which case the individual will probably be 
eliminated from the population by natural selection (Chinnery et al. 2000). This explains 
why offspring can be born with a higher proportion of mutated mtDNA than their 
mother, and why mtDNA mutations can go to fixation (via random genetic drift) within 
only a few generations (Chinnery et al. 2000). 
5.1.4 The Mitochondrial Electron Transport Chain 
Respiration can be divided into three main pathways: glycolysis, the mitochondrial 
tricarboxylic acid cycle (TCA), and the mitochondrial electron transport chain (Fernie et 
al. 2004). Glycolysis occurs in the cytosol and involves the oxidation of glucose to 
pyruvate. However, only a fraction (approximately 1/15th) of the potential energy from 
glucose is generated by glycolysis (Garett and Grisham 1995). Pyruvate is then oxidized by 
the mitochondrial TCA cycle producing the reduced coenzymes NADH and Succinate. 
Electrons are passed from the reduced coenzymes through four innermembrane protein 
complexes of the mitochondrial electron transport chain to oxygen, with the concomitant 
translocation of protons into the innermembrane space using the energy generated by 
oxidation of NADH and Succinate (Garett and Grisham 1995). This process creates a 
proton gradient across the innermembrane which serves as the energy reservoir to achieve 
ATP synthesis (chemiosmotic theory) (Garett and Grisham 1995; Fernie et al. 2004). The 
energy created by the difference in proton concentration is utilized by complex V, ATP 
synthase which catalyses the phosphorylation of ADP as protons flow through it down the 
concentration gradient and back into the mitochondrial matrix (Garett and Grisham 
1995). Thus ATP synthase couples the oxidation of substrates to the phosphorylation df 
ADP. A portion of the energy generated by the proton gradient must be used to transport 
ATP out of the mitochondria, and ADP and phosphate in. The rate of oxidative 
phosphorylation depends on the availability of important substrates; the reducing agent, 
NADH; the termina(oxidising agent, 02' and ADP. Approximately 15 ATP molecules 
are generated per pyruvate (Fernie et al. 2004). 
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Figure 5.2. Schematic illustration of the electron transport chain. (a) A mitochondrion with 
double membrane, and two mtDNA molecules close to the inner membrane. Two electron 
transport chain clusters are indicated in red. (b) Enlargement of boxed section; Complex I (dark 
blue), II (light blue), CoQ (pink), III (green), Cyt C (light pink in intermembrane space), IV 
(orange), and A TP synthase (yellow box and circle). Electron movement through the chain is: 
NADH+H+ to Complex I, CoQ, III, Cyt C, IV, V; and Succinate to Complex II, CoQ, III, Cyt C, 
IV, V. A very simplified version of Glycolysis in the cytoplasm of the eukaryotic cell and the TCA 
cycle are indicated on the left to show where the respiratory chain electrons originate. Adapted 
from DiMauro and Schon (2003). 
5.1.5 Mitochondrial Disease 
The mutation rate of mtDNA is estimated to be 10 times higher than that of nuclear 
DNA (wpeland et a1. 2003), because it is largely unprotected (free of histones) and is 
located close to the site of reactive oxygen species (ROS) produced as by-products of 
oxidative phosphorylation, making it vulnerable to DNA damage (Croteau and Bohr 
1997; Stevnsner et a1. 2002). It was traditionally thought that mitochondria lacked any 
sort of DNA repair mechanism, but most have since been observed to some degree in 
various animal models including those for HCI-, H20z-, and UV -induced damage, DNA 
glycosylases for base modification repair of 8-oxoG, thymidine glycol and uracil-DNA, a 
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small number of base excision repair (BER) enzymes, a MutT homolog, and some 
evidence of an ATP-dependent mismatch repair mechanism (Tomkinson et a1. 1990; 
Croteau and Bohr 1997; Stierum et a1. 1999; Stevnsner et a1. 2002; Mason et a1. 2003). 
The electron transport chain is under the control of both the mitochondrial and nuclear 
genoines, which impacts on the way mitochondrial diseases are inherited, and the 
phenotypes produced. While mutations of the nuclear derived components of energy 
production result in mitochondrial diseases inherited in a Mendelian fashion, 
mitochondrial genetics is vastly different (DiMauro and Schon 2003). With few 
exceptions, mtDNA is inherited uniparentally through the matemallineage, this means a 
motherpasses her mtDNA complement to all her children, but only her daughters pass it 
on to theirs (Wallace 1999). Once an mtDNA mutation arises the mitochondrion is said 
to have a heteroplasmic mtDNA population (two types), as does the eukaryotic cell. As 
cells divide, mitochondria are randomly assorted to daughter cells, leading to potentially 
disproportionate quantities of mutant mitochondria in daughter cells. A cell and tissue 
can tolerate a proportion of their mitochondria' functionirtg abnormally, but once cellular 
energy production drops below a minimum threshold level, symptoms of mitochondrial 
disease appear and usually become progressively worse. Different tissues have different 
tolerances, those highly dependent ort high energy production such as the brain, heart, 
muscle, retina, and endocrine glands have lower threshold levels (Wallace 1999; 
DiMauro and Schon 2003). 
Mitochondrial disease can result from mutation of any of the proteins associated with 
energy production. The fact that mitochondria are in almost every cell in the body means 
that mtDNA mutations often result in multiple organ or system pathologies (central and 
peripheral nervous, and endocrine systems), although single organ symptoms do occur 
(Taivassalo et a1. 1999; DiMauro and Schon 2003). The most common symptoms of 
mitochondrial disease are muscle weakness especially of those that control eye movement, 
degenerative disease of the central nervous system, and metabolic disorders commonly 
involving abnormally high levels oflactic acid ~1actic acidosis) (Spurger 2003). 
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Some mtDNA mutations cause recognisable phenotypes, for instance, all Leber's 
hereditary optic neuropathy patients have mutations of the ND genes, yet others produce 
highly variable symptoms. This is compounded by the random nature of mitochondrial 
segregation to daughter cells; a mother can transmit variable amounts of mutant and 
wild-type mitochondria to her offspring resulting in all, some, or none developing 
mitochondrial disease, and leading to vast differences in mtDNA mutation phenotypes 
among members of the same family, with the same mtDNA mutation (Wallace 1999). 
There is no effective treatment for mitochondrial disorders but therapies are. being 
developed that aim to preferentially allow wild-type mitochondria to replicate, diluting 
out mutated mitochondria (Taivassalo et a1. 1999; Mason et a1. 2003), or targeting 
proteins to selectively destroy mutant mtDNAand deliver wild-type copies of mutated 
proteins (DiMauro and Schon 2003). 
5.1.6 Mitochondrial Energy Production and Male Fertility 
Substantial amounts of energy is used by sperm to swim up the female reproductive tract 
during fertilization (Kao et a1. 1998). The relationship between a reduction in 
mitochondrial energy production and reduced sperm motility was first established by Ruiz~ 
Pesini et a1. (1998). While there had been some previous evidence to suggest a link 
between sperm mitochondria characteristics (number, location, volume) and quality of 
motility (Cardullo and Baltz 1991; Mundy et a1. 1995), this study represented the first 
biochemical evidence linking mitochondrial energy generation (as electron transport 
chain complex activity) and sperm motility. Control samples exhibited higher levels of 
electron transport chain complex activity than that of asthenozoospermic samples, and in 
addition, a direct correlation was observed within the population as a whole between 
sperm motility and complex activity (Ruiz~Pesini et a1. 1998). 
Research screening the mitochondrial genome indicates that asthenozoospermic 
individuals have a higher incidence of mtDNA deletion which might account for a 
reduction in activity of mitochondrially-encoded electron transport complexes (Kao et a1. 
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1995). Men with poor semen quality show a higher frequency of mtDNA nucleotide 
substitutions and deletions, produce greater levels of ROS, and have higher levels of 
ubiquination than normozoospermic men (Kao et a1. 1995; Lestienne et a1. 1997; Aitken 
et a1. 1998; Holyoake et a1. 2001; Sutovsky et a1. 2004a). In addition, there is evidence to 
suggest that mtDNA copy number is increased per mitochondrion in men with poor 
sperm quality; men with two suboptimal semen parameters (sperm count, motility or 
morphology) had six times the number of mtDNA copies in their mitochondria than men 
with normal semen parameters (May,Panloup et a1. 2003). It is hypothesised that this 
mechanism mightact to compensate for the reduction in energy production by the 
abnormally functioning mitochondria where cells require more poorly performing 
mitochondria to produce a similar amount of energy as a normal mitochondrial cell (May, 
Panloup et a1. 2003). However, the presence of large mtDNA deletions does not 
necessarily result in reduced semen quality (Cummins et a1. 1998). Considerable levels of 
the 4977 'common' mitochondrial deletion have been observed in men with normal 
semenparameters (Cummins et a1. 1998). It is possible that these deletions are occurring 
after spermiogenesis through oxidative damage by ROS (Cummins et a1. 1998). 
Paradoxically, while there is abundant evidence associating high levels ofROS production 
and defective sperm function {low motility and fertilising potential) (Aitken et a1. 1989a; 
Aitken et a1. 1989b; Aziz et a1. 2004) low levels of oxidative stress actually enhance the 
ability of sperm to fuse with the oocyte (Aitken et a1. 1998; Baker and Aitken 2004). 
There are concerns that intracytoplasmic sperm injection (ICSI) facilitates the 
fertilisation of oocytes with sperm cells subjected to high levels of oxidative stress (Twigg 
et a1. 1998). Direct injection of sperm cells into the oocyte bypasses the selection 
pressures acting in natural fertilisation because spermatocytes are not required to be 
motile or capable of fusing with the oocyte membrane. Although it is unlikely that 
paternal mtDNA will escape ubiquitin~mediated destruction, abnormally functioning 
nuclear respiratory proteins could be passed on (LestieMe et a1. 1997; St John et a1. 1997; 
Aitken et a1. 1998; Twigg et a1. 1998; Sutovsky et a1. 2000; Sutovsky et a1. 2004b). 
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5.1.7 The Mitochondrial DNA Polymerase Gamma 
Human mtDNA is replicated by a single nuclear-derived DNA polymerase: POLy, the 
catalytiC subunit of which is encoded by the POLy gene (15q24) (Ropp and Copeland 
1996). Like other y polymerases, POLy performs high-fidelity DNA synthesis due to 
efficient 3'-5' exonucleolytic proof-reading, and association with a small beta subunit, 
POLG2 (17q21), results in enhanced polymerase activity (Longley et a1. 1998a; Longley 
et al. 1998b; Longley et a1. 2001). Several amino-acid residues within both the polymerase 
and exonuclease domains of POLy are highly conserved among many polymerases 
including Pol I from Escherichia colJ~ Mip1p in yeast, and phage T7 DNA polymerase 
(Ropp and Copeland 1996). Substitution of two such residues, aspartate 198, and 
giutamate200 in the exonuclease motif I abolishes the exonuclease proof-reading ability of 
POLy while largely maintaining polymerase function (Figure 5.3) (Ropp and Copeland 
1996). In cell culture, the substitution of aspartate l98 (D198A) alone was sufficient to 
result in an accumulation of mtDNA point mutations and a mutational load of 1: 1700 
over a three month culture period. The analogous substitution in the yeast Mip 1 P 
produces the same error-prone polymerase resulting in a lO4-fold decrease in proof-
reading ability and a lOO-fold increase in the accumulation of mtDNA point mutations 
(Spelbrink et al. 2000). Furthermore, exonuclease-deficient MipJ mutations are partially 
dominant so that even in the presence of wild type Miplp, mtDNA mutations 
accumulate (Spelbrink et al. 2000). 
Human POLr gene 
B 9 10 11 II 13 21 2Z 13 
mt targeting exonuclease motifs polymerase motifS 
sequence "'ai.----ir--n--...,.,j----------.......:.,T-TT-------i"r---1 
Human POLy prOlein 
I (CA~)10 I 
Figure 5.3. Schematic of the POLy gene and protein with functional domains. The gene consists 
of 23 exons (not aU of which are translated). The yellow box indicates the polyglutamine repeat 
region associated with male infertility, the pink and orange boxes indicate amino-acid 
substitutions that result in error-prone mtDNA synthesis by POLy. Adapted from Copeland et al. 
(2003) with information from Ropp and Copeland (1996). 
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Similarly, three amino-acid residues in the polymerase motif B are highly conserved 
among DNA polymerases; these residues, arginine943 , tyrosine 955, and alanine957, form the 
recognition site for the incoming nucleoside triphosphate (dNTP) (Figure 5.3) (Copeland 
et al. 2003). Substitutions of these residues are associated with progressive external 
ophthalmoplegia (PEO) , a mitochondrial disease inherited in a Mendelian fashion 
(Lamantea et al. 2002). Heterozygous substitution of tyrosine955 (Y955C) is commonly 
associated with a dominant form of PEO; Y955C retains a wild-type polymerase rate but 
shows a marked decrease in dNTP binding-affinity leading to error-prone mtDNA 
synthesis. This suggests one explanation for the accumulation of mtDNA point mutations 
and deletions observed in PEO patients (Ponamarev et al. 2002). No mutations of 
POLG2havebeen identified associated with PEO (Lamantea et al. 2002). 
5.1.8 POL'Y and Male Infertility 
Unique to the human POLy gene is a CAG trinucleotide repeat that is maintained at 10 
repeat units in 88% of the population (Rovio et al. 1999). Recently it was observed that 
small variations in repeat number, above or below the common lO-unit repeat number is 
associated with reduced sperm production (oligozoospermia), and normozoospermic 
infertility (Rovio et al. 2001; Jensen et al. 2004). In vivo analysis of POLy catalytic 
activity in the absence of the lO-unit CAG repeat indicated that the polymerase is 
unaffected by elimination of the polyglutamine region, in fact, cell lines displayed a 7 to 
15-fold increase in polymerase activity (Spelbrink et al. 2000). While this might suggest 
that the polyglutamine repeat region does not impact on the enzymatic properties of 
POLy, a similar increase in activity was noted in the androgen receptor protein upon total 
deletion of a polyglutamine repeat region (Kazemi;Esfarjani et al. 1995). Complete 
deletion of either repeat region has not been observed in any individual to date, rather, 
association with poor semen quality is due to small increases in repeat number. However, 
no studies have analysed POLy activity with varying CAG repeat length alleles. Thus, it is 
unclear why a slight increase or decrease in repeat number on one or more alleles is 
significantly associated with a reduction in sperm production. Polyglutamine regions are 
known to be interfaces for protein interactions and so it is possible that deletion alters 
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interactions between POLy and sperm-specific proteins resulting in suboptimal 
polymerase activity and the accumulation of mtDNA mutation (Spelbrink et a1. 2000). 
The accumulation of both large deletions and single nucleotide polymorphisms of 
mtDNA is associated with reduced sperm production and poor motility (Kao et a1. 1995; 
Kao et a1. 1998; Holyoake et a1. 2001). These changes might be the result of oxidative 
DNA damage by reactive oxygen species produced in the mitochondrial innermembrane 
as by-products of cellular energy production (Aitken et a1. 1998; Graziewicz et a1. 2002). 
Alternatively, mutations of POLr that reduce the exonucleolytic proof-reading ability 
could produce the high frequency of mtDNA point mutations observed in these 
individuals. However, the maternal inheritance of mitochondria and biparental 
inheritance of POLr copies complicates matters since several genotype/phenotype 
situations are possible. A mother might have one mutated error-prone POLy enzyme that 
increases the frequency of mtDNA mutation in her mitochondrial population. It is 
possible therefore, for her son to inherit two normal POLr copies and her heterozygous 
mitochondrial population, or he could also inherit her error-prone polymerase which, 
even though a wild-type copy exists, will keep producing mtDNA replication errors. To 
date no studies have been conducted evaluating the prevalence of POLy exonuclease 
domain mutation within a human study population. 
5.1.9 Aim of Research 
I aim to establish the level of POLrmutation in my study population by firstly establishing 
the variation in CAG repeat allele distribution in relation to semen quality, and then 
screening for mutation within the three exonuclease motifs. The frequency of single 
nucleotide polymorphisms in several of the mtDNA OXPHOS genes is known for 109 
individuals of my study population through research conducted by previous students 
(Holyoake et a1. 2001), thus if exonuclease domain mutations are found they can be 
further analysed to establish whether POLrexonuclease domain mutation is correlated to 
nucleotide substitution levels in mtDNA. This data will be added to X and Y 
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chromosome mutation analysis to evaluate the relationship between mutational load and 
semen quality. 
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5.2 Method 
5.2.1 PCR Conditions for POLyCAG Repeat Amplification 
The PCR primer pair used to amplifY the POLr CAG repeat region consisted of the 
reverse primer previously published by Rovia et a1. (1999) and a forward primer designed 
to bind more 5' in the POLrsequence (version AF497906.1j NCBIj refer Chapter Two 
Section 2.3.2.1) to produce a larger PCR product for manual sequencing (Table 5.2) 
(Appendix G). 
Table 5.2. Primer pair used to amplifY the POLyCAG repeat region. 
Primer Nucleotide GC Tm Product 
Name location Sequence (1M Na+) Size content (bp) 
POLGF* 2364-2383 ccaaagccaggtgttc tgac 55% 70°C 
295 
MIP32 2632-2658 ctctcgagagcatctggatgtccaatg 51% 78°C 
POLGF* is the forward primer and MIP32 the reverse. Primer sequences are given in the 5'-3' 
direction. Refer Appendix G for nucleotide sequence. 
Only the final primer concentration (0.32 J.LM) was different from concentrations given in 
Chapter Two. The PCR cycling programme consisted of an initial denaturation at 96°C 
for 2 min, followed by 30 cycles of 95°C for 1 min, 62°C for 45 s, and noc for 2 min, with 
a final extension step ofnoC for 5 min. 
5.2.2 DNA Sequencing of the POLyCAG Repeat Region 
The purified PCR products were a,33p_dCTP internally labelled and DNA sequenced 
using a Thennosequenase sequencing kit (Amersham Pharmacia Biotech) as per Chapter 
Four Section 4.2.2.2. Sequencing was carried out using the reverse primer, Mip32, and 
the 295 bp product was obtained in a single run. CAG repeat number was determined by 
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visualisation of only the ddATP and ddTTP lanes for the final 104 samples, to increase 
sample throughput. 
5.2.3 Genotype Categorisation. 
Each sample was assigned a genotype based on the number of POLy CAG repeats in each 
allele as outlined by Rovio et a1. (2001). A WT (Wild-type) allele is defined as one 
carrying the 10-unit CAG repeat; hence a homozygous WT individual carries two WT 
alleles. Heterozygotes carry one WT and one 'other' allele. 'Other' alleles have either 
greater than or fewer than ten CAG repeat units. Homozygous mutants carry two 'other' 
alleles, either two copies of a single 'other' allele length, or two different alleles each with 
fewer or greater than 10 CAG units. 
5.2.4 Statistical Analysis of POLyCAG Repeat Variation 
A G-test of independence was conducted to test the null hypothesis that semen quality is 
independent of genotype (CAG repeat variation) against the alternate hypothesis that 
they are related (Sokal and Rohlf 1995; Zar 1996). ' 
5.2.5 PCR Amplification of the Three Exonuclease Motifs 
Three PCR primer pairs were designed to amplify each of the three motifs that make up 
the POLy exonuclease domain, using the nucleotide sequence AF497906 (NCB!) 
(Appendix G) (Table 5.3). 
Sample size was reduced for the analysis of exonuclease motifS II and III in order to 
conduct an initial screening and evaluation of mutation frequency in these motifs. 
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Table 53. Primer pairs used to ampUfy exonuclease domains I, II, and III. 
Exo Primer Nucleotide Sequence GC Tm Product Motif Name Location content (1M Na+) size (bp) 
ExoF2 2811-2830 gacaacctggaccagcactt 55% 70°C 
Motif! 
T3exoR3 3043-3060 taatacgactcactataggg-
cattggcggtggccatat 47% 83°C 
250bp 
Motif II Ex02F 7254-7273 gtggaagagcgttac tc ttg 50% 68°C 182bp 
Ex02R 7417-7435 tgatccaggtagggttcct 53% 63°C 
Motif III Ex03F 8773-8791 agaac tgtttgtgaagggc 47% 6YC 278bp 
Ex03R 9031-9050 ctaccgctc ttcttggagag 55% 62°C 
F denotes the fOlWard primer, R, the reverse. Nucleotide position is based on the AF497906 
sequence. The DNA sequence before the hyphen in T3exoR3 denotes the T3 tag; Refer 
Appendix G for nucleotide sequences. 
The PCR reaction mixes used standard concentrations of buffer, dNTP's, Taq polymerase 
and DNA (as per Chapter Two); the final primer concentration was 0.6 ,uM. The cycling 
program for exonuclease motif I consisted of a 2 min at 95°e, 30 cycles of 95°c and 58°e 
for 1 min each, and noe for 2 min, fO,llowed by a final, 7 min noc extension. 
Exonuclease motifs II and III were amplified with shorter cycling times; 95°C tOr 2 min, 
30 cycles of 95°C and 58°e for 40 s, and noc for 1 min, and a final noc for 5 min. 
5.2.6 DNA Sequencing of the Three POLy Exonuclease Motifs. 
5.2.6.1 Radioactive Sequencing of Exonuclease Motif I. 
Sequencing of 16 exonuclease motif I samples was conducted using y 33p_dA TP end-
labelled sequencing with a Thermosequenase Cycle Sequencing Kit (as per Chapter Four 
substituting e3p] -dA TP). Sequencing was c0!1ducted from both the forward and reverse 
primers, ExoF2 and T3exoR3 in a single electrophoresis run. 
5.2.6.2 Fluorescent Sequencing of Exonuclease Motif!. 
Themajodty of exonuclease I samples were DNA sequenced by fluorescent labelling of 
the T3-tagged PCR product (generated by T3-tagging of the reverse primer, T3exoR3 in 
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the PCR reaction), using the Thermosequenase sequencing kit, and electrophoresis 
through a 4% polyacrylamide gel overnight (4% acrylamide, 1 xTBE,8.3 M UREA; 
Appendix F) at 22~0\1, ~O.6mA, 68.8 W) .. The reactionswere prepared in ,a darkened 
room; the method is identical to that described in Chapter Four with the exception that 2 
pmol of T3 fluorescent primer is added in place of radioactive label. Sequencing reactions 
were initially tested at half volume and were reduced to quarter volumes. Reactions were 
stored and transported in a black box with watery ice in between cycling and 
electrophoresis. The cycle sequencing program consisted of 95°C for 4 min, 30 cycles of 
95°C for 15 s, 50°C for 30 s, and noc for 1 min, followed by 10 cycles of 95°C for 15 s, 
and n °C for 1 min. 
Samples were loadedin the dark and 2 pI of each sample was dotted onto parafilm before 
loading in order to prevent oil interfering with sample loading. 
5.2.6.3 Radioactive Sequencing of Exonuclease Motifs II and III. 
DNA sequencing of exonuclease motifs II and III was accomplished using y JJp_dA TP 
primer-labelled reactions as per Chapter Four. Initially only one primer for each domain 
was labelled; ex02R and exo3F, but sequencing was conducted in the opposite direction 
for samples that displayed changes to the reference sequence (AF497906). In addition, 
several exonuclease III motif gels (12 samples each) were repeated to capture the end of 
the motif if electrophoresis ran too long (Figure 5.7). 
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5.3 Results - POLyCAG Repeat Allele Distribution 
5.3.1 PCR Analysis of the POLyCAG Trinucleotide Repeat 
The 295 bp POLyCAG repeat region was successfully amplified by PCR in 275 samples 
(Figure 5.4) (Appendix D). 
293bp 
N N N N 
Figure 5.4. POLyCAG repeat PCR product of eight men with normozoospermia. The marker is 
pBS (H ae III) . 
5.3.2 DNA Sequencing Analysis and Genotype Categorisation. 
The POLy CAG repeat region was manually sequenced in 275 samples (182 men with 
poor semen quality, and 93 men with normal semen parameters) and genotype categories 
assigned (Table 5.4) (Figure 5.5). Because the sequencing product was a mixture of both 
POLy alleles, wild-type alleles ran together through the gel while alleles of greater than or 
fewer than 10 CAG repeats displaced the upstream sequence by multiples of three base 
pairs depending on the number of extra CAG repeats (Figure 5.5). These displaced bases 
were half as bright as the rest of the sequence. 
DNA sequencing using just the ddA TP and ddTTP lanes still allowed discrimination of 
allele repeat number and doubled the throughput (Figure 5.5). 
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Table 5.4. Distribution of POLrCAG trinucleotide repeat alleles. 
Homozygous 
Heterozygote Homozygous Semen Classification Wild-type Mutant n 
10 and 10 10 and:;tolD :;to10and:;tolO 
NormoZS 57 (61.3%) 33 (35.5%) 3 (3.2%) 93 
Total Non-normozs 134 (73.6%) 41 (22.5%) 7 (3.8%) 182 
AZS 10 (91 %) 1 (9%) 11 
Severely OligoasthenoZS 35 (74.5%) 10 (21.3%) 2 (4.2%) 47 
Severely OligoZS 14 (93.3%) 1 (6.7%) 15 
OligoasthenoZS 22 (75.9%) 5 (17.2%) 2 (6.9%) 29 
OligoZS 18 (66.7%) 8 (29.6%) 1 (3.7%) 27 
AsthenoZS 35 (66%) 16 (30.2%) 2 (3.8%) 53 
ZS signifIes 'zoospermia'. Non-normozs includes all individuals with reduced semen quality. The 
percentage in parentheses represents the proportion of the total number of individuals of that 
group. n indicates sample size. ~ 10 refers to 'other' alleles 'with greater than or fewer than 10 
CAG repeats. 
'lO_unit 
L--:--...J1 LI --=--.11 IL.-..,,----...J 
2 3 
II 
4 5 
Figure 5.5. Autoradiography images of the POLy CAG repeat region. Sample 1, 2, and 5 are all 
homozygous WT; with 2 copies of the lO-unit CAG repeat. Sample 3 is a heterozygote; two 
different alleles, one with the 10 unit repeat and one with 12 (the two fainter bands indicated by 
green arrow), producing a displacement of the repeat sequence 6 bps upwards (orange brackets). 
Sample 4 is a homozygous mutant; encoding one 11-lUlit allele (purple brackets) and one 12-unit 
allele (green) (up until 11 repeats the intensity of the bands is the same, the 12th is fainter). 
Sampie 6 is heterozygous (the rest are homozygous wild-type), only the ddATP and ddTIP lanes 
have been electrophoresed. The orange brackets indicate the upstream displacement that helps 
distinguish the allele CAG repeat number. 
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Among the 'other' alleles the most common in heterozygotes was an 11 ~unit CAG repeat 
allele (79%), then 12 (16%),9 (3%), and 8 (1%). Of homozygous mutant genotypes, just 
over half (six individuals; 55%) displayed CAG repeat alleles of 12+ 11, two individuals 
(18%) had 11+11, a further two (18%) had 8+11, and one (9%) had 9+11. This data 
suggests the POLy CAG trinucleotide repeat is more likely to undergo slight expansions 
in repeat number than contractions, although since the number of repeat units was not 
established in the parents it is impossible to determine whether the expansion occurred 
within these individuals or was inherited. 
5.3.3 Statistical Analysis 
A 2x3 contingency table (Table 5.5) was created to determine how likely it is that the 
two sample subpopulations (normozoospermic and non-normozoospermic) were drawn 
from the same overall population with the same POLyCAG repeat variation. 
Table 5.5. POLyCAG repeat variation contingency table. 
NormolS Non normolS Total 
HOW[ obs 57 134 191 
64.6 12604 exp 
HE obs 33 41 25.0 48.98 
74 
exp 
HOMut obs 3 7 3.38 6.6 
10 
exp 
Total 93 182 275 
ZS is zoospermia. HOWT refers to the homozygous wild-type genotype, HE is heterozygous, and 
HOMut is homozygous mutant. Obs is the observed number of individuals with the particular 
genotype, and exp is the expected value generated by multiplying the fraction of the total 
population with that genotype (row totaVtotal population), by the total number in that group 
(column total) to produce the ,expected. number in that sample if it came from the overall 
population (for example, exp for n~nnozs HOWT is 191/275 x 93 == 64.6), 
The hypotheses were: Ho: there is no association between semen quality and genotype 
against,· HA: semen quality and genotype are related. A G-test of independence was 
calculated with William's correction to lower the observed value of G slightly and give 
more confidence in the test (Sokal and Rohlf 1995; lar 1996). 
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Using the data in Table 5.5 and 0.=0.05, Gad;=4.962 and, therefore, because P(XZ ~ Xl) is 
equal to (5.99 ~ 4.962), Ho is true; there is no association between semen quality and 
POLy CAG repeat genotype in this New Zealand (X)pulation of men (Appendix H for 
derails of calculations) (Sokal and Rohlf 1995; Zar 1996) . 
5.4 Results - POLr Exonuclease Motif Analysis 
5.4.1 PCR Analysis of Exonuclease Motifs I, II, and! ill 
The first exonuclease motif was successfully amplified in 274 samp.[es (83 
normozoospermic and 191 non-normozoospermic), while motifs II and III were amplified 
in only a test sample of the total (X)pulation; 126 samples in motif II (61 normozoospermic 
and 65 non-normozoospermic) and 124 in motif III (60 normozoospennic and 64 non-
normozoospennic) (Figure 5.6). 
-
- -
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Figure 5.6. PCR images of POLy exonuclease motifs I, II, and m. The PCR images are left to 
right: exonuclease motifl, II, and III; with products sizes oflSObp, 182bp, and 278bp respectively. 
The marker (M) is pBS (HaeIII). 
5.4.2 DNA Sequencing Analysis 
DNA sequencing of PCR products of all three exonuclease motif regions detected no 
change from the reference sequence AF497906 (Figure 5.7) (Appendix G). Re-
sequencing of twenty sequences (16 motif II, and 4 motif III) confirmed the sequence to 
be the same as the reference. 
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Exonuclease I Exonuclease II Exonuclease lU 
Figure 5.7. Autoradiography images of exonuclease motifs I, II, and III DNA sequences. Purple 
arrow brackets indicate exonuclease motifs. The orange arrow indicates the intron sequence 
separating the two sides of exonuclease III motif, the other end is just off the bottom of the image. 
Nucleotide sequences are listed in Appendix G. 
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5.5 Discussion 
5.5.1 POLyCAG Repeat Allele Distribution 
The CAG repeat length variation was not statistically related to semen quality (P>0.05). 
Homozygous wild-type individuals predominated, making up 60% or higher of each semen 
quality grouping. Individuals with greater than or fewer than 10 CAG repeats on both 
alleles (homozygous mutants) were rare, and were not limited to classes of men with 
reduced sperm quality. The highest proportion of homozygous mutants was observed in 
men with both reduced sperm count and motility (oligoasthenozoospermia; 7%), although 
this actually represented only two individuals, and was not statistically significant. 
There was not a great range of allele sizes ~bserved, consistent with the idea that this is a 
stable trinucleotide repeat region (Rovio et al. 1999). The smallest CAG repeat length of 
eight repeats was found in three individuals, and the largest repeat length consisting of 
twelve was found in eighteen individuals. 
5.5.1.1 Comparison with Other Research 
The 10-unit allele is typically observed at a frequency of 80-90% in ethnically diverse 
populations (Rovio et al. 1999). The 10-unit allele was observed at a frequency of 0.83 
(83%) in my study population suggesting it isnot genetically unusual. 
Statistical analysis indicated that semen quality is not related to CAG repeat variation 
(genotype) in the present study, a contrast to the findings of two other studies which have 
found associations between the homozygous absence of the lO-unit allele and 
oligozoospermia (Rovio et al. 2001) and with normozoospermic infertility Oensen et al. 
2004). 
Interestingly, the differences between findings in the present study and Jensen et al. 
(2004) may not be as disparate as they first appear. Increasingly, population studies 
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investigating infertility are seeking to categorise participants based on their actual fertility 
status despite what semen category their sperm count, motility and morphology places 
them in according to World Health Guidelines. The study conducted by Jensen and 
colleagues found a significant proportion (14.3%) of their normozoospennic-yet-infertile 
men had two alleles with greater or fewer than 10 CAG repeats (homozygous mutants), 
compared to their group of unselected controls (men with unknown fertility; 2.3%) and 
recent fathers (0.9%). One of the difficulties with this New Zealand population is that 
their actual fertility status is unknown and thus they have been categorised according to 
semen parameters. Therefore, it is not known how many men are infertile but with 
normozoospennia. 
5.5.2 POLy Exonuclease Domain Analysis 
No nucleotide changes were observed within any of the three POLy exonuclease motifs, 
nor any heterozygosity noted. This suggests that the sequence integrity of this domain is 
important. Screening of this region in PEO (progressive external ophthalmoplegia) 
patients and their families has identified recessive mutations in the DNA regions broadly 
surrounding the exonuclease domain II (T2511 and R309L), however both fall well 
outside the region screened (Copeland et a1. 2003). The absence of mutation within the 
POLy exonuclease domain may not necessarily be surprising since while cell culture might 
tolerate a mutator POLy enzyme, it is unlikely that the production of an error-prone 
polymerase and consequent high mtDNA mutational load in every cell of the body would 
support a functional human being. This idea is somewhat supported by observations in 
PEO patients, where the same, or similar mutations produced a much slower rate of 
mtDNA mutation and was not accompanied by loss of millNA copy number than was 
reported in cell culture (Lamantea et a1. 2002). 
While 50 of the 109 individuals in the sample population had known polymorphisms 
within mtDNA genes (the other 59 had no changes in the gene sequences screened) a 
mutated POLy was not the underlying cause (Appendix E). Homoplasmic polymorphisms 
are likely to have been inherited however without sequencing of the maternal mtDNA 
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genome it cannot be determined whether heteroplasmic silent single nucleotide 
polymorphisms arose in these men or were inherited. 
Interestingly, while PEO is associated with an accumulation of mtDNA mutation, 
infertility is not mentioned as being associated with the disease although other symptoms 
characteristic of mitochondrial diseases are (Ponamarev et al. 2002). This could be for a 
number of reasons, even simply that not enough patients had attempted to have children, 
however, it is probable that a proportion of them would have reduced fertility given that 
an accumulation of mtDNA mutation is associated with poor semen quality (Kao et al. 
1995; Lestienne et al. 1997; Holyoake et al. 2001). 
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6.1 Conclusions of Thesis Research 
Of the three different gene regions analysed, only the Y chromosome AZF region showed 
an association between mutation and reduced semen quality; no mutation was observed 
in the nuclear POLygene, neither was X chromosomal AR gene variation correlated with 
semen quality. While, all three chromosomal regions play an important role in the 
development of fertility, AR and POLy mutation are likely to have a causal role in only 
rare cases of impaired spermatogenesis. While these results make it more difficult to 
establish the importance of trinucleotide repeat varia~ion in both the AR and POLy genes 
to infertility, it is consistent with the idea that many cases of infertility are due to an 
accumulation of minor changes in many fertility genes that cumulatively produce a 
reduction in semen quality. This idea suggests the presence of threshold levels such -th~t a 
gradient of impaired spenn production exists with different frequencies of mutation. It 
also does not rule out the likelihood that some mutations have more direct and severe 
consequences on spenn production. 
None of the 51 individuals previously identified with at least one mtDNA polymorphism, 
(several of which were heteroplasmic) had mutations within one or more of the three 
exonuclease motif regions of POLy to account for this (Appendix E). 
6.1.1 Analysis of the Three Genes Collectively 
Of the 321 individuals in the sample population, a total of 91 individuals (44 
nonnozoospermic and 47 men with poor semen quality) were screened for mutation in all 
five regions (AR CAG, Yqll AZF, POLy CAG and exonuclease motifs I, II, and III) 
(Table 6.1). Although sample size is low, there appears to be a general trend towards 
more severely impaired spennatogenesis in individuals with more than one high,risk 
criterion: moderately expanded AR CAG repeat region, Yq micro-deletion, HE or 
HOMut POLy alleles, and mtDNA SNPs. All five samples with both a Yq micro-deletion 
and at least one mtDNA SNP belong to the awospennic or severely 
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oligoasthenozoospennic semen classifications (Table 6.1); a sixth severely 
oligoasthenozoospermic sample has a Yq micro-deletion but has not been analysed for the 
presence of mtDNA SNPs. Two other individuals with less severely reduced semen 
quality have Yq micro-deletions but no mtDNA SNPs. A trend also seems to exist 
between mtDNA SNPs and asthenozoospem1ia, and two samples have both moderately 
expanded AR CAG repeat numbers (24 and 31) and more than one mtDNA SNP (Table 
6.1). 
As is often the case, associations between particular genetic changes and semen quality 
are not absolute since the presence ofYq micro-deletions and SNPs does not account for 
every azoospermic or severely oligoasthenozoospennic sample and several 
nonnozoospermic samples also have mtDNA SNPs (10/44; Table 6.1). However, it is 
important to note that the actual fertility status of this sample population is unknown. 
Each sample has been assigned a semen classification based on semen parameters but it is 
possible that a proportion of men in the normozoospermic group may have difficulty 
conceiving children, and similarly, inclusion within the non-normozoospermic group does 
not necessarily signify infertility. Without knowledge of actual fertility status, it becomes 
difficult to distinguish between harmless polymorphisms and important mutations. Yet, 
the fact that even increased frequencies of silent mtDNA SNPs are associated with 
reduced sperm production suggests that genetic background is an important determinant 
of fertility status (Holyoake et al. 2001). 
These observations are consistent with the idea that infertility is caused by multiple 
factors. Rare mutations such as some Yq AZF micro-deletions seem to act in a dominant 
fashion to result in severely impaired spennatogenesis, but that most infertility is due to 
the accumulation of multiple nucleotide substitutions and deletions that act 
synergistically to reduce semen quality. 
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Table6.1. Summary of individuals with aU five gene regions analysed. 
Semen Sample Yqll AR POLyCAG POLy mtDNA Classification CAG EXO Mutation* 
Az 1454 Yq 18 HOwr I, II, III NDl/4 
Az 2473 Yq 21 HOwr I, II, III ND6/4 
Az 3008 Yq 24 HOwr I, II, III NDl,2,3/4 
Az 4071 sY149 24 HOwr I, II, III NDI/3 
Az 4449 sY158 21 HE 10+11 I, II, III ND6/3 
SOAs 1028 Yq 21 HOwr I, II, III 0(2 
SOAs 2128 Yq 21 HE 10+11 I, II, III 0/5 
SOAs ' 2565 Yq 21 HOMut I, II, III ND5!3 11+12 
SOAs 2866 Yq 28 HOMut I, II, III 0/4 11+12 
SOAs 4110 Yq 19 HE 10+12 I, II, III NDl/3 
SOAs 4290 sY149 21 HOwr I, II, III NDl/2 
SOAs 4646 Yq 25 HOwr I, II, III 0(2 
SOAs 4823 Yq 20 HE 10+11 I, II, III 0(2 
SOAs 6290 sYl49 24 HOwr I, II, III 
SOAs BT sY146 13 HOwr I, II, III CO/1/3 
SOAs CP sY146,156 20 HE 10+11 I, II, III ND5!5 
SOAs SF96-333 Yq 21 HOwr I, II, III ND6, COIJI/7 
SO '2578 Yq 24 HOwr I, II, III ND5/3 
SO 4406 Yq 21 HOwr I, 11, III 
SO SF96-470 Yq 22 HOwr I, II, III NDl/3 
OAs 2275 Yq 21 HOwr I, II, III 
OAs 2908 Yq 20 HOwr I, II, III 
OAs 2935 Yq 29 HE 8+10 I, II, III 0/1 
OAs 3072 Yq 20 HOwr I, II, III 0/3 
OAs 3449 Yq 22 HOMut8+11 I, II, III 
OAs AM235Q Yq 31 HOwr I, II, III A 1Pase6, GLJIJI/6 
OAs AT734U Yq 18 HOwr I, II, III 0/4 
OAs MrX Yq 20 HOMut8+11 I, II, III 
OAs SF96- Yq 18 HE 10+11 I, II, III 0/1 1667 
0 1699 Yq 26 HE 10+11 I, II, III 0/3 
0 2410 Yq 21 HOwr I, II, III 0/5 
0 2686 Yq 24 HOwr I, II, III 0/1 
0 5597 Yq 28 HOMut I, II, III 0/1 11+12 
0 IN Yq 18 HOwr I, II, III NDl,CO/fl6 
0 SF94-380 sY149 22 HOm I, II, III 0/5 
As 1644 Yq 19 HE 10+11 I, II, JII 
As 3138 Yq 27 HE10H1 I, II, III 0(2 
As 94-110 Yq 24 HOwr I, II, III 0/5 
As 94-149 Yq 24 HE 10+11 I, II, III A 1Pase6, 8/5 
As AM433B Yq 19 HOwr I, II, III NDl, CO/1/4 
As AT665C Yq 18 HOwr I, II, III ND2, CO/fl8 
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As CCR Yq 21 HOwr I, II, III ND6, COI1!8 
As RJ Yq 21 HOwr I, II, III 0/1 
As SF94-303 Yq 17 HOwr I, II, III 0/2 
As SF95-590 Yq 22 HOwr I, II, III 0/2 
As SF96-166 Yq 25 HOwr I, II, III NDl/7 
As WT sY156 24 HE 10+12 I, II, III 0/4 
47 
N 1469 Yq 24 HE 10+11 I, II, III 0/3 
N 1535 Yq 21 HE 10+11 I, II, III 0/3 
N 1541 Yq 25 HE 9+10 I, II, III 0/4 
N 1738 Yq 21 HOwr I, II, III 0/4 
N 1751 Yq 21 HOwr I, II, III 0/1 
N 2016 Yq 24 HE 10+11 I, II, III 0/2 
N 2097 Yq 25 HOwr I, II, III 0/2 
N 2223 Yq 26 HOwr I, II, III 0/2 
N 2404 Yq 21 HE 10+11 I, II, III NDl/2 
N 2450 Yq 15 HOwr I, II, III 0/4 
N 2631 Yq 20 HOwr I, II, III 0/4 
N 2905 Yq 20 HE 10+11 I, II, III NDl/5 
N 3002 Yq 20 HOwr I, II, III 0/1 
N 3182 Yq 23 HOwr I, II, III 0/1 
N 3408 Yq 23 HOwr I, II, III NDl,3 
N 3598 Yq 19 HOwr I, II, III 
N 3725 Yq 19 HOwr I, II, III 0/2 
N 3967 Yq 9 HE 10+11 I, II, III 
N 3999 Yq 20 HOMut I, II, III 11+11 
N 4022 Yq 24 HOwr I, II, III 0/1 
N 4817 Yq 20 HE 10+12 I, II, III 0/3 
N 5016 Yq 20 HE 10+12 I, II, III 0/2 
N 5222 Yq 19 HOwr I, II, III 0/3 
N 5239 Yq 21 HOwr I, II, III 0/2 
N 5477 Yq 38 HOwr I, II, III 
N 6109 Yq 23 HE 10+11 I, II, III 0/2 
N 6169 Yq 20 HE 10+11 I, II, III 0/2 
N 95-27 Yq 22 HE 10+11 I, II, III NDl,6, COI1!7 
N AM422U Yq 22 HOwr I, II, III 0/5 
N AM447I Yq 21 HE 10+11 I, II, III 0/4 
N AM4670 Yq 21 HE 10+11 I, II, III 0/5 
N AM498B Yq 21 HOwr I, II, III COIII/8 
N AT689M Yq 26 HOwr I, II, III NDl, COII1!8 
N AT697N Yq 24 HE 10+11 I, II, III AlPase6l8 
N QD747V Yq 22 HOwr I, II, III A lPase8, COII/2 
N QD845B Yq 26 HE 10+11 I, II, III 0/5 
N RL1911 Yq 23 HE 10+11 I, II, III 
N SF155 Yq 20 HOwr I, II, III 0/3 
N SF289 Yq 21 HOwr I,ll, III 
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N SF437 Yq 23 HOW[ I, II, III Oil 
N SF94-399 Yq 21 HOW[ I, II, III AlPase614 
N SF95-122 Yq 25 HOMut9+11 I, II, III NDl, A lPase6, COIlI7 
N SF96-229 Yq 18 HOMut I, II, III 0/4 11+11 
N SF96-310 Yq 20 HE 10+12 I, II, III 0(2 
44 
This table is a summary of the information in Appendices D and E. *The mtDNA mutations 
column indicates known mtDNA mutations, if present, out of the number of mtDNA genes 
analysed, gathered from research previously conducted by other researchers. Dashes indicate the 
sample has not been analysed for mtDNA mutation. Bolded cells in the Yqll, AR CAG, and 
POLyCAG columns indicate results that in previous studies were associated with reduced semen 
quality; only the Yq 11 micro-deletions were significantly associated with reduced semen quality in 
the current study. 
The three men exposed to mutagens; chemotherapy (individual 8257, azoospermic) and 
occupational chemicals (R12012 and SF96-341, both nonnozoospermic) did not have an 
increased frequency of mutation, both orchardists were completely within the normal 
range for the three genes studied: 22 and 21 AR CAG repeats, no Yq micro~deletions, 
two lO~unit POLy alleles, and no mtDNA SNPs. While it is unknown what the fertility 
status or semen quality of 8257 was before chemotherapy, the cause of his azoospemlia is 
not due to an accumulation of Yql1 micro-deletions. A fourth individual (7234, 
azoospermic) is identified as having spermatid maturation arrest. Analysis conducted in 
this study suggests this impairment of spenn production is not due to Yq micro-deletion; 
however, the sample did display significant expansion of the AR CAG repeat region (27 
repeats). 
6.2 Discussion 
This study represents the first research effort analysing multiple fertility gene regions in a 
single study population. Three earlier studies evaluated the contribution of both androgen 
receptor (AR) trinucleotide repeat variation and Y chromosome micro-deletion to 
reduced semen quality in the same population (Yong et al. 2000; Madgar et al. 2002; 
Dhillon and Husain 2003) however, it is common practise to screen the Y chromosome 
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for micro-deletion since infertility-causing mutations are routinely observed in 
approximately six percent of men with reduced semen quality, and may therefore be an 
alternative reason for the observed infertility than mutation within the gene of interest. 
Although the sample size of the group analysed for mutation in all three genes plus 
mitochondrial single nucleotide polymorphism (SNP) analysis (Table 6.1) is small, the 
indication is there that the presence of more than one fertility gene mutation increases 
the risk of reduced semen quality. This outcome suggests that studies like this on a larger 
scale would produce valuable insight into threshold levels for semen quality, particularly 
of Y chromosome micro-deletion and mitochondrial SNPs. Despite the amount of 
research in these areas the level of tolerance for SNPs or micro-deletion is unclear. 
Normozoospermic individuals have been observed both with large deletions of the 
mitochondrial genome (Cummins et a1. 1998) and micro-deletions of AZF (Pryor et a1. 
1997; Kent~First et a1. 1999; Kerr et a1. 2000), the difference between these individuals 
and those with reduced semen quality has not yet been conclusively established. It is 
generally agreed that the genetic background of these individuals is more robust, and are 
possibly even super-fertile and can therefore tolerate a greater amount of tnildly 
deleterious mutations. Alternatively it is hypothesised that mutations observed in men 
with both normal and non-normal semen classifications are not dominant acting; and 
thus the reduction in semen quality is due to a dominant mutation or accumulation of 
weaker mutations in genes elsewhere in the genome; either undiscovered or not analysed 
(De Kretser and Baker 1999). 
6.2.1 Use of Human Study Populations to Investigate Male Infertility 
It is currently acknowledged that more meaningful associations between gene mutation 
and semen quality come from a sample population that is highly selected based on semen 
characteristics. This sounds quite obvious since it stands to reason that the same types of 
pathology will be produced from the same mutation or mutations of the same gene, 
however, in reality this has proven to be harder than it appears. Ideally, research would be 
based on a sample population of generous numbers with highly similar semen 
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characteristics, DNA would be available from the mother and at least one paternal 
relation (ideally brother and father) to determine the origin of the mutation, and in 
addition to the gene of interest, the Yqll AZF region, and mitochondrial genome would 
be analysed for mutation, given the known mutation rate of these areas. Studies that have 
all of these points are rare because it requires an exceptional level of organisation and 
participation. Furthermore, fertility seems to be far more complex than linking one 
abnonnally functioning protein with reduced sperm production. While there do seem to 
be dominant acting mutations associated with impaired spermatogenesis, such as micro-
deletions of AZF, even these can produce a frustrating amount of phenotypic variability 
in different individuals. 
Mouse models are more useful in the study of male infertility since the animals are more 
amenable to interference in mating choice (inbreeding and backcrossing to grandparents 
is commonplace), and chemical mutagenesis in order to create infertility where it wasn't 
previously. 
6.2.2 Future Research Direction 
We do not currently have a very good understanding of the numerous pathways and gene 
interactions involved in the development and maintenance of fertility; and in general 
most cases of fertility (where a genetic origin is suspected) go unexplained. This has 
repercussions for infertile couples since if the cause involves germ cells there is the 
potential to pass on infertility-causing mutations to offspring conceived via artificial 
reproductive techniques. 
Part of the problem is the lack of information on the number and function of genes and 
gene functions involved. In addition to gametogenesis defects in pathways contributing to 
sexual differentiation, fertilisation, and embryonic development can cause infertility or 
miscarriage (Matzuk and Lamb 2002). 
135 
Chapter Six - Conclusion 
Therefore, further research analysing multiple fertility regions in men with reduced semen 
quality is required before we can begin to understand the complexity of male infertility 
and develop effective treatments. Genetics and molecular medicine have an increasing 
need for rapid genotyping and mutational analysis. It is likely that future research will 
increasingly employ DNA technologies that allow analysis of genetic changes and 
expression patterns rapidly, with high throughput and enable parallel analysis of very large 
number of genes (Matzuk and Lamb 2002; Carella et a1. 2003). 
For examples, micro array technology has the potential to be used for a variety of 
applications including genotyping and diagnosis using a set of known mutations or 
polymorprusms, gene expression, predicting gene function and linking cell pathways 
(based on expression pattems), and drug discovery and drug target validation (Carella et 
a1. 2003). Once genes have been identified in relation to disease the next stage is to 
understand gene function and interaction with other cellular components and processes. 
Microarrays (oligonucleotide and cDNA arrays) can provide information regarding the 
localisation of gene expression how the expression pattem of one gene relates to those of 
others (Carella et a1. 2003). A relatively new technology is protein arrays which allow 
high~throughput detection of proteins in biomedical samples. In addition, since most 
biological activities are mediated by protein~protein interactions, the technology has been 
adapted to detect macromolecular interactions, such as those between proteins and 
potential drugs (Carella et a1. 2003). 
Two notable studies using this type of technology to specifically search for genes 
expressed in mouse male germ cells have identified 19 novel premeiotic testis-specific 
transcripts, nine of which were X-linked (Wang et a1. 2001), and 1,652 transcripts whose 
expression increased during or after meiosis (Schultz et a1. 2003). These genes represent 
candidate infertility genes and are also possible targets for male contraceptives (Schultz et 
a1. 2003). 
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APPENDIX A, ABBREVIATIONS 
Az60 light absorbance at 260nm PAGE Polyacrylamide Gel Electrophoresis 
A zBo light absorbance at 280nm PAIS partial androgen insensitivity 
aa amino-acid syndrome 
APS ammonium persulfate peR Polymerase Chain Reaction 
AR androgen receptor PEO progressive external ophthalmoplegia 
As Asthenozoospermia POLy Polymerase gamma 
AZ Azoospermia 
AZF Azoospermic Factor 0 Oligozoospermia 
OAs Oligoasthenozoospermia 
bp base pairs of DNA OD optical density 
OXPHOS oxidative phosphorylation 
CAIS complete androgen insensitivity 
syndrome ROS reactive oxygen species 
cpm counts per minute 
s seconds 
dATP deoxyadenosine triphosphate SBMA Small bulbar muscular atrophy 
DAZ Deleted in Azoospermia (Kennedy's Disease) 
DBD DNA-binding domain SNP single nucleotide polymorphism 
dCTP deoxycytidine triphosphate SO Severe Oligozoospermia 
ddHzO deionised, distilled water SOAs Severe Oligoasthenozoospermia 
dGTP deoxyguanosine triphosphate STS sequence tagged site 
DNA deoxyribonucleic acid 
dNTP deoxyribonucleoside triphosphate TAD transcription-activating domain 
ds double~stranded TAE T ris/acetate electrophoresis buffer 
dTTP deoxythymidine triphosphate Taq Thennus aquaticus 
DTT dithiothreiotol TBE Tris;borate electrophoresis buffer 
TEMED tetramethylethylenediamine 
EDTA etyhylenediaminetetra acetic acid temp temperature 
GC Guanine ~ Cytosine base pairing UV ultraviolet 
HCI Hydrogen Chloride V Volts (a measure of voltage) 
ICSI Intracytoplasmic sperm injection W Watts (a measure of power) 
JVF In vitro fertilisation w/v weight per volume 
kcal Kilocalories ZS Zoospermia 
LBD ligand -binding domain 
M molar Units: g grams 
rnA milliamps (a measure of current) I litres 
Mg2+ Magnesium m meters 
min minutes 
centi (lxlO'Z) MSY male specific region ofY Prefixes: c 
mtDNA mitochondrial DNA m. milli (lxlO'3) 
ft micro (lx 10'6) 
NaCl Sodium Chloride n nano (lxlO'9) 
nm nanometer p pico (lxlO'1Z) 
NormoZS Normozoosperrnia f femto (lx1O,15) 
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AP~ENOIXB-CHEMICAL Sl.JPPLIE~ .. 
Product 
Acrylamide:bisacrylamide 19: 1 
(40%) 
Acrylamide:bisacrylamide 29:1 
(30%) 
Agarose 
Ammonium ace tate 
Ammonium persulfute (APS) 
Blocking reagent 
Bromophenol blue 
Chloroform 
Dexonucleoside triphosphates 
(dN1Ps) 
1,4-Dithiothreitol (DTT) 
Ethanol 
EthidiumBrornide 
Ethylene diarnlnetetra-acetic 
acid (EDT A) 
Isoamyl alcohol 
Isopropanol 
MineraloU 
Orange G 
Orthoboric acid 
Phenol 
Proteinase K 
SigmaCote 
Supplier 
BioRad 
BioRad 
Pure Sciences 
NEN, PerkinElmer 
Life Sciences Inc. 
BDH 
Boehringer Mannheim 
(Roche) 
Roche 
Sigma 
BDH 
Eppendorf 
Boehringer 
Mannheim (Roche) 
BDH 
Sigma 
Scharlau (Scientific 
Supplies Ltd) 
BDH 
BDH 
Sigma 
Sigma 
BDH 
Scharlau (Scientific 
Supplies Ltd) 
Roche 
Sigma 
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Product 
Sodium acetate 
Sodium chloride 
Sodium dodecyl sulfate (SDS) 
Sodium hydroxide 
Sodium citrate 
N,N,N',N'-Tetramethyl-
ethylenediamine (TIMED) 
Tris Base 
Urea 
Xylene cyanol FF 
Supplier 
BDH 
Scharlau (Scientific 
Supplies Ltd) 
Gibcb BRL 
(Invitrogen) 
Panreac (Scientific 
Supplies Ltd) 
BDH 
Sigma 
Boehringer 
Mannheim (Roche) 
BDH 
Sigma 















APPENDIX E ... POLy EXONUCLEASE DOMAIN SAMPLES 
POLyCAG POLyEXO Sample mtONA Mutation'" Semen Count Motility Code Classification (106/ml) (%) 
HOWT I, II, III 1454 NOl/4 Az 0.00 0 
HOWT I, II, III 2473 ND6/4 Az 0.00 0 
HOWT I, II, III 3008 NOl, 2, 3/4 Az 0.00 0 
HOWT I, II, III 4071 NOW Az 0.00 0 
HE 10+11- I, II, III 4449 N06/3 Az 0.00 0 
HOMut 11+12 I, II, III 2565 N05/3 SOAs 4.30 20 
HE 10+12 I, II, III 4110 NOl/3 SOAs LSO 31 
HOWT I, II, III 4290 NOl/2 SOAs 0.28 18 
HE 10+11 I, II, III 4300 NOl/2 SOAs 4.00 45 
HOWT I, II, III BT COIV3 SOAs 3.70 31 
HE 10+11 I, II, III CP NDS/5 SOAs 1.60 10 
HOWT I, II, III SF96-333 N06, COIII/7 SOAs 0.50 33 
HOWT II TI N01, A TPase8/7 SOAs 1.35 22 
II, III 2070 NOl/4 SO 3.20 54 
HOWT I, II, III 2578 N05/3 SO . 2.20 68 
HOWT I, II, III SF96-470 NOl!3 SO 0.03 100 
HOWT I, II, III 95-17 A TPase6, 8/5 OAs 5.30 26 
HOWT I, II, III 95-34 ATPase6,8/4 OAs 7.2 47 
HOWT I, II, III AM235Q A TPase6, COIII/6 OAs 9.90 32 
HE 10+11 I, II, III 5378 NOl/3 0 16.20 57 
HOWT I, II, III EV ATPase6/2 0 7.70 53 
HOWT I, II, III IN N01,COIV6 0 15.00 61 
HOWT I, II, III OP883E NOS, A TPase6/3 0 5.00 58 
HOWT I, II, III 3505 NOl/3 As 27.70 49 
HOWT I, II, III 5288 NOl/2 As 233.00 0 
HE 10+11 I, II, III 94-149 A TPase6, 8/5 As 34.00 40 
HOWT I, II, III AM433B N01, COII/4 As 49.00 36 
HOWT I, II, III AT665C N02, COII/8 As 51.00 29 
HOWT I, II, III CCR N06, COII/8 As 152.00 1 
II, III QonOl A TPase8, COII/7 As 54.00 31 
HE 10+11 I, II RS NOl/5 As 45.00 20 
HOMut 11+12 I, II, III SF94-86 N01, A TPase8/7 As 85.70 35 
HOWT I, II, III SF96-166 NO 1/7 As 186.00 38 
HE 10+11 I, II, III 2404 NOl/2 N 92.00 55 
HE 10+11 I, II, III 2607 NOl/3 N 100.00 68 
HE 10+11 I, II, III 2905 NOl/5 N 135.00 64 
HOWT I, II, III 2945 N01,6/3 N 59.00 62 
HOWT I, II, III 3408 N01,3 N 102.50 62 
HOWT I, II, III 95-05 A TPase6, 8/4 N 24.00 75 
HE 10+11 I, II, III 95-27 N01, 6, COIl/7 N 79.00 69 
HOWT I, II, III AM498B COnU8 N 22.70 64 
HOWT I, II, III AT689M N01, COlIl/8 N 41.00 81 
HE 10+11 I, II, III AT697N ATPase6!8 N 25.00 73 
HOWT I, II, III OP927S NOl/2 N 135.00 69 
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HOWT I, II, III QD747V A TPase8, COII/2 N 200.00 57 
HOWT lI,m QD788L COIl/4 N 85.00 50 
HOWT II, III QRS09H ND1, COIl/S N 222.00 57 
HOWT II, III SF94-97 NDl/4 N 86.00· 72 
HOW[ I, II, III SF94-399 ATPase6/4 N 81.00 60 
HOMut9+11 I, II, III SF95-122 ND1, A TPase6, COIl/7 N 26.00 50 
HOWT II, III SF96-305 ND1, A TPase617 N 140.00 67 
51 
POLyCAG POLyEXO Sample mtDNA Mutation 
Semen Count Motility 
Code Classification (106/ml) (%) 
HOWT I, II, III 1028 0/2 SOAs 0.15 0 
HE 10+11 I, II, III 2128 0/5 SOAs 0.30 10 
HOMut 11+12 I, II, III 2866 0/4 SOAs 0.70 29 
HOWT I, II, III 4646 0/2 SOAs 2.30 29 
HE 10+11 I, II, III 4823 0/2 SOAs 0.80 9 
HOWT I, II, III 5349 0/2 SOAs 1.90 5 
I, II, III 2583 0/2 SO 4.70 54 
HE 8+10 I, II, III 2935 0/1 OAs 10.00 41 
HOWT I, II, III 3072 0/3 OAs 12.00 26 
HOWT I, II, III AT734U 0/4 OAs 13.10 29 
HE 10+11 I, II, III SF96-1667 0/1 OAs 17.00 17 
HE 10+11 I, II, III 1699 0/3 0 10.70 67 
HOWT I, II, III 2410 0/5 0 15.00 54 
HOWT I, II, III 2686 0/1 0 14.90 61 
HOMut 11+12 I, II, III 5597 0/1 0 16.80 63 
HOWT I, II, III SF94-380 0/5 0 15.80 66 
I, II, III 3047 0/3 As 29.00 29 
HE 10+11 I, II, III 3138 0/2 As 114.00 31 
HOWT I, II, III 94-110 0/5 As 446.00 42 
HOWT I, II, III RJ 0/1 As 43.00 2 
HOWT I, II, III SF94-303 0/2 As 22.10 6 
HOWT I, II, III SF95-590 0/2 As 80.00 35 
HE 10+12 I, II, III WT 0/4 As 110.00 26 
HE 10+11 I, II, III 1469 0/3 N 265.00 61 
HE 10+11 I, II, III 1535 0/3 N 33.00 75 
HE 9+10 I, II, III 1541 0/4 N 54.00 74 
HOWT I, II, III 1738 0/4 .N 147.00 62 
HOWT I, II, III 1751 0/1 N 76.00 57 
HE 10+11 I, II, III 2016 0/2 N 23.00 68 
HOWT I, II, III 2097 0/2 N 55.00 54 
HOWT I, II, III 2223 0/2 N 57.00 55 
HOWT I, II, III 2450 0/4 N 113.00 70 
I, II, III 2520 0/2 N 107.00 67 
HOWT I, II, III 2631 0/4 N 109.00 52 
HOWT I, II, III 3002 0/1 N 49.20 59 
HOWT I, II, III 3182 0/1 N 194.00 52 
HE 10+11 I, II 3309 0/1 N 81.00 58 
HOWT I, II, III 3725 0/2 N 80.00 60 
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HaW[ I, II, III 4022 0/1 N 73.00 71 
HE 10+11 I, II, III 4510 0/3 N 51.30 74 
HE 10+12 I, II, III 4817 0/3 N 57.00 63 
HE 10+12 I, II, III 5016 0/2 ·N 22.00 57 
HaW[ I, II, III 5222 0/3 N 97.00 81 
HaW[ I, II, III 5239 0/2 N 36.70 89 
HE 10+11 I, II, III 6109 0/2 N 75.00 67 
HE 10+11 I, II, III 6169 0/2 N 70.40 56 
HaW[ I, II, III AM422U 0/5 N 114.00 55 
HE 10+11 I, II, III AM447I 0/4 N 73.00 79 
HE 10+11 I, II, III AM4670 0/5 N 290.00 52 
I, II, III AM468P 0/5 N 124.00 55 
HE 10+11 I, II, III QD845B 0/5 N 101.00 58 
HE 10+11 II, III QH516G 0/3 N 262.00 61 
II, III QH529M 0/2 N 80.00 51 
HE 10+12 I, II, III QN237R 0/4 N 136.00 68 
HOMut 11+12 II, III QU447K 0/2 N 48.60 85 
HaW[ I, II, III SF155 0/3 N 129.00 70 
HOW[ I, II, III SF437 0/1 N 125.00 66 
HOMut 11+11 I, II, III SF96-229 0/4 N 75.00 50 
HE 10+12 I, II, III SF96-31O 0/2 N 152.00 56 
HaW[ II, III SF96-341 0/4 N 126.00 50 
HaW[ I, II, III 6290 SOAs 0.01 36 
HOW[ I, II, III ze SOAs 0.50 6 
HaW[ I, II, III 4406 SO 1.20 50 
HaW[ I, II, III 7704 SO 0.833 69 
HOW[ I, II, III 2275 OAs 8.50 7 
HaW[ I, II, III 2908 OAs 17.10 3 
HOMut8+11 I, II, III 3449 OAs 6.50 35 
HOMut8+11 I, II, III MrX OAs 5.70 43 
HE 10+11 I, II, III 1644 As 36.00 43 
HaW[ I, II, III 3598 N 40.00 83 
HE 10+11 I, II, III 3967 N 21.00 50 
HOMut 11+11 I, II, III 3999 N 348.00 66 
HaW[ I, II, III 5477 N 100.00 57 
HE 10+11 I, II, III RL1911 N 41.60 90 
HaW[ I, II, III SF289 N 106.00 60 
75 
Notes: The Table lists samples previously screened for mtDNA mutation. As per Appendix D the POLy 
CAG results and exonuclease domains sequenced are listed against each sample; a blank indicates the 
sequencing was repeatedly not s'uccessful or not attempted. The mtDNA mutation column indicates 
which genes SNP's were identified in out of how many mitochondrial genes were screened, for example, 
ND1/4 indicates there was a polymorphism identified in NDl of the four mtDNA genes screened, while 
0/3 denotes no mutation found in any of the three mtDNA genes sequenced. 
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APPENDIX F .. RECIPES 
5% PAGE ~ Visualisation ofYq Mulitplex peR Groups 3 & 4 
Two glass plates (1Ocm x 7cm (short plate) and 10cm x 8cm (long plate)) should be cleaned with 96% 
ethanol and the gel apparatus assembled in the casting tray before mixing the following in a small (100ml) 
volumetric flask: 
1.66 ml 
1.0ml 
7.27 ml 
0.07 ml 
0.035 ml 
30% acrylamide:bisacrylamide (29:1) 
10x1BE 
ddHzO 
10% ammonium persulfate (APS) 
TEMED 
The PAGE solution was swirled several times to mix and then pipetted between the plates using a Pasteur 
pipette until full, before adding the 15~wel11.Omm comb. The gel was left for 40 min to polymerise before 
sample loading. A Ix TBE buffer (300ml) was used for electrophoresis. 
Pre~hybridisation Solution fur Southern Blot Hybridisation. 
The final amount of solution required is 0.1ml/cm2 of membrane, but make excess. For 30ml of pre~ 
hybridisation solution mix the following in a 100ml volumetric flask: 
9.0 ml 20x SSC 
18.0ml 
Heat at 6YC (along with the trozen Denhardts solution) 20 min, and then add: 
1.5 ml Denhardts 
1.5 ml 10% SDS 
0.15 g blocking reagent 
Stir on a moderate heat for 2 hrs. 
6% Polyacrylamide Gels - fur DNA Sequencing 
In a 250 ml beaker measure: 
35g 
7.0ml 
10.5 ml 
UREA 
10x1BE 
40% acrylamide:bisacrylamide (19:1) 
Make up to 60 mls with ddH20, and dissolve with moderate heat and stirring. 
When completely dissolved make up to 70mls and pour into a vacuum flask for de~gassing 10 min .. 
Thoroughly clean one long (42 x 34) and one short (40 x 34) glass plate with water and finally 96% 
ethanol. The short plate was siliconised with Sigmacote® (Sigma Chemical Co.) so that the gel stays on 
the long plate when separated after electrophoresis. Plates are placed together separated by OAmm 
spacers and clamped tight arOlllld three sides excluding the top. 
158 
Add 700fLI of 10% ammonium persulfate CAPS) and 14fL TEMED to the flask, swirl and pour into a 
plastic measuring cylinder forlie1 pburing. The acrylamide solutiohwaspoureq between the plates raised 
on an angle, and left to polymerise for 40 min. Excess acrylamide and lJREA should be cleaned off the 
outside and edges of the plates before assembling in the gel rig for electrophoresis. 
4% Polyacrylamide gels ~ LICOR Fluorescently~tagged DNA Sequencing. 
In a 250 rnl beaker measure: 
33.6g 
8.0 rnl 
6.4 rnl 
UREA 
1Ox1BE 
" 
40% acrylamide:bisacrylamide (19:1) 
. ' , 
Make up to 70 rnls with ddHzO, and dissolve with moderate heat and stirring. 
When completely dissolved make up to 80mls and pour into a vacuum flask for de-gassing 10 min. 
Thoroughly clean the LICOR glass plates with water and 96% ethanol. Assemble the plates, spacers and 
clamps, and tighten. 
After de-gas add 500fLI of 10% APS and 40fLI TEMED, swirl to mix, and transfer to a 100rnl measuring 
cylinder to pour between tilted plates. Remove an bubbles and insert wen comb. Leave to polymerise for 
40 min. Thoroughly clean the outside of both plates, paying particular attention to the bottom 10cm 
where the laser runs across. Prepare 500rnl of Ix 1BE buffer. 
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APPENDIX H - STATISTICAL CALClTLATIONS. ' ' 
Table 5.5. POLrCAG repeat variation contingency table. 
NonnoZS NonnonnoZS Total 
HOWT obs 57 134 191 
exp 64.6 126.4 
HE obs 33 41 74 
exp 25.0 48.98 
HOMut obs 3 7 10 
exp 3.38 6.6 
Total 9j 182 275 
Obs is the observed number of individuals with the particular genotype, and expis the expected value 
generated by multiplying the fractiol1 of the total population with that genotype (row total/total 
population), by the total number in that group (column total) to produce the expected number in that 
sample if it came from the overall population (for example, exp fornormozs HOWT is 191/275 x 93 = 
64.6) 
a=0.05, Ho= Genotype is independent of semen quality. 
HA = Genotype is related to semen quality. 
G:;::: 4.60517[~~tljlogfij, ~RilogRi' ~CjlogCj + nlogn] 
G = 4.60517 [57(1.7559) + 33(1.5185) + 3(0.4771) + 134(2.1271) + 41(1.6128) + 7(0.8451) 
-93(1.9685) -182(2.2601) -191(2.2810) -74(1.8692) -10(1) + 275(2.4393)] 
G = 4.60517 [100.085 + 50.111 + 1.431 + 285.032 + 66.124 + 5.916 -183.069 - 411.333-
435.677 - 138.323 - 10 + 670.816] 
G = 4.60517 [1.113] 
G = 5.126 with df = (r-1) (c-1) = 2 
Williams' correction for a Rx C table is: q = 1 + [275(1/191 + 104 + 1/10) - n [275(1/93 + 1/182) - 1] 
6(275)(2) (1) 
q = 1 + [31.6561 [3.468] 
3300 
q = 1.033 
G.dj = G/q 
Gadj = 5.126/1.033 
G.dj = 4.962 
Since X2o.o5,2=5.991zGadj=4.962 we accept Ho that genotype is independent of semen quality 
(Sokal and Rohlf 1995; Zar 1996). 
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ABSTRACT: 
This study investigated the relationship between variation in the polymorphic CAG 
trinucleotide repeat (TNR) region of the human androgen receptor (AR) gene and semen 
quality in a Caucasian sample population. These men were patients attending the New Zealand 
Centre for Reproductive Medicine in Christchurch. The AR TNR region was amplified by PCR 
and then DNA sequenced to determine exact numbers of CAG repeats for each sample. In 
addition, the samples were screened for microdeletions within the 
AZFc region of the Y-chromosome. A total of 105 men with poor semen quality were compared· 
to a group of93 men with normal semen quality. Men with poor semen quality had similar CAG 
repeat number to men with normal semen quality (21.46 ± 0.30 
vs 20.99 ± 0.28, p = 0.126). Y-chromosome microdeletions were only detected in men with 
suboptimal semen parameters (7.4%). However, the presence of a deletion was not related to 
CAG repeat number. The CAG repeat number in the men with nonnal semen quality in the 
present study is similar to the Australian and German samples, but lower than those reported for 
the Swedes, Dutch and Danes. These results argued against the hypothesis that higher CAG 
repeats are associated with infertility in men, but strongly suggest that different populations may 
show different number ofCAG repeats in addition to racial variation reported in previous 
studies. 
INTRODUCTION: 
It has been suggested that mutations in the androgen receptor (AR) gene causes reduced spenn 
production inl0~20%of men who areotherwise healthy (Yong et aI., 1998). The 
AR proteiD triggers differentiation of male secondary sexual characteristics and initiates and 
maintains sperm production in response to stimulation by the male sex androgens, testosterone 
anddihydrotestosterone(Yong et aI., 2000; Mifsud et al., 2001). 
The AR~CAG repeat region in ex on 1 of the AR gene is unstable and undergoes 
expansions and contractions in repeat number during meiotic DNA replication (Kovtun et al., 
2001). Thus the number of CAG repeats is polymorphic in different populations and between 
different races, with a range between 9 and 36 repeats (Dadze et al., 2000). 
African American men have shorter repeat lengths (19 repeats), Asian men have longer repeat 
lengths (23~24 repeats), and Caucasian men have around 21 repeats (Hardy et al., 1996; Sartor 
et al., 1999; Yoshida et al., 1999; Mifsud et aI., 2001). It is known that patients with Kennedy's 
disease, a fatal neurodegenerative disease, have over 40 CAG repeats in the AR TNR and are 
subfertile resulting from reduced sperm production (Puscheck et al., 1994). 
Recent studies have suggested that expansion increasing the number of AR~CAG repeats 
above the mean is a significant risk determinant of reduced sperm production in otherwise 
healthy males (Dowsing et aI., 1999; Yoshida et aI., 1999; Mifsud et aI., 2001; Patrizio et al., 
2001). In vitro studies have demonstrated a reduction in AR~transcription factor interaction, 
. and transcription~activating potential with increases in repeat number within the nonnal 
polymorphicrange(Kazemi~Esfarjani et aI., 1995;Tut et aI., 1997; Hsaio et al., 1999; Irvine et 
aI., 2000). This presumably alters rates of transcription of genes involved in spennatogenesis. 
This increased risk. of defective sperm production is predicted to be four times greater when 
repeat numbers near the extremes of the normal range, greater than or equal to 28 CAG repeats 
(Tut et aI., 1997). 
This present study analysed the AR~CAG repeat lengths of93 Caucasian men with 
normal semen ql,lalityand 105 men with poor semen quality. We showed that there was no 
significant variation in the CAG repeat lengths between the two groups of men in the 
ChristGhurch population. 
METHODS: 
Patients and Semen Classification 
Semen samples were obtained with written consent from couples attending the New Zealand 
Centre for Reproductive Medicine: EthiCal approval was obta.ined from the Canterbury Health 
Ethics Committee. 
Samples were assigned a fertility category based on the World Health Organisation 
criteria (WHO, 1999). Men who had greaterthan 20 million spermatozoa/ml andover 50% of 
which were motile were classified as normozoospermic (n=93). Asthenozoospermic samples had 
greater than 20 million spermatozoa/mlbut less than 50% motility (n=53). An other patients 
were classified as having poor semen quality. Se~en samples with less than 20 million 
spermatozoa/ml were classified as oligowospermic(between5 and 20 million sperm/ml) (n=52), 
severely oligowospermic (0.1,5 million sperm/ml) (n=45), or azoospem1ic (no sperm was found 
in the ejaculate) (n=8). None ofthe~e individuals had hypogonadism, cryptorchidism, 
obstructions or infection that might have otherwise explained the observed poor semen' 
parameters. In addition, 98% of samples were examined for deletions within the AZFc region of 
the Y,chromosome (Human STS's sY146, 149,156,157, 158,239,254,269,277) by peR using 
conditions described previously (Kerr et at., 2000) . 
. . 
AR gene analysis 
Sperm DNA was isolated from 200 ILl of semen samples using a standard phenol/chloroform 
, . .' , 
extraction protocol (Holyoake et at., 2001).200 ng of DNA was used to amplify the AR,CAG 
repeat region by polymerase chain reactions (PCR) Using primers specific t6 DNA flanking the 
repeat (forward primer 5'tccagaatctgttccagagcgtgc 3' and reverse primer 5' 
gctgtgaaggttgctgttcctcat 3',Yoshida et at., 1999). PCR analysis was conducted on a MJ Research 
Inc. PTC,100 thermo-cycler. The programme consisted of an initial denaturation at 94°C for 
four minutes followed by 30 cycles of 94°C, 58°C, and noc for one minute each, and a final ten, 
minute extension at n°c. For bNA sequencing an 265 sampl~s were either end-labelled with y 
dCTP 32P (approximately 3000 Ci/mmol) or internally labeled with a dCTP 33P (approximately 
3000 Ci/mmol), and sequenced using a Thermosequenase (Amersham Pharmacia Biotech) or 
Amplicycle (Applied Biosystems) sequencing kit respectively. Samples were run through a 6% 
denaturing polyacrylamide gel at a constant 70W power (approximately 1500V and 45mA) and 
a direct count of CAG repeat number taken. 
Statistical Analysis 
The mean ± standard error of mean (SE) , mode, median, interquartile range (IQR) , and range 
were calculated for each group of men. In addition, the numbers of CAG repeat lengths falling 
outside 1.5 x IQR (~ 15 and ~ 28 repeats based on an IQR of 3 and quartiles oflO and 23 
repeats calculated for the total subfertile population) were compared between men with poor 
semen quality and normozoospermic populations. Multiple comparisons were perfonned to 
test whether groups of men with poor semen quality had significantly greater mean AR,CAG 
repeat lengths compared to normozoospermic men using both one, and two,tailed two,sample t, 
tests (Zar et al. 1996). The null hypothesis was Ho:,usubfertile ~ ,unormozs against 
Ha:,usubfertile > ,unormozs (one tailed) and Ho: ,usubfertile = ,unormozs against Hal ,usubfertile 
-:;t:. ,unonnozs (two, taile d) , p < 0.05. Asthenozoospermic individuals were not included in this 
comparison. 
RESULTS: 
All mean CAG repeat lengths were within one repeat of one another, and of the average normal 
repeatlength for Caucasian men (21 repeats). 
Statistical analysis of AR,CAG repeat length is summarised in Table 1. Mean repeat 
length of each group of men with poor semen quality, and the group as a whole (total subfertile 
population) was compared to the group of normozoospermic men using one, tailed and two,tailed 
two,sample t,tests (Table 1). This indicated that men with poor semen quality did not have a 
significantly different distribution of CAG repeat numbers than men with normal semen quality. 
Azoospermic men had the highest mean CAG repeat length (21. 75 ± 0.86), and men with 
normal semen quality the lowest (20.99 ± 0.28). As the severity of reduced sperm production 
increased (oligozoospermy through to azoospermy), the mean CAG repeat numbers remained 
the same (21.42 ± 0,41 to 21.75 0.86, p> 0.05). However, the group with poor semen quality 
had some members with longer CAG repeat lengths (> 26 repeats) than the maximum length 
observed for normowospermic men. These individuals represented 5% of the total population of 
men with poor semen quality (Table 1). 
AZFc micro deletions were detected in 7.4% (12/163) of men with suboptimal semen 
parameters (two asthenowopsermic men, four oligowospermic men, five severely 
oligowospermic, and one awospermic men) but were not detected in normowospermic men. 
The presence ofY-chormosome microdeletions was not related to AR CAG repeat length. The 
number of AR CAG repeats observed in these men ranged between 12 and repeats with a mean 
oflO.22 ± 1.13 and median ofll repeats. 
DISCUSSION 
Since the correlation between expanded, yet normal AR TNR lengths was suggested to be a 
significant risk factor for reduced sperm production by Tut et al. (1997) and Dowsing et al. 
(1999) many other studies have sought to clarify this association in other popula,tions. We 
found no significant association between poor semen quality and moderate AR-CAG repeat 
(} 
expansion in our analysis of a group of Christchurch men who identify themselves as Caucasian. 
Comparison with other studies indicates that for men with reduced sperm count there is little 
variation in mean CAG repeat number between Caucasian populations (approximately 21.5 - 22 
CAG repeats), where sample sizes are high (Dadze et al., 2000; Mifsud et al., 2001; Wallerand et 
al., 2001; Rajpert-De Meyts et al., 2002; Van Goldeet al., 2002) (Table 2). However, two 
separate studies ofJapanese men revealed slight variation in CAG repeats amongst Awospermic 
men (Yoshida et al., 1999; Sasagawa etal., 2001) (Table 2). This might also suggest that for 
those Caucasian populations where the mean CAG repeat number is greater than 22 repeat 
units the sample size might not be large enough. It appears that different populations may have 
different CAG repeat length distributions. For example, a mean ofl2 repeats in subfertile men 
vs 20.8 in fertile is not significant in a German Caucasian population (Dadze et al., 2000) but 
21.95 repeats vs 20.72 is significant in a Texan Caucasian population (Mifsud et al., 2001). Also, 
the ranges of AR-CAG repeat lengths observed are remarkably shnilar betw~enfertile and 
subfertile populations, usually spanning much of the normal polymorphic range (~-3&rept::,ats). 
Additionally several studies indicate that the population of men with poor semen quality 
are not always the group with the greatest proportion oflong CAG repeat lengths (2:2&), 
proposed by Tut et al. (1997) as being at especially high risk of reduced sperm production 
(Giwercman et al., 1998; Komori et al., 1999). 
In light of these observations it seems unlikely that a small expansion in the AR CAG 
repeat number within the nonnal polymorphic range represents a significant risk factor for 
reduced spenn production in healthy men. 
It is widely accepted that AR-CAG repeat length distribution varies slightly between 
ethnicities, and for this reason recent studies have attempted to analyse predominantly 
homogeneous sample populations. With this in mind we believe it is possible that there may be a 
geographic influence due to genealogy on AR-CAG repeat distribution. Comparison of mean 
CAG repeat length in nonnozoospermic men suggests that the mean length in our New Zealand 
Caucasian population is low compared to that in European Caucasian populations of similar 
sample size (Table 2). This might reflect a 
Polynesian ethnic influence in our sample group's genealogy, although our patients identified 
themselves as of European descent. Other studies have reported a higher mean CAG repeat 
length in Caucasian azoospermic men than observed in their fertile control group. One further 
problem is that most studies had a small sample size for the azoospennic group (e.g. Dowsing et 
al., 1999). We believe that a larger sample size may provide further insights into the relationship 
between the AR-CAG repeat lengths and human male infertility. 
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Table 1. Statistical Characteristics of AR-CAG length 
Fertility 
Mean± SE 
Mode 
pValue 
Q3~Q1= %~lsa o/~8a 
n Range 
Status (Median) IQR CAG's CAG's 
NormoZS 93 20.99±0.28 20(21) 9-26 23-19=4 3% 0% 
Total Suhfertile 105b 21.46±0.30 20(21) 0.126
c 
12-30 23-20=03 2% 5% 0.252d 
AZS 8 21.75±0.86 21(21.5) 0.212c 17-25 23-20=3 0% 0% 0,424d 
Severely OligoZS 45 21.40±0,48 21 (21) 0.207
c 
12-28 24-20=4 4% 4% 0,414d 
OligoZS 52 21.42±0,41 20(21) 0.183
c 
17-30 23-20=3 0% 6% 0.366d 
AsthenoZS 53 21.70±0,47 21 (22) 0.095" 8-26 24-20=4 4% 4% 0.190d 
ZS refers to 'zoospennic' for example, Normozoospennic. 
15' and 28· refer to CAG repeat lengths that for the boundaries 1.5 x 3 (IQR of the total infertile 
population), considered extreme lengths for the distribution. Values represent the proportion of samples 
that fall outside these values. Q1 and Q3 are the lower and upper quartiles, IQR is the interquartile 
range. Total Subfertile Population sizeb does not include Asthenozoospennic samples (n=53) because 
their sperm count is normal (more than 20 x 106 sperm/ml). 
P values were calculated using either a one-tailedc or two-tailedd two-sample t-test with Ho: /Linfertile ~ 
/Lfertile against Ha: /Linfertile > /LfertileC, or Ho: /Linfertile == /Lfertile against Ha: /Linfertile :;t: /Lfertiled. 
Values were considered significant if p < 0.05. 
Table 2. Comparison of population subgroup statistics onAR-CAG length variability, and its association with 
infertility in other studies. 
Fertility Population Mean±SE (N) Range pVALUEa REFERENCE Status Ethnicity CAG's 
Caucasian* 21.75 ± 0.86 (8) 17-25 Not significant This Study 
Caucasian* 23.0 ± 0.63 (16) 19-26 Not significant Patrizio et aI, 2001 
25.40 ± 0.77 (27) 20-39 p =0.0005 (<1x106 spm/ml) 
Caucasian* 23.91 ±O.50(37) Significant Wallerand et at, 2001 
AZS Gemmn 21.4 ± 0.64 (18) 16-26 Not significant Dadze et aI, 2000 
21.9 ± 0.34 (59) 16-29 Not significant (<1x106 spm/ml) 
Caucasian* 24.70 ± 1.0 (10) 20-29 .001< p <.0025 Dowsing et aI, 1999 
US (Texan) 22.91 ± 0.73 (23) 17-31 p =0.019 Mifsud et aI, 2001 Chinese 23.82 ± 0.52 (33) 18-33 p =0.043 
Japanese 23.4± 0.52 (30) 19-30 Not Significant Sasagawa et aI., 2001 
Japanese 26.5 ± 0.54 (41) 20-34 p= 0.0013 Yoshida etal, 1999 
Caucasian* 21.40 ± 0.48 (45) 12-28 Not significant This Study 
Severely Caucasian* 22.20 ± 0.45 (26) 18-26 Not significant Patrizio et al, 2001 
OligoZS Geffilan 22.3 ± 0.80 (29) 16-34 Not significant Dadze et aI, 2000 
Caucasian* 23.0 ± 1.2(13) 15-34 .025<p<.05 Dowsing et aI, 1999 
Caucasian* 21.42 ± 0.42 (52) 17-30 Not significant This Study 
Geffilan 23 ± 0.94 (13) 17-28 Not significant Dadze et aI, 2000 
OligoZS 
Caucasian* 22.0 ± 1.0 (7) 20-27 Not significant Dowsing et aI, 1999 
US (Texan) 21.65 ± 0.34 (72) 14-29 Not significant Mifsud et aI, 2001 Chinese 22.85 ± 0.33 (87) 14-32 Not significant 
Japanese 21.2 ± 0.55 (59) 14-32 Not significant Komori et al, 1999 
Caucasian* 21.46 ± 0.30 (105) 12-30 Not significant This Study 
Dane 21.5 ± 0.26 (119) 15-29 Not significant Rajpert-De Meyts et aI, 2002 
Total Dutch 22.2 ± 0.36 (75) 13-36 Not significant Van Golde et aI, 2002 
Subfertile Caucasian* 23.5 ± 0.41 (69) 18-39 p =0.03 Patrizio etal,2001 
Population German 22 ± 0.29 (119) 16-34 Not significant Dadze et aI, 2000 
Swedish 21.9 (33) 16-27 Not significant Giwercman et al, 1998 
US (Texan) 21.95 ± 0.31 (95) 17-31 p =0.034 Mifsud et aI, 2001 Chinese 23.82 {120~ 18-33 p =0.032 
NormaZS Caucasian* 20.99 ± 0.28 (93) 9-26 This Study 
Dane 21.8 ± 0.32 (110) 14-33 Rajpert-De Meyts et al, 2002 
Dutch 21.7±0,41(70) 15-31 Van Golde et aI, 2002 
Caucasian* 22.0 ± 0.42 (45) 12-30 Patrizio et aI, 2001 
Caucasian* 22.2 ± 0040 (50) Wallerand et al., 2001 
German 20.8 ± 0.70 (22) 15,26 Dadze et 81, 2000 
Caucasian* 20.5 ± 0.3 (32) 17,25 Dowsing et aI, 1999 
Swedish 23.2 (294) 8,30 Giwercman et aI, 1998 
US (Texan) 20.72 ± 0.52 (55) 8,27 Mifsud et aI, 2001 Chinese 22.38 ± 0.32 (87) 11,29 
Japanese 23.7 ± 0044 (51) 17,28 Sasagawa et aL, 2001 
Japanese 21.4 ± 0.58 (36) 16,31 Komori et aI, 1999 
Japanese 23.9 ± 0.42 (48) 17,30 Yoshida et aI, 1999 
(N) indicates the sample size of each fertility classification. 
* indicates that the sample population is predominantly Caucasian in composition. 
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